Background  ||| S:24 E:43 ||| NNP
Differentiation  ||| S:43 E:59 ||| NNP
is  ||| S:59 E:62 ||| VBZ
commonly  ||| S:62 E:71 ||| RB
associated  ||| S:71 E:82 ||| VBN
with  ||| S:82 E:87 ||| IN
intermingled  ||| S:87 E:108 ||| JJ
changes  ||| S:108 E:116 ||| NNS
in  ||| S:116 E:119 ||| IN
gene  ||| S:119 E:124 ||| NN
expression  ||| S:124 E:135 ||| NN
and  ||| S:135 E:139 ||| CC
cellular  ||| S:139 E:148 ||| JJ
proliferation ||| S:148 E:161 ||| NN
.  ||| S:161 E:163 ||| .
In  ||| S:163 E:174 ||| IN
some  ||| S:174 E:179 ||| DT
differentiating  ||| S:179 E:195 ||| JJ
cell  ||| S:195 E:200 ||| NN
types ||| S:200 E:205 ||| NNS
,  ||| S:205 E:207 ||| ,
changes  ||| S:207 E:215 ||| NNS
in  ||| S:215 E:218 ||| IN
both  ||| S:218 E:223 ||| DT
gene  ||| S:223 E:236 ||| NN
transcription  ||| S:236 E:250 ||| NNS
and  ||| S:250 E:254 ||| CC
proliferation  ||| S:254 E:268 ||| NNS
are  ||| S:268 E:272 ||| VBP
regulated  ||| S:272 E:282 ||| VBN
by  ||| S:282 E:285 ||| IN
the  ||| S:285 E:289 ||| DT
same  ||| S:289 E:302 ||| JJ
transcription  ||| S:302 E:316 ||| JJ
factor  ||| S:316 E:323 ||| NN
[  ||| S:323 E:325 ||| -LRB-
1  ||| S:325 E:327 ||| CD
2  ||| S:327 E:329 ||| CD
3  ||| S:329 E:331 ||| CD
4  ||| S:331 E:333 ||| CD
5  ||| S:333 E:335 ||| CD
6  ||| S:335 E:337 ||| CD
7  ||| S:337 E:339 ||| CD
8  ||| S:339 E:341 ||| CD
9  ||| S:341 E:343 ||| CD
]  ||| S:343 E:345 ||| -RRB-
.  ||| S:345 E:347 ||| .
CCAAT ||| S:347 E:352 ||| NNP
/ ||| S:352 E:353 ||| FW
Enhancer  ||| S:353 E:370 ||| FW
Binding  ||| S:370 E:378 ||| FW
Protein  ||| S:378 E:386 ||| FW
alpha  ||| S:386 E:392 ||| FW
( ||| S:392 E:393 ||| -LRB-
C ||| S:393 E:394 ||| NNP
/ ||| S:394 E:395 ||| NNP
EBPα ||| S:395 E:399 ||| NNP
)  ||| S:399 E:401 ||| -RRB-
is  ||| S:401 E:404 ||| VBZ
a  ||| S:404 E:406 ||| DT
transcription  ||| S:406 E:420 ||| JJ
factor  ||| S:420 E:435 ||| NN
that  ||| S:435 E:440 ||| WDT
is  ||| S:440 E:443 ||| VBZ
required  ||| S:443 E:452 ||| VBN
for  ||| S:452 E:456 ||| IN
the  ||| S:456 E:460 ||| DT
differentiation  ||| S:460 E:476 ||| NN
of  ||| S:476 E:479 ||| IN
a  ||| S:479 E:481 ||| DT
number  ||| S:481 E:488 ||| NN
of  ||| S:488 E:499 ||| IN
tissues  ||| S:499 E:507 ||| NNS
[  ||| S:507 E:509 ||| -LRB-
10  ||| S:509 E:512 ||| CD
11  ||| S:512 E:515 ||| CD
12  ||| S:515 E:518 ||| CD
13  ||| S:518 E:521 ||| CD
14  ||| S:521 E:524 ||| CD
15  ||| S:524 E:527 ||| CD
16  ||| S:527 E:530 ||| CD
17  ||| S:530 E:533 ||| CD
18  ||| S:533 E:536 ||| CD
]  ||| S:536 E:538 ||| -RRB-
.  ||| S:538 E:540 ||| .
Mice  ||| S:540 E:545 ||| JJ
homozygous  ||| S:545 E:564 ||| NN
for  ||| S:564 E:568 ||| IN
C ||| S:568 E:569 ||| $
/ ||| S:569 E:570 ||| CD
EBPα  ||| S:570 E:575 ||| JJ
null  ||| S:575 E:580 ||| JJ
alleles  ||| S:580 E:588 ||| NNS
have  ||| S:588 E:593 ||| VBP
severe  ||| S:593 E:600 ||| JJ
defects  ||| S:600 E:608 ||| NNS
in  ||| S:608 E:611 ||| IN
tissues  ||| S:611 E:627 ||| NNS
involved  ||| S:627 E:636 ||| VBN
in  ||| S:636 E:639 ||| IN
metabolic  ||| S:639 E:649 ||| JJ
homeostasis  ||| S:649 E:661 ||| NNS
[  ||| S:661 E:663 ||| -LRB-
19  ||| S:663 E:666 ||| CD
20  ||| S:666 E:669 ||| CD
21  ||| S:669 E:672 ||| CD
]  ||| S:672 E:674 ||| -RRB-
.  ||| S:674 E:676 ||| .
Cellular  ||| S:676 E:693 ||| JJ
proliferation  ||| S:693 E:707 ||| NN
is  ||| S:707 E:710 ||| VBZ
elevated  ||| S:710 E:719 ||| VBN
in  ||| S:719 E:722 ||| IN
the  ||| S:722 E:726 ||| DT
liver  ||| S:726 E:732 ||| NN
of  ||| S:732 E:735 ||| IN
these  ||| S:735 E:741 ||| DT
knockout  ||| S:741 E:758 ||| JJ
mice  ||| S:758 E:763 ||| NNS
[  ||| S:763 E:765 ||| -LRB-
22  ||| S:765 E:768 ||| CD
]  ||| S:768 E:770 ||| -RRB-
suggesting  ||| S:770 E:781 ||| VBG
that  ||| S:781 E:786 ||| IN
C ||| S:786 E:787 ||| $
/ ||| S:787 E:788 ||| CD
EBPα  ||| S:788 E:793 ||| JJ
blocks  ||| S:793 E:800 ||| NNS
proliferation  ||| S:800 E:823 ||| NN
in  ||| S:823 E:826 ||| IN
vivo ||| S:826 E:830 ||| NN
.  ||| S:830 E:832 ||| .
In  ||| S:832 E:835 ||| IN
cultured  ||| S:835 E:844 ||| JJ
cells ||| S:844 E:849 ||| NNS
,  ||| S:849 E:851 ||| ,
C ||| S:851 E:852 ||| NNP
/ ||| S:852 E:853 ||| NNP
EBPα  ||| S:853 E:866 ||| JJ
expression  ||| S:866 E:877 ||| NN
leads  ||| S:877 E:883 ||| VBZ
to  ||| S:883 E:886 ||| TO
decreased  ||| S:886 E:896 ||| VB
colony  ||| S:896 E:903 ||| NN
formation  ||| S:903 E:913 ||| NN
upon  ||| S:913 E:926 ||| IN
antibiotic  ||| S:926 E:937 ||| JJ
selection  ||| S:937 E:947 ||| NN
[  ||| S:947 E:949 ||| -LRB-
23  ||| S:949 E:952 ||| CD
24  ||| S:952 E:955 ||| CD
25  ||| S:955 E:958 ||| CD
]  ||| S:958 E:960 ||| -RRB-
,  ||| S:960 E:962 ||| ,
decreased  ||| S:962 E:972 ||| VBD
DNA  ||| S:972 E:976 ||| NNP
synthesis  ||| S:976 E:994 ||| NNS
[  ||| S:994 E:996 ||| -LRB-
22  ||| S:996 E:999 ||| CD
24  ||| S:999 E:1002 ||| CD
25  ||| S:1002 E:1005 ||| CD
26  ||| S:1005 E:1008 ||| CD
27  ||| S:1008 E:1011 ||| CD
]  ||| S:1011 E:1013 ||| -RRB-
and  ||| S:1013 E:1017 ||| CC
an  ||| S:1017 E:1020 ||| DT
enhanced  ||| S:1020 E:1029 ||| JJ
proportion  ||| S:1029 E:1040 ||| NN
of  ||| S:1040 E:1043 ||| IN
cells  ||| S:1043 E:1049 ||| NNS
in  ||| S:1049 E:1060 ||| IN
the  ||| S:1060 E:1064 ||| DT
G1  ||| S:1064 E:1067 ||| JJ
phase  ||| S:1067 E:1073 ||| NN
of  ||| S:1073 E:1076 ||| IN
the  ||| S:1076 E:1080 ||| DT
cell  ||| S:1080 E:1085 ||| NN
cycle  ||| S:1085 E:1091 ||| NN
[  ||| S:1091 E:1093 ||| -LRB-
26  ||| S:1093 E:1096 ||| CD
]  ||| S:1096 E:1098 ||| -RRB-
.  ||| S:1098 E:1100 ||| .
Thus ||| S:1100 E:1104 ||| RB
,  ||| S:1104 E:1106 ||| ,
C ||| S:1106 E:1107 ||| NNP
/ ||| S:1107 E:1108 ||| NNP
EBPα  ||| S:1108 E:1121 ||| NNP
regulates  ||| S:1121 E:1131 ||| VBZ
cellular  ||| S:1131 E:1140 ||| JJ
proliferation ||| S:1140 E:1153 ||| NN
,  ||| S:1153 E:1155 ||| ,
as  ||| S:1155 E:1158 ||| RB
well  ||| S:1158 E:1163 ||| RB
as  ||| S:1163 E:1166 ||| IN
gene  ||| S:1166 E:1179 ||| NN
transcription ||| S:1179 E:1192 ||| NN
.  ||| S:1192 E:1202 ||| .
C ||| S:1202 E:1203 ||| SYM
/ ||| S:1203 E:1204 ||| FW
EBPα  ||| S:1204 E:1209 ||| FW
contains  ||| S:1209 E:1218 ||| VBZ
a  ||| S:1218 E:1220 ||| DT
bZIP  ||| S:1220 E:1225 ||| JJ
domain  ||| S:1225 E:1232 ||| NN
conserved  ||| S:1232 E:1242 ||| NN
at  ||| S:1242 E:1245 ||| IN
the  ||| S:1245 E:1249 ||| DT
carboxy  ||| S:1249 E:1265 ||| JJ
terminus  ||| S:1265 E:1274 ||| NN
of  ||| S:1274 E:1277 ||| IN
a  ||| S:1277 E:1279 ||| DT
number  ||| S:1279 E:1286 ||| NN
of  ||| S:1286 E:1289 ||| IN
transcription  ||| S:1289 E:1303 ||| JJ
factors  ||| S:1303 E:1311 ||| NNS
[  ||| S:1311 E:1313 ||| -LRB-
12  ||| S:1313 E:1316 ||| CD
28  ||| S:1316 E:1319 ||| CD
]  ||| S:1319 E:1321 ||| -RRB-
.  ||| S:1321 E:1331 ||| .
The  ||| S:1331 E:1335 ||| DT
bZIP  ||| S:1335 E:1340 ||| JJ
domain  ||| S:1340 E:1347 ||| NN
consists  ||| S:1347 E:1356 ||| VBZ
of  ||| S:1356 E:1359 ||| IN
a  ||| S:1359 E:1361 ||| DT
basic  ||| S:1361 E:1367 ||| JJ
region  ||| S:1367 E:1374 ||| NN
that  ||| S:1374 E:1379 ||| WDT
binds  ||| S:1379 E:1393 ||| VBP
directly  ||| S:1393 E:1402 ||| RB
to  ||| S:1402 E:1405 ||| TO
DNA ||| S:1405 E:1408 ||| NNP
,  ||| S:1408 E:1410 ||| ,
followed  ||| S:1410 E:1419 ||| VBD
immediately  ||| S:1419 E:1431 ||| RB
by  ||| S:1431 E:1434 ||| IN
a  ||| S:1434 E:1436 ||| DT
leucine  ||| S:1436 E:1444 ||| JJ
zipper ||| S:1444 E:1450 ||| NN
.  ||| S:1450 E:1460 ||| .
C ||| S:1460 E:1461 ||| SYM
/ ||| S:1461 E:1462 ||| CD
EBPα  ||| S:1462 E:1467 ||| JJ
dimerizes  ||| S:1467 E:1477 ||| NN
via  ||| S:1477 E:1481 ||| IN
the  ||| S:1481 E:1485 ||| DT
leucine  ||| S:1485 E:1493 ||| JJ
zipper ||| S:1493 E:1499 ||| NN
.  ||| S:1499 E:1501 ||| .
This  ||| S:1501 E:1506 ||| DT
dimerization  ||| S:1506 E:1527 ||| NN
is  ||| S:1527 E:1530 ||| VBZ
required  ||| S:1530 E:1539 ||| VBN
for  ||| S:1539 E:1543 ||| IN
DNA  ||| S:1543 E:1547 ||| NNP
binding  ||| S:1547 E:1555 ||| NNS
[  ||| S:1555 E:1557 ||| -LRB-
28  ||| S:1557 E:1560 ||| CD
29  ||| S:1560 E:1563 ||| CD
]  ||| S:1563 E:1565 ||| -RRB-
.  ||| S:1565 E:1567 ||| .
At  ||| S:1567 E:1570 ||| IN
least  ||| S:1570 E:1576 ||| JJS
three  ||| S:1576 E:1590 ||| CD
transcription  ||| S:1590 E:1604 ||| CD
activation  ||| S:1604 E:1615 ||| CD
functions  ||| S:1615 E:1625 ||| NNS
have  ||| S:1625 E:1630 ||| VBP
been  ||| S:1630 E:1635 ||| VBN
described  ||| S:1635 E:1645 ||| VBN
in  ||| S:1645 E:1656 ||| IN
the  ||| S:1656 E:1660 ||| DT
more  ||| S:1660 E:1665 ||| RBR
amino  ||| S:1665 E:1671 ||| JJ
terminal  ||| S:1671 E:1680 ||| NN
regions  ||| S:1680 E:1688 ||| NNS
of  ||| S:1688 E:1691 ||| IN
C ||| S:1691 E:1692 ||| NNP
/ ||| S:1692 E:1693 ||| NNP
EBPα  ||| S:1693 E:1698 ||| NNP
[  ||| S:1698 E:1700 ||| -LRB-
30  ||| S:1700 E:1703 ||| CD
31  ||| S:1703 E:1706 ||| CD
32  ||| S:1706 E:1709 ||| CD
]  ||| S:1709 E:1711 ||| -RRB-
.  ||| S:1711 E:1721 ||| .
C ||| S:1721 E:1722 ||| SYM
/ ||| S:1722 E:1723 ||| FW
EBPα  ||| S:1723 E:1728 ||| FW
domains  ||| S:1728 E:1736 ||| FW
and  ||| S:1736 E:1740 ||| CC
activities  ||| S:1740 E:1751 ||| NNS
associated  ||| S:1751 E:1762 ||| VBN
with  ||| S:1762 E:1767 ||| IN
proliferation  ||| S:1767 E:1789 ||| NN
arrest  ||| S:1789 E:1796 ||| NN
also  ||| S:1796 E:1801 ||| RB
have  ||| S:1801 E:1806 ||| VBP
been  ||| S:1806 E:1811 ||| VBN
identified ||| S:1811 E:1821 ||| VBN
,  ||| S:1821 E:1823 ||| ,
but  ||| S:1823 E:1827 ||| CC
vary  ||| S:1827 E:1832 ||| VBP
considerably  ||| S:1832 E:1853 ||| RB
between  ||| S:1853 E:1861 ||| IN
studies  ||| S:1861 E:1869 ||| NNS
[  ||| S:1869 E:1871 ||| -LRB-
23  ||| S:1871 E:1874 ||| CD
25  ||| S:1874 E:1877 ||| CD
33  ||| S:1877 E:1880 ||| CD
34  ||| S:1880 E:1883 ||| CD
35  ||| S:1883 E:1886 ||| CD
36  ||| S:1886 E:1889 ||| CD
]  ||| S:1889 E:1891 ||| -RRB-
.  ||| S:1891 E:1901 ||| .
C ||| S:1901 E:1902 ||| SYM
/ ||| S:1902 E:1903 ||| FW
EBPα  ||| S:1903 E:1908 ||| FW
binds  ||| S:1908 E:1914 ||| FW
to  ||| S:1914 E:1917 ||| TO
and  ||| S:1917 E:1921 ||| CC
activates  ||| S:1921 E:1931 ||| JJ
transcription  ||| S:1931 E:1945 ||| NN
of  ||| S:1945 E:1948 ||| IN
the  ||| S:1948 E:1952 ||| DT
gene  ||| S:1952 E:1965 ||| NN
promoter  ||| S:1965 E:1974 ||| NN
for  ||| S:1974 E:1978 ||| IN
the  ||| S:1978 E:1982 ||| DT
p21  ||| S:1982 E:1986 ||| JJ
inhibitor  ||| S:1986 E:1996 ||| NN
of  ||| S:1996 E:1999 ||| IN
cyclin-dependent  ||| S:1999 E:2016 ||| JJ
kinase  ||| S:2016 E:2031 ||| NNS
( ||| S:2031 E:2032 ||| -LRB-
CDK ||| S:2032 E:2035 ||| NNP
)  ||| S:2035 E:2037 ||| -RRB-
[  ||| S:2037 E:2039 ||| -LRB-
37  ||| S:2039 E:2042 ||| CD
]  ||| S:2042 E:2044 ||| -RRB-
.  ||| S:2044 E:2046 ||| .
This  ||| S:2046 E:2051 ||| DT
led  ||| S:2051 E:2055 ||| VBN
to  ||| S:2055 E:2058 ||| TO
speculation  ||| S:2058 E:2070 ||| NN
that  ||| S:2070 E:2075 ||| IN
p21  ||| S:2075 E:2079 ||| CD
gene  ||| S:2079 E:2092 ||| NN
activation  ||| S:2092 E:2103 ||| NNS
may  ||| S:2103 E:2107 ||| MD
contribute  ||| S:2107 E:2118 ||| VB
to  ||| S:2118 E:2121 ||| TO
cell  ||| S:2121 E:2126 ||| NN
cycle  ||| S:2126 E:2132 ||| NN
arrest  ||| S:2132 E:2139 ||| NN
by  ||| S:2139 E:2142 ||| IN
C ||| S:2142 E:2143 ||| NNP
/ ||| S:2143 E:2144 ||| NNP
EBPα  ||| S:2144 E:2149 ||| NNP
[  ||| S:2149 E:2159 ||| -LRB-
37  ||| S:2159 E:2162 ||| CD
]  ||| S:2162 E:2164 ||| -RRB-
.  ||| S:2164 E:2166 ||| .
Similarly ||| S:2166 E:2175 ||| RB
,  ||| S:2175 E:2177 ||| ,
suppression  ||| S:2177 E:2189 ||| NN
of  ||| S:2189 E:2192 ||| IN
mitotic  ||| S:2192 E:2200 ||| JJ
growth  ||| S:2200 E:2207 ||| NN
during  ||| S:2207 E:2222 ||| IN
adipocyte  ||| S:2222 E:2232 ||| JJ
differentiation  ||| S:2232 E:2248 ||| NN
was  ||| S:2248 E:2252 ||| VBD
associated  ||| S:2252 E:2263 ||| VBN
with  ||| S:2263 E:2268 ||| IN
C ||| S:2268 E:2269 ||| $
/ ||| S:2269 E:2270 ||| CD
EBPα  ||| S:2270 E:2283 ||| JJ
activation  ||| S:2283 E:2294 ||| NN
of  ||| S:2294 E:2297 ||| IN
the  ||| S:2297 E:2301 ||| DT
promoters  ||| S:2301 E:2311 ||| NNS
of  ||| S:2311 E:2314 ||| IN
gadd45  ||| S:2314 E:2321 ||| NNP
( ||| S:2321 E:2322 ||| -LRB-
growth  ||| S:2322 E:2329 ||| NN
arrest  ||| S:2329 E:2336 ||| NN
and  ||| S:2336 E:2348 ||| CC
DNA  ||| S:2348 E:2352 ||| NNP
damage-inducible  ||| S:2352 E:2369 ||| JJ
gene  ||| S:2369 E:2374 ||| NN
45 ||| S:2374 E:2376 ||| CD
) ||| S:2376 E:2377 ||| -RRB-
,  ||| S:2377 E:2379 ||| ,
gas2  ||| S:2379 E:2384 ||| NNP
and  ||| S:2384 E:2388 ||| CC
gas3  ||| S:2388 E:2393 ||| NNP
( ||| S:2393 E:2394 ||| -LRB-
growth  ||| S:2394 E:2409 ||| NN
arrest-associated  ||| S:2409 E:2427 ||| JJ
genes  ||| S:2427 E:2433 ||| NNS
2  ||| S:2433 E:2435 ||| CD
and  ||| S:2435 E:2439 ||| CC
3 ||| S:2439 E:2440 ||| LS
)  ||| S:2440 E:2442 ||| -RRB-
[  ||| S:2442 E:2444 ||| -LRB-
5  ||| S:2444 E:2446 ||| CD
6  ||| S:2446 E:2448 ||| CD
38  ||| S:2448 E:2451 ||| CD
39  ||| S:2451 E:2454 ||| CD
]  ||| S:2454 E:2456 ||| -RRB-
.  ||| S:2456 E:2458 ||| .
However ||| S:2458 E:2465 ||| RB
,  ||| S:2465 E:2475 ||| ,
C ||| S:2475 E:2476 ||| NNP
/ ||| S:2476 E:2477 ||| NNP
EBPα  ||| S:2477 E:2482 ||| NNP
mutants  ||| S:2482 E:2490 ||| VBD
defective  ||| S:2490 E:2500 ||| JJ
in  ||| S:2500 E:2503 ||| IN
DNA  ||| S:2503 E:2507 ||| NNP
binding  ||| S:2507 E:2515 ||| VBD
still  ||| S:2515 E:2521 ||| RB
blocked  ||| S:2521 E:2537 ||| VBN
proliferation  ||| S:2537 E:2551 ||| NN
[  ||| S:2551 E:2553 ||| -LRB-
25  ||| S:2553 E:2556 ||| CD
33  ||| S:2556 E:2559 ||| CD
]  ||| S:2559 E:2561 ||| -RRB-
.  ||| S:2561 E:2563 ||| .
This  ||| S:2563 E:2568 ||| DT
suggested  ||| S:2568 E:2578 ||| VBN
that  ||| S:2578 E:2583 ||| IN
direct  ||| S:2583 E:2598 ||| JJ
promoter  ||| S:2598 E:2607 ||| NN
activation  ||| S:2607 E:2618 ||| NNS
was  ||| S:2618 E:2622 ||| VBD
unnecessary ||| S:2622 E:2633 ||| JJ
,  ||| S:2633 E:2635 ||| ,
or  ||| S:2635 E:2638 ||| CC
redundant ||| S:2638 E:2647 ||| NN
,  ||| S:2647 E:2649 ||| ,
for  ||| S:2649 E:2661 ||| IN
C ||| S:2661 E:2662 ||| $
/ ||| S:2662 E:2663 ||| CD
EBPα  ||| S:2663 E:2668 ||| JJ
proliferation  ||| S:2668 E:2682 ||| NN
arrest  ||| S:2682 E:2689 ||| NN
[  ||| S:2689 E:2691 ||| -LRB-
18  ||| S:2691 E:2694 ||| CD
]  ||| S:2694 E:2696 ||| -RRB-
.  ||| S:2696 E:2706 ||| .
Possible  ||| S:2706 E:2715 ||| JJ
mechanisms  ||| S:2715 E:2726 ||| NNS
of  ||| S:2726 E:2729 ||| IN
transcription-independent  ||| S:2729 E:2763 ||| JJ
proliferation  ||| S:2763 E:2777 ||| NN
arrest  ||| S:2777 E:2784 ||| NN
by  ||| S:2784 E:2787 ||| IN
C ||| S:2787 E:2788 ||| $
/ ||| S:2788 E:2789 ||| CD
EBPα  ||| S:2789 E:2794 ||| NNS
have  ||| S:2794 E:2799 ||| VBP
been  ||| S:2799 E:2804 ||| VBN
suggested  ||| S:2804 E:2814 ||| VBN
by  ||| S:2814 E:2817 ||| IN
a  ||| S:2817 E:2827 ||| DT
number  ||| S:2827 E:2834 ||| NN
of  ||| S:2834 E:2837 ||| IN
studies ||| S:2837 E:2844 ||| NNS
.  ||| S:2844 E:2846 ||| .
Decreased  ||| S:2846 E:2856 ||| JJ
proliferation  ||| S:2856 E:2870 ||| NN
was  ||| S:2870 E:2874 ||| VBD
associated  ||| S:2874 E:2893 ||| VBN
with  ||| S:2893 E:2898 ||| IN
C ||| S:2898 E:2899 ||| $
/ ||| S:2899 E:2900 ||| CD
EBPα  ||| S:2900 E:2905 ||| JJ
stabilization  ||| S:2905 E:2919 ||| NN
of  ||| S:2919 E:2922 ||| IN
the  ||| S:2922 E:2926 ||| DT
p21  ||| S:2926 E:2930 ||| JJ
protein  ||| S:2930 E:2938 ||| NN
[  ||| S:2938 E:2940 ||| -LRB-
22  ||| S:2940 E:2943 ||| CD
24  ||| S:2943 E:2946 ||| CD
]  ||| S:2946 E:2948 ||| -RRB-
.  ||| S:2948 E:2958 ||| .
p21  ||| S:2958 E:2962 ||| SYM
interacted  ||| S:2962 E:2973 ||| VBZ
directly  ||| S:2973 E:2982 ||| RB
with  ||| S:2982 E:2987 ||| IN
a  ||| S:2987 E:2989 ||| DT
large  ||| S:2989 E:2995 ||| JJ
internal  ||| S:2995 E:3004 ||| JJ
segment  ||| S:3004 E:3012 ||| NN
of  ||| S:3012 E:3023 ||| IN
C ||| S:3023 E:3024 ||| $
/ ||| S:3024 E:3025 ||| CD
EBPα  ||| S:3025 E:3030 ||| NN
that  ||| S:3030 E:3035 ||| WDT
included  ||| S:3035 E:3044 ||| VBD
transcription  ||| S:3044 E:3058 ||| JJ
activation  ||| S:3058 E:3069 ||| JJ
domain  ||| S:3069 E:3076 ||| NN
3  ||| S:3076 E:3078 ||| CD
[  ||| S:3078 E:3080 ||| -LRB-
25  ||| S:3080 E:3091 ||| CD
]  ||| S:3091 E:3093 ||| -RRB-
( ||| S:3093 E:3094 ||| -LRB-
see  ||| S:3094 E:3098 ||| VB
Fig.  ||| S:3098 E:3103 ||| CD
1A ||| S:3103 E:3105 ||| CD
) ||| S:3105 E:3106 ||| -RRB-
.  ||| S:3106 E:3108 ||| .
CDK2  ||| S:3108 E:3113 ||| NNP
and  ||| S:3113 E:3117 ||| CC
CDK4  ||| S:3117 E:3122 ||| NNP
also  ||| S:3122 E:3127 ||| RB
interacted  ||| S:3127 E:3138 ||| VBN
with  ||| S:3138 E:3151 ||| IN
segments  ||| S:3151 E:3160 ||| NNS
of  ||| S:3160 E:3163 ||| IN
C ||| S:3163 E:3164 ||| $
/ ||| S:3164 E:3165 ||| CD
EBPα  ||| S:3165 E:3170 ||| JJ
close  ||| S:3170 E:3176 ||| NN
to ||| S:3176 E:3178 ||| TO
,  ||| S:3178 E:3180 ||| ,
and  ||| S:3180 E:3184 ||| CC
within ||| S:3184 E:3190 ||| IN
,  ||| S:3190 E:3192 ||| ,
transcription  ||| S:3192 E:3214 ||| JJ
activation  ||| S:3214 E:3225 ||| JJ
domain  ||| S:3225 E:3232 ||| NN
3  ||| S:3232 E:3234 ||| CD
[  ||| S:3234 E:3236 ||| -LRB-
36  ||| S:3236 E:3239 ||| CD
]  ||| S:3239 E:3241 ||| -RRB-
.  ||| S:3241 E:3243 ||| .
CDK2  ||| S:3243 E:3248 ||| NNP
also  ||| S:3248 E:3253 ||| RB
interacted  ||| S:3253 E:3264 ||| VBN
with  ||| S:3264 E:3269 ||| IN
the  ||| S:3269 E:3281 ||| DT
basic  ||| S:3281 E:3287 ||| JJ
region  ||| S:3287 E:3294 ||| NN
of  ||| S:3294 E:3297 ||| IN
the  ||| S:3297 E:3301 ||| DT
C ||| S:3301 E:3302 ||| NNP
/ ||| S:3302 E:3303 ||| NNP
EBPα  ||| S:3303 E:3308 ||| NNP
[  ||| S:3308 E:3310 ||| -LRB-
25  ||| S:3310 E:3313 ||| CD
]  ||| S:3313 E:3315 ||| -RRB-
.  ||| S:3315 E:3317 ||| .
p21  ||| S:3317 E:3321 ||| SYM
also  ||| S:3321 E:3326 ||| RB
has  ||| S:3326 E:3330 ||| VBZ
a  ||| S:3330 E:3332 ||| DT
second  ||| S:3332 E:3347 ||| JJ
interaction  ||| S:3347 E:3359 ||| JJ
site ||| S:3359 E:3363 ||| NN
,  ||| S:3363 E:3365 ||| ,
within  ||| S:3365 E:3372 ||| IN
the  ||| S:3372 E:3376 ||| DT
leucine  ||| S:3376 E:3384 ||| JJ
zipper  ||| S:3384 E:3391 ||| NN
of  ||| S:3391 E:3394 ||| IN
C ||| S:3394 E:3395 ||| NNP
/ ||| S:3395 E:3396 ||| NNP
EBPα  ||| S:3396 E:3401 ||| NNP
[  ||| S:3401 E:3403 ||| -LRB-
25  ||| S:3403 E:3414 ||| CD
]  ||| S:3414 E:3416 ||| -RRB-
.  ||| S:3416 E:3427 ||| .
in  ||| S:3427 E:3430 ||| IN
vitro ||| S:3430 E:3435 ||| NN
,  ||| S:3435 E:3437 ||| ,
C ||| S:3437 E:3438 ||| NNP
/ ||| S:3438 E:3439 ||| NNP
EBPα  ||| S:3439 E:3444 ||| NNP
enhanced  ||| S:3444 E:3453 ||| VBD
p21  ||| S:3453 E:3465 ||| CD
inhibition  ||| S:3465 E:3476 ||| NN
of  ||| S:3476 E:3479 ||| IN
CDK2  ||| S:3479 E:3484 ||| CD
activity ||| S:3484 E:3492 ||| NN
.  ||| S:3492 E:3494 ||| .
C ||| S:3494 E:3495 ||| SYM
/ ||| S:3495 E:3496 ||| CD
EBPα  ||| S:3496 E:3501 ||| JJ
inhibition  ||| S:3501 E:3512 ||| NN
of  ||| S:3512 E:3515 ||| IN
CDK2  ||| S:3515 E:3528 ||| CD
activity  ||| S:3528 E:3537 ||| NN
correlated  ||| S:3537 E:3548 ||| NN
with  ||| S:3548 E:3553 ||| IN
p21  ||| S:3553 E:3557 ||| CD
binding  ||| S:3557 E:3565 ||| NN
to  ||| S:3565 E:3568 ||| TO
C ||| S:3568 E:3569 ||| $
/ ||| S:3569 E:3570 ||| CD
EBPα  ||| S:3570 E:3583 ||| JJ
transcription  ||| S:3583 E:3597 ||| JJ
activation  ||| S:3597 E:3608 ||| JJ
domain  ||| S:3608 E:3615 ||| NN
3  ||| S:3615 E:3617 ||| CD
[  ||| S:3617 E:3619 ||| -LRB-
25  ||| S:3619 E:3622 ||| CD
]  ||| S:3622 E:3624 ||| -RRB-
.  ||| S:3624 E:3626 ||| .
However ||| S:3626 E:3633 ||| RB
,  ||| S:3633 E:3643 ||| ,
proliferation  ||| S:3643 E:3657 ||| NN
arrest  ||| S:3657 E:3664 ||| NN
by  ||| S:3664 E:3667 ||| IN
C ||| S:3667 E:3668 ||| NNP
/ ||| S:3668 E:3669 ||| NNP
EBPα  ||| S:3669 E:3674 ||| NNP
still  ||| S:3674 E:3680 ||| RB
occurred  ||| S:3680 E:3689 ||| VBN
in  ||| S:3689 E:3692 ||| IN
cell  ||| S:3692 E:3697 ||| NN
lines  ||| S:3697 E:3711 ||| NNS
not  ||| S:3711 E:3715 ||| RB
containing  ||| S:3715 E:3726 ||| VBG
p21  ||| S:3726 E:3730 ||| CD
genes  ||| S:3730 E:3736 ||| NNS
[  ||| S:3736 E:3738 ||| -LRB-
40  ||| S:3738 E:3741 ||| CD
]  ||| S:3741 E:3743 ||| -RRB-
.  ||| S:3743 E:3745 ||| .
This  ||| S:3745 E:3750 ||| DT
indicated  ||| S:3750 E:3760 ||| VBN
that  ||| S:3760 E:3773 ||| IN
proliferation  ||| S:3773 E:3787 ||| NN
arrest  ||| S:3787 E:3794 ||| NN
by  ||| S:3794 E:3797 ||| IN
C ||| S:3797 E:3798 ||| NNP
/ ||| S:3798 E:3799 ||| NNP
EBPα  ||| S:3799 E:3804 ||| NNP
did  ||| S:3804 E:3808 ||| VBD
not  ||| S:3808 E:3812 ||| RB
rely  ||| S:3812 E:3817 ||| VB
solely  ||| S:3817 E:3824 ||| RB
upon  ||| S:3824 E:3837 ||| IN
C ||| S:3837 E:3838 ||| $
/ ||| S:3838 E:3839 ||| CD
EBPα  ||| S:3839 E:3844 ||| JJ
enhancement  ||| S:3844 E:3856 ||| NN
of  ||| S:3856 E:3859 ||| IN
CDK  ||| S:3859 E:3863 ||| NNP
inhibition  ||| S:3863 E:3874 ||| NN
by  ||| S:3874 E:3877 ||| IN
p21 ||| S:3877 E:3880 ||| CD
.  ||| S:3880 E:3890 ||| .
Another  ||| S:3890 E:3898 ||| DT
mechanism  ||| S:3898 E:3908 ||| NN
reported  ||| S:3908 E:3917 ||| VBD
for  ||| S:3917 E:3921 ||| IN
proliferation  ||| S:3921 E:3935 ||| NN
blockage  ||| S:3935 E:3944 ||| NN
by  ||| S:3944 E:3955 ||| IN
C ||| S:3955 E:3956 ||| NNP
/ ||| S:3956 E:3957 ||| NNP
EBPα  ||| S:3957 E:3962 ||| NNP
involves  ||| S:3962 E:3971 ||| VBZ
the  ||| S:3971 E:3975 ||| DT
E2F-DP1  ||| S:3975 E:3983 ||| CD
transcription  ||| S:3983 E:3997 ||| CD
complexes ||| S:3997 E:4006 ||| NNS
.  ||| S:4006 E:4008 ||| .
E2F  ||| S:4008 E:4020 ||| NNP
complexes  ||| S:4020 E:4030 ||| NNS
activate  ||| S:4030 E:4039 ||| VBP
genes  ||| S:4039 E:4045 ||| NNS
required  ||| S:4045 E:4054 ||| VBN
for  ||| S:4054 E:4058 ||| IN
entry  ||| S:4058 E:4064 ||| NN
into  ||| S:4064 E:4069 ||| IN
S  ||| S:4069 E:4071 ||| NNP
phase ||| S:4071 E:4076 ||| NN
.  ||| S:4076 E:4086 ||| .
C ||| S:4086 E:4087 ||| SYM
/ ||| S:4087 E:4088 ||| FW
EBPα  ||| S:4088 E:4093 ||| FW
binds  ||| S:4093 E:4099 ||| FW
to  ||| S:4099 E:4102 ||| TO
and  ||| S:4102 E:4106 ||| CC
inhibits  ||| S:4106 E:4115 ||| JJ
transcriptional  ||| S:4115 E:4131 ||| JJ
activation  ||| S:4131 E:4142 ||| NN
by  ||| S:4142 E:4153 ||| IN
E2F  ||| S:4153 E:4157 ||| NNP
[  ||| S:4157 E:4159 ||| -LRB-
26  ||| S:4159 E:4162 ||| CD
33  ||| S:4162 E:4165 ||| CD
]  ||| S:4165 E:4167 ||| -RRB-
.  ||| S:4167 E:4169 ||| .
The  ||| S:4169 E:4173 ||| DT
complex  ||| S:4173 E:4181 ||| NN
of  ||| S:4181 E:4184 ||| IN
E2F  ||| S:4184 E:4188 ||| CD
with  ||| S:4188 E:4193 ||| IN
the  ||| S:4193 E:4205 ||| DT
retinoblastoma-related  ||| S:4205 E:4228 ||| JJ
p107  ||| S:4228 E:4233 ||| CD
protein  ||| S:4233 E:4241 ||| NN
is  ||| S:4241 E:4244 ||| VBZ
prevalent  ||| S:4244 E:4254 ||| VBN
in  ||| S:4254 E:4257 ||| IN
cycling  ||| S:4257 E:4273 ||| JJ
cells ||| S:4273 E:4278 ||| NNS
.  ||| S:4278 E:4280 ||| .
Transcription  ||| S:4280 E:4294 ||| JJ
activation  ||| S:4294 E:4305 ||| JJ
domain  ||| S:4305 E:4312 ||| NN
2  ||| S:4312 E:4314 ||| CD
of  ||| S:4314 E:4317 ||| IN
C ||| S:4317 E:4318 ||| NNP
/ ||| S:4318 E:4319 ||| NNP
EBPα  ||| S:4319 E:4324 ||| NNP
was  ||| S:4324 E:4336 ||| VBD
observed  ||| S:4336 E:4345 ||| VBN
to  ||| S:4345 E:4348 ||| TO
interact  ||| S:4348 E:4357 ||| VB
specifically  ||| S:4357 E:4370 ||| RB
with  ||| S:4370 E:4375 ||| IN
p107  ||| S:4375 E:4380 ||| CD
to  ||| S:4380 E:4383 ||| TO
disrupt  ||| S:4383 E:4399 ||| VB
p107 ||| S:4399 E:4403 ||| CD
/ ||| S:4403 E:4404 ||| CD
E2F  ||| S:4404 E:4408 ||| CD
complex  ||| S:4408 E:4416 ||| JJ
formation  ||| S:4416 E:4426 ||| NN
[  ||| S:4426 E:4428 ||| -LRB-
34  ||| S:4428 E:4431 ||| CD
35  ||| S:4431 E:4434 ||| CD
]  ||| S:4434 E:4436 ||| -RRB-
.  ||| S:4436 E:4438 ||| .
Disruption  ||| S:4438 E:4449 ||| NN
of  ||| S:4449 E:4452 ||| IN
E2F  ||| S:4452 E:4464 ||| CD
activity  ||| S:4464 E:4473 ||| NN
also  ||| S:4473 E:4478 ||| RB
was  ||| S:4478 E:4482 ||| VBD
associated  ||| S:4482 E:4493 ||| VBN
the  ||| S:4493 E:4497 ||| DT
basic  ||| S:4497 E:4503 ||| JJ
domain  ||| S:4503 E:4510 ||| NN
of  ||| S:4510 E:4513 ||| IN
C ||| S:4513 E:4514 ||| NNP
/ ||| S:4514 E:4515 ||| NNP
EBPα  ||| S:4515 E:4520 ||| NNP
[  ||| S:4520 E:4530 ||| -LRB-
33  ||| S:4530 E:4533 ||| CD
34  ||| S:4533 E:4536 ||| CD
]  ||| S:4536 E:4538 ||| -RRB-
.  ||| S:4538 E:4548 ||| .
Thus ||| S:4548 E:4552 ||| RB
,  ||| S:4552 E:4554 ||| ,
a  ||| S:4554 E:4556 ||| DT
variety  ||| S:4556 E:4564 ||| NN
of  ||| S:4564 E:4567 ||| IN
interactions  ||| S:4567 E:4580 ||| NNS
and  ||| S:4580 E:4584 ||| CC
mechanisms  ||| S:4584 E:4595 ||| NNS
are  ||| S:4595 E:4607 ||| VBP
potentially  ||| S:4607 E:4619 ||| RB
involved  ||| S:4619 E:4628 ||| VBN
in  ||| S:4628 E:4631 ||| IN
proliferation  ||| S:4631 E:4645 ||| NN
arrest  ||| S:4645 E:4652 ||| NN
by  ||| S:4652 E:4655 ||| IN
C ||| S:4655 E:4656 ||| NNP
/ ||| S:4656 E:4657 ||| NNP
EBPα ||| S:4657 E:4661 ||| NNP
.  ||| S:4661 E:4671 ||| .
This  ||| S:4671 E:4676 ||| DT
variability  ||| S:4676 E:4688 ||| NN
may  ||| S:4688 E:4692 ||| MD
indicate  ||| S:4692 E:4701 ||| VB
divergent  ||| S:4701 E:4711 ||| JJ
mechanisms  ||| S:4711 E:4722 ||| NNS
for  ||| S:4722 E:4726 ||| IN
the  ||| S:4726 E:4738 ||| DT
block  ||| S:4738 E:4744 ||| NN
of  ||| S:4744 E:4747 ||| IN
proliferation  ||| S:4747 E:4761 ||| NN
by  ||| S:4761 E:4764 ||| IN
C ||| S:4764 E:4765 ||| $
/ ||| S:4765 E:4766 ||| CD
EBPα  ||| S:4766 E:4771 ||| NN
in  ||| S:4771 E:4774 ||| IN
different  ||| S:4774 E:4784 ||| JJ
study  ||| S:4784 E:4798 ||| NN
conditions  ||| S:4798 E:4809 ||| NNS
and ||| S:4809 E:4812 ||| CC
/ ||| S:4812 E:4813 ||| NNP
or  ||| S:4813 E:4816 ||| CC
cell  ||| S:4816 E:4821 ||| NN
types ||| S:4821 E:4826 ||| NNS
.  ||| S:4826 E:4828 ||| .
In  ||| S:4828 E:4831 ||| IN
pituitary  ||| S:4831 E:4841 ||| JJ
cells ||| S:4841 E:4846 ||| NNS
,  ||| S:4846 E:4848 ||| ,
C ||| S:4848 E:4849 ||| NNP
/ ||| S:4849 E:4850 ||| NNP
EBPα  ||| S:4850 E:4855 ||| NNP
is  ||| S:4855 E:4866 ||| VBZ
part  ||| S:4866 E:4871 ||| NN
of  ||| S:4871 E:4874 ||| IN
a  ||| S:4874 E:4876 ||| DT
multi-subunit  ||| S:4876 E:4890 ||| JJ
complex  ||| S:4890 E:4898 ||| NN
[  ||| S:4898 E:4900 ||| -LRB-
41  ||| S:4900 E:4903 ||| CD
42  ||| S:4903 E:4906 ||| CD
]  ||| S:4906 E:4908 ||| -RRB-
that  ||| S:4908 E:4913 ||| WDT
activates  ||| S:4913 E:4931 ||| VBZ
the  ||| S:4931 E:4935 ||| DT
growth  ||| S:4935 E:4942 ||| NN
hormone  ||| S:4942 E:4950 ||| NN
[  ||| S:4950 E:4952 ||| -LRB-
42  ||| S:4952 E:4955 ||| CD
]  ||| S:4955 E:4957 ||| -RRB-
and  ||| S:4957 E:4961 ||| CC
prolactin  ||| S:4961 E:4971 ||| NNS
[  ||| S:4971 E:4973 ||| -LRB-
43  ||| S:4973 E:4976 ||| CD
44  ||| S:4976 E:4979 ||| CD
]  ||| S:4979 E:4989 ||| -RRB-
promoters ||| S:4989 E:4998 ||| NNS
.  ||| S:4998 E:5000 ||| .
Full-length  ||| S:5000 E:5012 ||| JJ
C ||| S:5012 E:5013 ||| NNP
/ ||| S:5013 E:5014 ||| NNP
EBPα  ||| S:5014 E:5019 ||| NNP
is  ||| S:5019 E:5022 ||| VBZ
absent  ||| S:5022 E:5029 ||| VBN
from  ||| S:5029 E:5034 ||| IN
the  ||| S:5034 E:5038 ||| DT
pituitary  ||| S:5038 E:5056 ||| JJ
progenitor  ||| S:5056 E:5067 ||| NN
GHFT1-5  ||| S:5067 E:5075 ||| CD
cell  ||| S:5075 E:5080 ||| NN
line  ||| S:5080 E:5085 ||| NN
[  ||| S:5085 E:5087 ||| -LRB-
42  ||| S:5087 E:5090 ||| CD
45  ||| S:5090 E:5093 ||| CD
]  ||| S:5093 E:5095 ||| -RRB-
in  ||| S:5095 E:5098 ||| IN
which  ||| S:5098 E:5104 ||| WDT
ectopically  ||| S:5104 E:5124 ||| VBZ
expressed  ||| S:5124 E:5134 ||| VBN
C ||| S:5134 E:5135 ||| $
/ ||| S:5135 E:5136 ||| CD
EBPα  ||| S:5136 E:5141 ||| JJ
activates  ||| S:5141 E:5151 ||| JJ
co-transfected  ||| S:5151 E:5166 ||| JJ
growth  ||| S:5166 E:5173 ||| NN
hormone  ||| S:5173 E:5189 ||| NN
and  ||| S:5189 E:5193 ||| CC
prolactin  ||| S:5193 E:5203 ||| JJ
promoters  ||| S:5203 E:5213 ||| NNS
[  ||| S:5213 E:5215 ||| -LRB-
42  ||| S:5215 E:5218 ||| CD
44  ||| S:5218 E:5221 ||| CD
45  ||| S:5221 E:5224 ||| CD
]  ||| S:5224 E:5226 ||| -RRB-
.  ||| S:5226 E:5228 ||| .
We  ||| S:5228 E:5231 ||| PRP
show  ||| S:5231 E:5236 ||| VBP
here  ||| S:5236 E:5241 ||| RB
that  ||| S:5241 E:5254 ||| IN
ectopically  ||| S:5254 E:5266 ||| NN
expressed  ||| S:5266 E:5276 ||| VBD
C ||| S:5276 E:5277 ||| $
/ ||| S:5277 E:5278 ||| CD
EBPα  ||| S:5278 E:5283 ||| JJ
prolongs  ||| S:5283 E:5292 ||| NN
GHFT1-5  ||| S:5292 E:5300 ||| CD
cells  ||| S:5300 E:5306 ||| NNS
in  ||| S:5306 E:5309 ||| IN
the  ||| S:5309 E:5321 ||| DT
G1  ||| S:5321 E:5324 ||| NNP
and  ||| S:5324 E:5328 ||| CC
S  ||| S:5328 E:5330 ||| NNP
phases  ||| S:5330 E:5337 ||| NNS
of  ||| S:5337 E:5340 ||| IN
the  ||| S:5340 E:5344 ||| DT
cell  ||| S:5344 E:5349 ||| NN
cycle  ||| S:5349 E:5355 ||| NN
in  ||| S:5355 E:5358 ||| IN
a  ||| S:5358 E:5368 ||| DT
transcription-independent  ||| S:5368 E:5394 ||| JJ
fashion ||| S:5394 E:5401 ||| NN
.  ||| S:5401 E:5403 ||| .
Different  ||| S:5403 E:5413 ||| JJ
C ||| S:5413 E:5414 ||| $
/ ||| S:5414 E:5415 ||| CD
EBPα  ||| S:5415 E:5420 ||| JJ
domains  ||| S:5420 E:5436 ||| NN
were  ||| S:5436 E:5441 ||| VBD
required  ||| S:5441 E:5450 ||| VBN
for  ||| S:5450 E:5454 ||| IN
G1-  ||| S:5454 E:5458 ||| NNP
and  ||| S:5458 E:5462 ||| CC
S-phase  ||| S:5462 E:5470 ||| JJ
arrest ||| S:5470 E:5476 ||| NN
.  ||| S:5476 E:5478 ||| .
C ||| S:5478 E:5479 ||| SYM
/ ||| S:5479 E:5480 ||| CD
EBPα  ||| S:5480 E:5485 ||| JJ
domains  ||| S:5485 E:5501 ||| NNS
previously  ||| S:5501 E:5512 ||| RB
described  ||| S:5512 E:5522 ||| VBN
for  ||| S:5522 E:5526 ||| IN
the  ||| S:5526 E:5530 ||| DT
interaction  ||| S:5530 E:5542 ||| NN
with  ||| S:5542 E:5547 ||| IN
p21  ||| S:5547 E:5551 ||| NNP
were  ||| S:5551 E:5556 ||| VBD
not  ||| S:5556 E:5568 ||| RB
required  ||| S:5568 E:5577 ||| VBN
for  ||| S:5577 E:5581 ||| IN
arrest  ||| S:5581 E:5588 ||| NN
in  ||| S:5588 E:5591 ||| IN
GHFT1-5  ||| S:5591 E:5599 ||| CD
cells ||| S:5599 E:5604 ||| NNS
.  ||| S:5604 E:5606 ||| .
Rather ||| S:5606 E:5612 ||| RB
,  ||| S:5612 E:5614 ||| ,
domains  ||| S:5614 E:5630 ||| VBD
previously  ||| S:5630 E:5641 ||| RB
implicated  ||| S:5641 E:5652 ||| VBN
in  ||| S:5652 E:5655 ||| IN
the  ||| S:5655 E:5659 ||| DT
regulation  ||| S:5659 E:5670 ||| NN
of  ||| S:5670 E:5673 ||| IN
the  ||| S:5673 E:5677 ||| DT
E2F  ||| S:5677 E:5681 ||| NNP
and  ||| S:5681 E:5685 ||| CC
CDK2  ||| S:5685 E:5698 ||| CD
pathways  ||| S:5698 E:5707 ||| NN
by  ||| S:5707 E:5710 ||| IN
C ||| S:5710 E:5711 ||| NNP
/ ||| S:5711 E:5712 ||| NNP
EBPα  ||| S:5712 E:5717 ||| NNP
were  ||| S:5717 E:5722 ||| VBD
required  ||| S:5722 E:5731 ||| VBN
for  ||| S:5731 E:5735 ||| IN
arrest  ||| S:5735 E:5742 ||| NN
of  ||| S:5742 E:5745 ||| IN
these  ||| S:5745 E:5759 ||| DT
progenitor  ||| S:5759 E:5770 ||| JJ
cells ||| S:5770 E:5775 ||| NNS
.  ||| S:5775 E:5799 ||| .
Results  ||| S:5799 E:5826 ||| NNS
Transcriptionally  ||| S:5826 E:5844 ||| JJ
active  ||| S:5844 E:5851 ||| JJ
and  ||| S:5851 E:5855 ||| CC
inactive  ||| S:5855 E:5864 ||| JJ
GFP  ||| S:5864 E:5868 ||| NNP
fusions  ||| S:5868 E:5886 ||| NN
with  ||| S:5886 E:5891 ||| IN
C ||| S:5891 E:5892 ||| $
/ ||| S:5892 E:5893 ||| CD
EBPα  ||| S:5893 E:5908 ||| JJ
The  ||| S:5908 E:5912 ||| DT
domains  ||| S:5912 E:5920 ||| NN
of  ||| S:5920 E:5923 ||| IN
C ||| S:5923 E:5924 ||| NNP
/ ||| S:5924 E:5925 ||| NNP
EBPα  ||| S:5925 E:5930 ||| NNP
and  ||| S:5930 E:5934 ||| CC
their  ||| S:5934 E:5940 ||| PRP$
known  ||| S:5940 E:5946 ||| JJ
interactions  ||| S:5946 E:5969 ||| NNS
with  ||| S:5969 E:5974 ||| IN
cell-cycle  ||| S:5974 E:5985 ||| JJ
proteins  ||| S:5985 E:5994 ||| NNS
are  ||| S:5994 E:5998 ||| VBP
summarized  ||| S:5998 E:6009 ||| VBN
in  ||| S:6009 E:6012 ||| IN
figure  ||| S:6012 E:6019 ||| NN
1A ||| S:6019 E:6021 ||| NN
.  ||| S:6021 E:6023 ||| .
We  ||| S:6023 E:6036 ||| PRP
conducted  ||| S:6036 E:6046 ||| VBD
studies  ||| S:6046 E:6054 ||| NNS
to  ||| S:6054 E:6057 ||| TO
determine  ||| S:6057 E:6067 ||| VB
which ||| S:6067 E:6072 ||| WDT
,  ||| S:6072 E:6074 ||| ,
if  ||| S:6074 E:6077 ||| IN
any ||| S:6077 E:6080 ||| DT
,  ||| S:6080 E:6082 ||| ,
of  ||| S:6082 E:6085 ||| IN
those  ||| S:6085 E:6101 ||| DT
activities  ||| S:6101 E:6112 ||| NNS
affect  ||| S:6112 E:6119 ||| VBP
the  ||| S:6119 E:6123 ||| DT
proliferation  ||| S:6123 E:6137 ||| NN
of  ||| S:6137 E:6140 ||| IN
GHFT1-5  ||| S:6140 E:6148 ||| CD
pituitary  ||| S:6148 E:6168 ||| CD
progenitor  ||| S:6168 E:6179 ||| CD
cells ||| S:6179 E:6184 ||| NNS
.  ||| S:6184 E:6186 ||| .
In  ||| S:6186 E:6189 ||| IN
prior  ||| S:6189 E:6195 ||| JJ
studies ||| S:6195 E:6202 ||| NNS
,  ||| S:6202 E:6204 ||| ,
we  ||| S:6204 E:6207 ||| PRP
noticed  ||| S:6207 E:6215 ||| VBD
that  ||| S:6215 E:6220 ||| IN
fewer  ||| S:6220 E:6236 ||| JJR
cells  ||| S:6236 E:6242 ||| NNS
were  ||| S:6242 E:6247 ||| VBD
present  ||| S:6247 E:6255 ||| JJ
in  ||| S:6255 E:6258 ||| IN
GHFT1-5  ||| S:6258 E:6266 ||| CD
cell  ||| S:6266 E:6271 ||| NN
cultures  ||| S:6271 E:6280 ||| NNS
transfected  ||| S:6280 E:6302 ||| VBN
with  ||| S:6302 E:6307 ||| IN
the  ||| S:6307 E:6311 ||| DT
C ||| S:6311 E:6312 ||| $
/ ||| S:6312 E:6313 ||| CD
EBPα  ||| S:6313 E:6318 ||| JJ
expression  ||| S:6318 E:6329 ||| NN
vector  ||| S:6329 E:6336 ||| NN
than  ||| S:6336 E:6341 ||| IN
in  ||| S:6341 E:6344 ||| IN
cultures  ||| S:6344 E:6363 ||| JJ
transfected  ||| S:6363 E:6375 ||| NN
with  ||| S:6375 E:6380 ||| IN
control  ||| S:6380 E:6388 ||| NN
vectors  ||| S:6388 E:6396 ||| NNS
( ||| S:6396 E:6397 ||| -LRB-
X ||| S:6397 E:6398 ||| NNP
.  ||| S:6398 E:6400 ||| .
Wang ||| S:6400 E:6404 ||| NNP
,  ||| S:6404 E:6406 ||| ,
F.  ||| S:6406 E:6409 ||| NNP
S. ||| S:6409 E:6411 ||| NNP
,  ||| S:6411 E:6423 ||| ,
unpublished  ||| S:6423 E:6435 ||| JJ
data ||| S:6435 E:6439 ||| NNS
) ||| S:6439 E:6440 ||| -RRB-
.  ||| S:6440 E:6442 ||| .
The  ||| S:6442 E:6446 ||| DT
decreased  ||| S:6446 E:6456 ||| JJ
cell  ||| S:6456 E:6461 ||| NN
number  ||| S:6461 E:6468 ||| NN
might  ||| S:6468 E:6474 ||| MD
be  ||| S:6474 E:6477 ||| VB
due  ||| S:6477 E:6491 ||| JJ
to  ||| S:6491 E:6494 ||| TO
impaired  ||| S:6494 E:6503 ||| VB
proliferation  ||| S:6503 E:6517 ||| NN
of  ||| S:6517 E:6520 ||| IN
GHFT1-5  ||| S:6520 E:6528 ||| CD
cells  ||| S:6528 E:6534 ||| NNS
expressing  ||| S:6534 E:6555 ||| VBG
C ||| S:6555 E:6556 ||| NNP
/ ||| S:6556 E:6557 ||| NNP
EBPα ||| S:6557 E:6561 ||| NNP
.  ||| S:6561 E:6563 ||| .
To  ||| S:6563 E:6566 ||| TO
examine  ||| S:6566 E:6574 ||| VB
if  ||| S:6574 E:6577 ||| IN
C ||| S:6577 E:6578 ||| NNP
/ ||| S:6578 E:6579 ||| NNP
EBPα  ||| S:6579 E:6584 ||| NNP
affected  ||| S:6584 E:6593 ||| VBD
the  ||| S:6593 E:6597 ||| DT
progression  ||| S:6597 E:6609 ||| NN
of  ||| S:6609 E:6622 ||| IN
GHFT1-5  ||| S:6622 E:6630 ||| CD
cells  ||| S:6630 E:6636 ||| NNS
through  ||| S:6636 E:6644 ||| IN
the  ||| S:6644 E:6648 ||| DT
cell  ||| S:6648 E:6653 ||| NN
cycle ||| S:6653 E:6658 ||| NN
,  ||| S:6658 E:6660 ||| ,
we  ||| S:6660 E:6663 ||| PRP
needed  ||| S:6663 E:6670 ||| VBD
to  ||| S:6670 E:6683 ||| TO
distinguish  ||| S:6683 E:6695 ||| VB
transfected  ||| S:6695 E:6707 ||| JJ
cells  ||| S:6707 E:6713 ||| NNS
that  ||| S:6713 E:6718 ||| WDT
expressed  ||| S:6718 E:6728 ||| VBD
C ||| S:6728 E:6729 ||| $
/ ||| S:6729 E:6730 ||| CD
EBPα  ||| S:6730 E:6735 ||| NN
from  ||| S:6735 E:6750 ||| IN
those  ||| S:6750 E:6756 ||| DT
that  ||| S:6756 E:6761 ||| WDT
did  ||| S:6761 E:6765 ||| VBD
not ||| S:6765 E:6768 ||| RB
.  ||| S:6768 E:6770 ||| .
We  ||| S:6770 E:6773 ||| PRP
fused  ||| S:6773 E:6779 ||| VBD
the  ||| S:6779 E:6783 ||| DT
cDNA  ||| S:6783 E:6788 ||| JJ
for  ||| S:6788 E:6792 ||| IN
the  ||| S:6792 E:6796 ||| DT
green  ||| S:6796 E:6812 ||| JJ
fluorescence  ||| S:6812 E:6825 ||| JJ
protein  ||| S:6825 E:6833 ||| NN
( ||| S:6833 E:6834 ||| -LRB-
GFP ||| S:6834 E:6837 ||| NNP
)  ||| S:6837 E:6839 ||| -RRB-
to  ||| S:6839 E:6842 ||| TO
either  ||| S:6842 E:6849 ||| VB
the  ||| S:6849 E:6853 ||| DT
5 ||| S:6853 E:6854 ||| CD
'  ||| S:6854 E:6856 ||| ''
( ||| S:6856 E:6857 ||| -LRB-
GFP-C ||| S:6857 E:6862 ||| NNP
/ ||| S:6862 E:6863 ||| NNP
EBPα ||| S:6863 E:6867 ||| NNP
)  ||| S:6867 E:6879 ||| -RRB-
or  ||| S:6879 E:6882 ||| CC
the  ||| S:6882 E:6886 ||| DT
3 ||| S:6886 E:6887 ||| CD
'  ||| S:6887 E:6889 ||| ''
( ||| S:6889 E:6890 ||| -LRB-
C ||| S:6890 E:6891 ||| NNP
/ ||| S:6891 E:6892 ||| NNP
EBPα-GFP ||| S:6892 E:6900 ||| NNP
)  ||| S:6900 E:6902 ||| -RRB-
end  ||| S:6902 E:6906 ||| NN
of  ||| S:6906 E:6909 ||| IN
the  ||| S:6909 E:6913 ||| DT
coding  ||| S:6913 E:6920 ||| JJ
sequence  ||| S:6920 E:6929 ||| NN
of  ||| S:6929 E:6932 ||| IN
the  ||| S:6932 E:6946 ||| DT
C ||| S:6946 E:6947 ||| NNP
/ ||| S:6947 E:6948 ||| NNP
EBPα  ||| S:6948 E:6953 ||| NNP
cDNA ||| S:6953 E:6957 ||| NNP
.  ||| S:6957 E:6959 ||| .
The  ||| S:6959 E:6963 ||| DT
cDNAs  ||| S:6963 E:6969 ||| JJ
for  ||| S:6969 E:6973 ||| IN
the  ||| S:6973 E:6977 ||| DT
GFP-C ||| S:6977 E:6982 ||| JJ
/ ||| S:6982 E:6983 ||| NNP
EBPα  ||| S:6983 E:6988 ||| NNP
and  ||| S:6988 E:6992 ||| CC
C ||| S:6992 E:6993 ||| $
/ ||| S:6993 E:6994 ||| CD
EBPα-GFP  ||| S:6994 E:7013 ||| JJ
fusion  ||| S:7013 E:7020 ||| NN
proteins  ||| S:7020 E:7029 ||| NNS
were  ||| S:7029 E:7034 ||| VBD
inserted  ||| S:7034 E:7043 ||| VBN
into  ||| S:7043 E:7048 ||| IN
an  ||| S:7048 E:7051 ||| DT
expression  ||| S:7051 E:7062 ||| NN
vector  ||| S:7062 E:7079 ||| NN
and  ||| S:7079 E:7083 ||| CC
transfected  ||| S:7083 E:7095 ||| NN
into  ||| S:7095 E:7100 ||| IN
GHFT1-5  ||| S:7100 E:7108 ||| CD
cells ||| S:7108 E:7113 ||| NNS
.  ||| S:7113 E:7115 ||| .
Flow  ||| S:7115 E:7120 ||| NN
cytometry  ||| S:7120 E:7130 ||| NNS
was  ||| S:7130 E:7144 ||| VBD
used  ||| S:7144 E:7149 ||| VBN
to  ||| S:7149 E:7152 ||| TO
specifically  ||| S:7152 E:7165 ||| RB
identify  ||| S:7165 E:7174 ||| VB
green  ||| S:7174 E:7180 ||| JJ
fluorescent ||| S:7180 E:7191 ||| NN
,  ||| S:7191 E:7203 ||| ,
C ||| S:7203 E:7204 ||| NNP
/ ||| S:7204 E:7205 ||| NNP
EBPα-expressing  ||| S:7205 E:7221 ||| JJ
cells ||| S:7221 E:7226 ||| NNS
.  ||| S:7226 E:7238 ||| .
We  ||| S:7238 E:7241 ||| PRP
initially  ||| S:7241 E:7251 ||| RB
characterized  ||| S:7251 E:7265 ||| VBN
the  ||| S:7265 E:7269 ||| DT
abilities  ||| S:7269 E:7279 ||| NN
of  ||| S:7279 E:7282 ||| IN
the  ||| S:7282 E:7296 ||| DT
C ||| S:7296 E:7297 ||| NNP
/ ||| S:7297 E:7298 ||| NNP
EBPα-GFP  ||| S:7298 E:7307 ||| NNP
and  ||| S:7307 E:7311 ||| CC
GFP-C ||| S:7311 E:7316 ||| JJ
/ ||| S:7316 E:7317 ||| CD
EBPα  ||| S:7317 E:7322 ||| JJ
fusion  ||| S:7322 E:7329 ||| NN
proteins  ||| S:7329 E:7338 ||| NNS
to  ||| S:7338 E:7341 ||| TO
bind  ||| S:7341 E:7346 ||| VB
DNA  ||| S:7346 E:7350 ||| NNP
and  ||| S:7350 E:7364 ||| CC
activate  ||| S:7364 E:7373 ||| JJ
transcription  ||| S:7373 E:7387 ||| NN
in  ||| S:7387 E:7390 ||| IN
GHFT1-5  ||| S:7390 E:7398 ||| CD
cells  ||| S:7398 E:7404 ||| NNS
( ||| S:7404 E:7405 ||| -LRB-
Fig.  ||| S:7405 E:7410 ||| CD
2 ||| S:7410 E:7411 ||| CD
) ||| S:7411 E:7412 ||| -RRB-
.  ||| S:7412 E:7414 ||| .
The  ||| S:7414 E:7428 ||| DT
C ||| S:7428 E:7429 ||| NNP
/ ||| S:7429 E:7430 ||| NNP
EBPα-GFP  ||| S:7430 E:7439 ||| NNP
or  ||| S:7439 E:7442 ||| CC
GFP-C ||| S:7442 E:7447 ||| JJ
/ ||| S:7447 E:7448 ||| CD
EBPα  ||| S:7448 E:7453 ||| JJ
expression  ||| S:7453 E:7464 ||| NN
vectors  ||| S:7464 E:7472 ||| NNS
were  ||| S:7472 E:7487 ||| VBD
transfected  ||| S:7487 E:7499 ||| VBN
into  ||| S:7499 E:7504 ||| IN
GHFT1-5  ||| S:7504 E:7512 ||| CD
cells  ||| S:7512 E:7518 ||| NNS
with  ||| S:7518 E:7523 ||| IN
a  ||| S:7523 E:7525 ||| DT
promoter  ||| S:7525 E:7534 ||| NN
consisting  ||| S:7534 E:7555 ||| VBG
of  ||| S:7555 E:7558 ||| IN
a  ||| S:7558 E:7560 ||| DT
single  ||| S:7560 E:7567 ||| JJ
C ||| S:7567 E:7568 ||| $
/ ||| S:7568 E:7569 ||| CD
EBPα  ||| S:7569 E:7574 ||| JJ
binding  ||| S:7574 E:7582 ||| JJ
site  ||| S:7582 E:7587 ||| NN
upstream  ||| S:7587 E:7596 ||| NN
of  ||| S:7596 E:7599 ||| IN
the  ||| S:7599 E:7603 ||| DT
growth  ||| S:7603 E:7620 ||| NN
hormone  ||| S:7620 E:7628 ||| NN
TATA  ||| S:7628 E:7633 ||| NNP
box ||| S:7633 E:7636 ||| NN
.  ||| S:7636 E:7638 ||| .
This  ||| S:7638 E:7643 ||| DT
minimal  ||| S:7643 E:7651 ||| JJ
promoter  ||| S:7651 E:7660 ||| NN
was  ||| S:7660 E:7664 ||| VBD
specifically  ||| S:7664 E:7687 ||| RB
responsive  ||| S:7687 E:7698 ||| JJ
to  ||| S:7698 E:7701 ||| TO
C ||| S:7701 E:7702 ||| $
/ ||| S:7702 E:7703 ||| CD
EBPα  ||| S:7703 E:7708 ||| JJ
expression  ||| S:7708 E:7719 ||| NN
in  ||| S:7719 E:7722 ||| IN
GHFT1-5  ||| S:7722 E:7730 ||| CD
cells  ||| S:7730 E:7736 ||| NNS
[  ||| S:7736 E:7738 ||| -LRB-
45  ||| S:7738 E:7741 ||| CD
46  ||| S:7741 E:7754 ||| CD
]  ||| S:7754 E:7756 ||| -RRB-
.  ||| S:7756 E:7758 ||| .
Cells  ||| S:7758 E:7764 ||| NNS
transfected  ||| S:7764 E:7776 ||| VBN
with  ||| S:7776 E:7781 ||| IN
the  ||| S:7781 E:7785 ||| DT
C ||| S:7785 E:7786 ||| $
/ ||| S:7786 E:7787 ||| CD
EBPα-GFP  ||| S:7787 E:7796 ||| JJ
expression  ||| S:7796 E:7817 ||| NN
vector  ||| S:7817 E:7824 ||| NN
showed  ||| S:7824 E:7831 ||| VBD
a  ||| S:7831 E:7833 ||| DT
statistically  ||| S:7833 E:7847 ||| JJ
significant  ||| S:7847 E:7859 ||| JJ
( ||| S:7859 E:7860 ||| -LRB-
p  ||| S:7860 E:7861 ||| CD
< ||| S:7861 E:7862 ||| SYM
0.05 ||| S:7862 E:7866 ||| CD
,  ||| S:7866 E:7868 ||| ,
n  ||| S:7868 E:7870 ||| VBG
=  ||| S:7870 E:7882 ||| SYM
5 ||| S:7882 E:7883 ||| CD
)  ||| S:7883 E:7885 ||| -RRB-
9.66  ||| S:7885 E:7890 ||| CD
+ ||| S:7890 E:7891 ||| CD
/ ||| S:7891 E:7892 ||| CD
-  ||| S:7892 E:7894 ||| :
6.08-fold  ||| S:7894 E:7904 ||| CD
higher  ||| S:7904 E:7911 ||| JJR
promoter  ||| S:7911 E:7920 ||| NN
activity  ||| S:7920 E:7929 ||| NN
than  ||| S:7929 E:7934 ||| IN
did  ||| S:7934 E:7948 ||| VBD
cells  ||| S:7948 E:7954 ||| NNS
sham-transfected  ||| S:7954 E:7971 ||| JJ
with  ||| S:7971 E:7976 ||| IN
the  ||| S:7976 E:7980 ||| DT
same  ||| S:7980 E:7985 ||| JJ
expression  ||| S:7985 E:7996 ||| NN
vector  ||| S:7996 E:8013 ||| VBZ
deleted  ||| S:8013 E:8021 ||| VBN
of  ||| S:8021 E:8024 ||| IN
the  ||| S:8024 E:8028 ||| DT
C ||| S:8028 E:8029 ||| NNP
/ ||| S:8029 E:8030 ||| NNP
EBPα  ||| S:8030 E:8035 ||| NNP
cDNA  ||| S:8035 E:8040 ||| NNP
( ||| S:8040 E:8041 ||| -LRB-
Fig.  ||| S:8041 E:8046 ||| NNP
2A ||| S:8046 E:8048 ||| NNP
) ||| S:8048 E:8049 ||| -RRB-
.  ||| S:8049 E:8051 ||| .
In  ||| S:8051 E:8054 ||| IN
contrast ||| S:8054 E:8062 ||| NN
,  ||| S:8062 E:8074 ||| ,
activation  ||| S:8074 E:8085 ||| VBG
by  ||| S:8085 E:8088 ||| IN
GFP-C ||| S:8088 E:8093 ||| NNP
/ ||| S:8093 E:8094 ||| NNP
EBPα  ||| S:8094 E:8099 ||| NNP
was  ||| S:8099 E:8103 ||| VBD
a  ||| S:8103 E:8105 ||| DT
statistically  ||| S:8105 E:8129 ||| JJ
insignificant  ||| S:8129 E:8143 ||| JJ
1.88  ||| S:8143 E:8148 ||| CD
+ ||| S:8148 E:8149 ||| CD
/ ||| S:8149 E:8150 ||| CD
-  ||| S:8150 E:8152 ||| :
1.48-fold  ||| S:8152 E:8162 ||| CD
( ||| S:8162 E:8163 ||| -LRB-
Fig.  ||| S:8163 E:8168 ||| NNP
2A ||| S:8168 E:8170 ||| NNP
) ||| S:8170 E:8171 ||| -RRB-
.  ||| S:8171 E:8173 ||| .
Promoter  ||| S:8173 E:8192 ||| JJ
activation  ||| S:8192 E:8203 ||| NN
by  ||| S:8203 E:8206 ||| IN
C ||| S:8206 E:8207 ||| NNP
/ ||| S:8207 E:8208 ||| NNP
EBPα-GFP  ||| S:8208 E:8217 ||| NNP
was  ||| S:8217 E:8221 ||| VBD
reproducibly  ||| S:8221 E:8234 ||| RB
less  ||| S:8234 E:8239 ||| JJR
than  ||| S:8239 E:8254 ||| IN
promoter  ||| S:8254 E:8263 ||| JJ
activation  ||| S:8263 E:8274 ||| NN
by  ||| S:8274 E:8277 ||| IN
unfused  ||| S:8277 E:8285 ||| JJ
C ||| S:8285 E:8286 ||| NNP
/ ||| S:8286 E:8287 ||| NNP
EBPα ||| S:8287 E:8291 ||| NNP
.  ||| S:8291 E:8293 ||| .
Western  ||| S:8293 E:8301 ||| JJ
blots  ||| S:8301 E:8307 ||| NN
of  ||| S:8307 E:8320 ||| IN
nuclear  ||| S:8320 E:8328 ||| JJ
extracts  ||| S:8328 E:8337 ||| NN
from  ||| S:8337 E:8342 ||| IN
the  ||| S:8342 E:8346 ||| DT
transfected  ||| S:8346 E:8358 ||| JJ
cells  ||| S:8358 E:8364 ||| NNS
showed  ||| S:8364 E:8371 ||| VBD
that  ||| S:8371 E:8386 ||| DT
unfused  ||| S:8386 E:8394 ||| JJ
C ||| S:8394 E:8395 ||| NNP
/ ||| S:8395 E:8396 ||| NNP
EBPα  ||| S:8396 E:8401 ||| NNP
was  ||| S:8401 E:8405 ||| VBD
expressed  ||| S:8405 E:8415 ||| VBN
at  ||| S:8415 E:8418 ||| IN
marginally  ||| S:8418 E:8429 ||| RB
higher  ||| S:8429 E:8436 ||| JJR
levels  ||| S:8436 E:8453 ||| NNS
( ||| S:8453 E:8454 ||| -LRB-
Fig.  ||| S:8454 E:8459 ||| NNP
2B ||| S:8459 E:8461 ||| NNP
) ||| S:8461 E:8462 ||| -RRB-
.  ||| S:8462 E:8474 ||| .
C ||| S:8474 E:8475 ||| NNP
/ ||| S:8475 E:8476 ||| NNP
EBPα-GFP  ||| S:8476 E:8485 ||| NNP
and  ||| S:8485 E:8489 ||| CC
GFP-C ||| S:8489 E:8494 ||| NNP
/ ||| S:8494 E:8495 ||| NNP
EBPα  ||| S:8495 E:8500 ||| NNP
both  ||| S:8500 E:8505 ||| CC
were  ||| S:8505 E:8510 ||| VBD
expressed  ||| S:8510 E:8520 ||| VBN
as  ||| S:8520 E:8533 ||| IN
intact ||| S:8533 E:8539 ||| JJ
,  ||| S:8539 E:8541 ||| ,
full-length  ||| S:8541 E:8553 ||| JJ
proteins  ||| S:8553 E:8562 ||| NNS
of  ||| S:8562 E:8565 ||| IN
the  ||| S:8565 E:8569 ||| DT
appropriate  ||| S:8569 E:8581 ||| JJ
molecular  ||| S:8581 E:8601 ||| JJ
weight  ||| S:8601 E:8608 ||| NN
[  ||| S:8608 E:8610 ||| -LRB-
45  ||| S:8610 E:8613 ||| CD
]  ||| S:8613 E:8615 ||| -RRB-
( ||| S:8615 E:8616 ||| -LRB-
Fig.  ||| S:8616 E:8621 ||| NNP
2B ||| S:8621 E:8623 ||| NNP
,  ||| S:8623 E:8625 ||| ,
arrow ||| S:8625 E:8630 ||| CD
) ||| S:8630 E:8631 ||| -RRB-
.  ||| S:8631 E:8633 ||| .
In  ||| S:8633 E:8636 ||| IN
addition ||| S:8636 E:8644 ||| NN
,  ||| S:8644 E:8646 ||| ,
both  ||| S:8646 E:8661 ||| DT
C ||| S:8661 E:8662 ||| NNP
/ ||| S:8662 E:8663 ||| NNP
EBPα-GFP  ||| S:8663 E:8672 ||| NNP
and  ||| S:8672 E:8676 ||| CC
GFP-C ||| S:8676 E:8681 ||| JJ
/ ||| S:8681 E:8682 ||| CD
EBPα  ||| S:8682 E:8687 ||| NNS
bound  ||| S:8687 E:8693 ||| VBN
similarly  ||| S:8693 E:8703 ||| RB
to  ||| S:8703 E:8706 ||| TO
DNA  ||| S:8706 E:8710 ||| NNP
( ||| S:8710 E:8711 ||| -LRB-
Fig.  ||| S:8711 E:8726 ||| NNP
2C ||| S:8726 E:8728 ||| NNP
) ||| S:8728 E:8729 ||| -RRB-
.  ||| S:8729 E:8731 ||| .
Extracts  ||| S:8731 E:8740 ||| NNP
of  ||| S:8740 E:8743 ||| IN
cells  ||| S:8743 E:8749 ||| NNS
expressing  ||| S:8749 E:8760 ||| VBG
either  ||| S:8760 E:8767 ||| DT
C ||| S:8767 E:8768 ||| NNP
/ ||| S:8768 E:8769 ||| NNP
EBPα-GFP  ||| S:8769 E:8778 ||| NNP
or  ||| S:8778 E:8791 ||| CC
GFP-C ||| S:8791 E:8796 ||| NNP
/ ||| S:8796 E:8797 ||| NNP
EBPα  ||| S:8797 E:8802 ||| NNP
shifted  ||| S:8802 E:8810 ||| VBD
the  ||| S:8810 E:8814 ||| DT
electrophoretic  ||| S:8814 E:8830 ||| JJ
mobility  ||| S:8830 E:8839 ||| NN
of  ||| S:8839 E:8842 ||| IN
a  ||| S:8842 E:8854 ||| DT
radiolabeled  ||| S:8854 E:8867 ||| JJ
oligonucleotide  ||| S:8867 E:8883 ||| NNS
containing  ||| S:8883 E:8894 ||| VBG
a  ||| S:8894 E:8896 ||| DT
C ||| S:8896 E:8897 ||| $
/ ||| S:8897 E:8898 ||| CD
EBPα  ||| S:8898 E:8903 ||| JJ
binding  ||| S:8903 E:8921 ||| JJ
site  ||| S:8921 E:8926 ||| NN
( ||| S:8926 E:8927 ||| -LRB-
Fig.  ||| S:8927 E:8932 ||| NNP
2C ||| S:8932 E:8934 ||| NNP
) ||| S:8934 E:8935 ||| -RRB-
.  ||| S:8935 E:8937 ||| .
No  ||| S:8937 E:8940 ||| DT
shift  ||| S:8940 E:8946 ||| NN
was  ||| S:8946 E:8950 ||| VBD
observed  ||| S:8950 E:8959 ||| VBN
with  ||| S:8959 E:8974 ||| IN
sham-transfected  ||| S:8974 E:8991 ||| JJ
cells  ||| S:8991 E:8997 ||| NNS
( ||| S:8997 E:8998 ||| -LRB-
not  ||| S:8998 E:9002 ||| RB
shown ||| S:9002 E:9007 ||| VBN
) ||| S:9007 E:9008 ||| -RRB-
.  ||| S:9008 E:9010 ||| .
The  ||| S:9010 E:9014 ||| DT
shifted  ||| S:9014 E:9022 ||| JJ
bands  ||| S:9022 E:9038 ||| NNS
were  ||| S:9038 E:9043 ||| VBD
specifically  ||| S:9043 E:9056 ||| RB
competed  ||| S:9056 E:9065 ||| VBN
by  ||| S:9065 E:9068 ||| IN
a  ||| S:9068 E:9070 ||| DT
100-fold  ||| S:9070 E:9079 ||| JJ
molar  ||| S:9079 E:9085 ||| JJ
excess  ||| S:9085 E:9092 ||| NN
of  ||| S:9092 E:9105 ||| IN
the  ||| S:9105 E:9109 ||| DT
cold  ||| S:9109 E:9114 ||| JJ
oligonucleotide  ||| S:9114 E:9130 ||| NN
and  ||| S:9130 E:9134 ||| CC
were  ||| S:9134 E:9139 ||| VBD
supershifted  ||| S:9139 E:9152 ||| VBN
with  ||| S:9152 E:9157 ||| IN
an  ||| S:9157 E:9170 ||| DT
antibody  ||| S:9170 E:9179 ||| NN
directed  ||| S:9179 E:9188 ||| VBN
against  ||| S:9188 E:9196 ||| IN
C ||| S:9196 E:9197 ||| NNP
/ ||| S:9197 E:9198 ||| NNP
EBPα ||| S:9198 E:9202 ||| NNP
.  ||| S:9202 E:9204 ||| .
GFP-C ||| S:9204 E:9209 ||| NNP
/ ||| S:9209 E:9210 ||| NNP
EBPα  ||| S:9210 E:9215 ||| JJ
truncated  ||| S:9215 E:9225 ||| NN
of  ||| S:9225 E:9238 ||| IN
its  ||| S:9238 E:9242 ||| PRP$
leucine  ||| S:9242 E:9250 ||| JJ
zipper  ||| S:9250 E:9257 ||| NNS
( ||| S:9257 E:9258 ||| -LRB-
Fig.  ||| S:9258 E:9263 ||| NNP
1B ||| S:9263 E:9265 ||| NNP
)  ||| S:9265 E:9267 ||| -RRB-
was  ||| S:9267 E:9271 ||| VBD
ineffective  ||| S:9271 E:9283 ||| VBN
at  ||| S:9283 E:9286 ||| IN
shifting  ||| S:9286 E:9305 ||| VBG
the  ||| S:9305 E:9309 ||| DT
binding  ||| S:9309 E:9317 ||| JJ
site  ||| S:9317 E:9322 ||| NN
( ||| S:9322 E:9323 ||| -LRB-
Fig.  ||| S:9323 E:9328 ||| NNP
2C ||| S:9328 E:9330 ||| NNP
,  ||| S:9330 E:9332 ||| ,
ΔLZ ||| S:9332 E:9335 ||| NNP
) ||| S:9335 E:9336 ||| -RRB-
.  ||| S:9336 E:9338 ||| .
Flow  ||| S:9338 E:9343 ||| NN
cytometry  ||| S:9343 E:9363 ||| NNS
( ||| S:9363 E:9364 ||| -LRB-
discussed  ||| S:9364 E:9374 ||| VBN
later ||| S:9374 E:9379 ||| RB
)  ||| S:9379 E:9381 ||| -RRB-
showed  ||| S:9381 E:9388 ||| VBD
that  ||| S:9388 E:9393 ||| DT
comparable  ||| S:9393 E:9404 ||| JJ
levels  ||| S:9404 E:9411 ||| NNS
of  ||| S:9411 E:9414 ||| IN
green  ||| S:9414 E:9430 ||| JJ
fluorescence  ||| S:9430 E:9443 ||| NN
were  ||| S:9443 E:9448 ||| VBD
emitted  ||| S:9448 E:9456 ||| VBN
from  ||| S:9456 E:9461 ||| IN
cells  ||| S:9461 E:9467 ||| NNS
expressing  ||| S:9467 E:9488 ||| VBG
C ||| S:9488 E:9489 ||| NNP
/ ||| S:9489 E:9490 ||| NNP
EBPα-GFP ||| S:9490 E:9498 ||| NNP
,  ||| S:9498 E:9500 ||| ,
GFP-C ||| S:9500 E:9505 ||| NNP
/ ||| S:9505 E:9506 ||| NNP
EBPα  ||| S:9506 E:9511 ||| NNP
and  ||| S:9511 E:9515 ||| CC
ΔLZ ||| S:9515 E:9518 ||| NNP
.  ||| S:9518 E:9520 ||| .
Thus ||| S:9520 E:9524 ||| RB
,  ||| S:9524 E:9526 ||| ,
C ||| S:9526 E:9527 ||| NNP
/ ||| S:9527 E:9528 ||| NNP
EBPα-GFP  ||| S:9528 E:9537 ||| NNP
and  ||| S:9537 E:9551 ||| CC
GFP-C ||| S:9551 E:9556 ||| NNP
/ ||| S:9556 E:9557 ||| NNP
EBPα  ||| S:9557 E:9562 ||| NNP
were  ||| S:9562 E:9567 ||| VBD
expressed  ||| S:9567 E:9577 ||| VBN
and  ||| S:9577 E:9581 ||| CC
could  ||| S:9581 E:9587 ||| MD
bind  ||| S:9587 E:9592 ||| VB
to  ||| S:9592 E:9595 ||| TO
C ||| S:9595 E:9596 ||| $
/ ||| S:9596 E:9597 ||| CD
EBPα  ||| S:9597 E:9612 ||| JJ
binding  ||| S:9612 E:9620 ||| JJ
sites  ||| S:9620 E:9626 ||| NNS
in  ||| S:9626 E:9629 ||| IN
DNA ||| S:9629 E:9632 ||| NNP
,  ||| S:9632 E:9634 ||| ,
but  ||| S:9634 E:9638 ||| CC
differed  ||| S:9638 E:9647 ||| NN
in  ||| S:9647 E:9650 ||| IN
their  ||| S:9650 E:9656 ||| PRP$
ability  ||| S:9656 E:9664 ||| NN
to  ||| S:9664 E:9677 ||| TO
activate  ||| S:9677 E:9686 ||| VB
gene  ||| S:9686 E:9691 ||| NN
transcription ||| S:9691 E:9704 ||| NN
.  ||| S:9704 E:9734 ||| .
Cell  ||| S:9734 E:9739 ||| NN
cycle  ||| S:9739 E:9745 ||| NN
distribution  ||| S:9745 E:9758 ||| NN
of  ||| S:9758 E:9761 ||| IN
GHFT1-5  ||| S:9761 E:9769 ||| CD
cells  ||| S:9769 E:9785 ||| NNS
Transcriptionally  ||| S:9785 E:9803 ||| JJ
active  ||| S:9803 E:9810 ||| JJ
C ||| S:9810 E:9811 ||| NNP
/ ||| S:9811 E:9812 ||| NNP
EBPα-GFP  ||| S:9812 E:9821 ||| NNP
and  ||| S:9821 E:9835 ||| CC
transcriptionally  ||| S:9835 E:9853 ||| JJ
inactive  ||| S:9853 E:9862 ||| JJ
GFP-C ||| S:9862 E:9867 ||| JJ
/ ||| S:9867 E:9868 ||| NNP
EBPα  ||| S:9868 E:9873 ||| NNP
were  ||| S:9873 E:9878 ||| VBD
compared  ||| S:9878 E:9887 ||| VBN
for  ||| S:9887 E:9901 ||| IN
their  ||| S:9901 E:9907 ||| PRP$
effects  ||| S:9907 E:9915 ||| NNS
on  ||| S:9915 E:9918 ||| IN
proliferation  ||| S:9918 E:9932 ||| NN
of  ||| S:9932 E:9935 ||| IN
GHFT1-5  ||| S:9935 E:9943 ||| CD
cells ||| S:9943 E:9948 ||| NNS
.  ||| S:9948 E:9950 ||| .
We  ||| S:9950 E:9953 ||| PRP
first  ||| S:9953 E:9969 ||| RB
determined  ||| S:9969 E:9980 ||| VBN
the  ||| S:9980 E:9984 ||| DT
distribution  ||| S:9984 E:9997 ||| NN
of  ||| S:9997 E:10000 ||| IN
untransfected  ||| S:10000 E:10014 ||| CD
GHFT1-5  ||| S:10014 E:10032 ||| CD
cells  ||| S:10032 E:10038 ||| NNS
in  ||| S:10038 E:10041 ||| IN
each  ||| S:10041 E:10046 ||| DT
phase  ||| S:10046 E:10052 ||| NN
of  ||| S:10052 E:10055 ||| IN
the  ||| S:10055 E:10059 ||| DT
cell  ||| S:10059 E:10064 ||| NN
cycle ||| S:10064 E:10069 ||| NN
.  ||| S:10069 E:10071 ||| .
GHFT1-5  ||| S:10071 E:10079 ||| NNP
cells  ||| S:10079 E:10085 ||| NNS
were  ||| S:10085 E:10100 ||| VBD
grown  ||| S:10100 E:10106 ||| VBN
to  ||| S:10106 E:10109 ||| TO
subconfluence ||| S:10109 E:10122 ||| VB
,  ||| S:10122 E:10124 ||| ,
collected  ||| S:10124 E:10134 ||| VBN
and  ||| S:10134 E:10138 ||| CC
the  ||| S:10138 E:10142 ||| DT
DNA  ||| S:10142 E:10146 ||| NN
within  ||| S:10146 E:10153 ||| IN
the  ||| S:10153 E:10167 ||| DT
cells  ||| S:10167 E:10173 ||| NNS
was  ||| S:10173 E:10177 ||| VBD
stained  ||| S:10177 E:10185 ||| VBN
with  ||| S:10185 E:10190 ||| IN
propidium  ||| S:10190 E:10200 ||| JJ
iodide ||| S:10200 E:10206 ||| NN
.  ||| S:10206 E:10208 ||| .
The  ||| S:10208 E:10212 ||| DT
DNA  ||| S:10212 E:10216 ||| NN
content  ||| S:10216 E:10234 ||| NN
within  ||| S:10234 E:10241 ||| IN
each  ||| S:10241 E:10246 ||| DT
cell  ||| S:10246 E:10251 ||| NN
was  ||| S:10251 E:10255 ||| VBD
quantified  ||| S:10255 E:10266 ||| VBN
by  ||| S:10266 E:10269 ||| IN
flow  ||| S:10269 E:10274 ||| NN
cytometry  ||| S:10274 E:10284 ||| NN
as  ||| S:10284 E:10287 ||| IN
the  ||| S:10287 E:10301 ||| DT
amount  ||| S:10301 E:10308 ||| NN
of  ||| S:10308 E:10311 ||| IN
orange  ||| S:10311 E:10318 ||| JJ
fluorescence  ||| S:10318 E:10331 ||| NN
from  ||| S:10331 E:10336 ||| IN
the  ||| S:10336 E:10340 ||| DT
propidium  ||| S:10340 E:10360 ||| JJ
iodide-stained  ||| S:10360 E:10375 ||| JJ
DNA  ||| S:10375 E:10379 ||| NN
( ||| S:10379 E:10380 ||| -LRB-
see  ||| S:10380 E:10384 ||| VB
Materials  ||| S:10384 E:10394 ||| NNPS
and  ||| S:10394 E:10398 ||| CC
Methods  ||| S:10398 E:10406 ||| NNP
for  ||| S:10406 E:10420 ||| IN
details ||| S:10420 E:10427 ||| NNS
) ||| S:10427 E:10428 ||| -RRB-
.  ||| S:10428 E:10430 ||| .
The  ||| S:10430 E:10434 ||| DT
fluorescence  ||| S:10434 E:10447 ||| JJ
intensity  ||| S:10447 E:10457 ||| NN
measured  ||| S:10457 E:10466 ||| VBN
from  ||| S:10466 E:10471 ||| IN
each  ||| S:10471 E:10486 ||| DT
cell  ||| S:10486 E:10491 ||| NN
falls  ||| S:10491 E:10497 ||| VBZ
into  ||| S:10497 E:10502 ||| IN
one  ||| S:10502 E:10506 ||| CD
of  ||| S:10506 E:10509 ||| IN
three  ||| S:10509 E:10515 ||| CD
populations ||| S:10515 E:10526 ||| NNS
:  ||| S:10526 E:10528 ||| :
cells  ||| S:10528 E:10534 ||| NNS
centered  ||| S:10534 E:10553 ||| VBN
around  ||| S:10553 E:10560 ||| IN
the  ||| S:10560 E:10564 ||| DT
lowest  ||| S:10564 E:10571 ||| JJS
level  ||| S:10571 E:10577 ||| NN
of  ||| S:10577 E:10580 ||| IN
orange  ||| S:10580 E:10587 ||| JJ
fluorescence ||| S:10587 E:10599 ||| NN
,  ||| S:10599 E:10601 ||| ,
cells  ||| S:10601 E:10617 ||| NNS
centered  ||| S:10617 E:10626 ||| VBN
around  ||| S:10626 E:10633 ||| IN
the  ||| S:10633 E:10637 ||| DT
highest  ||| S:10637 E:10645 ||| JJS
level  ||| S:10645 E:10651 ||| NN
of  ||| S:10651 E:10654 ||| IN
orange  ||| S:10654 E:10661 ||| JJ
fluorescence  ||| S:10661 E:10684 ||| NN
which  ||| S:10684 E:10690 ||| WDT
is  ||| S:10690 E:10693 ||| VBZ
twice  ||| S:10693 E:10699 ||| RB
that  ||| S:10699 E:10704 ||| IN
of  ||| S:10704 E:10707 ||| IN
the  ||| S:10707 E:10711 ||| DT
lowest ||| S:10711 E:10717 ||| JJS
,  ||| S:10717 E:10719 ||| ,
and  ||| S:10719 E:10723 ||| CC
cells  ||| S:10723 E:10729 ||| NNS
with  ||| S:10729 E:10744 ||| IN
intermediate  ||| S:10744 E:10757 ||| JJ
levels  ||| S:10757 E:10764 ||| NNS
of  ||| S:10764 E:10767 ||| IN
orange  ||| S:10767 E:10774 ||| JJ
fluorescence ||| S:10774 E:10786 ||| NN
.  ||| S:10786 E:10788 ||| .
This  ||| S:10788 E:10803 ||| DT
corresponds ||| S:10803 E:10814 ||| NN
,  ||| S:10814 E:10816 ||| ,
respectively ||| S:10816 E:10828 ||| RB
,  ||| S:10828 E:10830 ||| ,
to  ||| S:10830 E:10833 ||| TO
cells  ||| S:10833 E:10839 ||| NNS
containing  ||| S:10839 E:10850 ||| VBG
a  ||| S:10850 E:10852 ||| DT
2n  ||| S:10852 E:10855 ||| NNP
DNA  ||| S:10855 E:10869 ||| NNP
complement  ||| S:10869 E:10880 ||| VBD
prior  ||| S:10880 E:10886 ||| RB
to  ||| S:10886 E:10889 ||| TO
duplication  ||| S:10889 E:10901 ||| VB
of  ||| S:10901 E:10904 ||| IN
the  ||| S:10904 E:10908 ||| DT
genome  ||| S:10908 E:10915 ||| NN
( ||| S:10915 E:10916 ||| -LRB-
in  ||| S:10916 E:10919 ||| IN
G1  ||| S:10919 E:10932 ||| CD
phase ||| S:10932 E:10937 ||| NN
) ||| S:10937 E:10938 ||| -RRB-
,  ||| S:10938 E:10940 ||| ,
cells  ||| S:10940 E:10946 ||| NNS
containing  ||| S:10946 E:10957 ||| VBG
a  ||| S:10957 E:10959 ||| DT
4n  ||| S:10959 E:10962 ||| NNP
DNA  ||| S:10962 E:10966 ||| NNP
complement  ||| S:10966 E:10977 ||| FW
following  ||| S:10977 E:10997 ||| FW
genome  ||| S:10997 E:11004 ||| FW
duplication  ||| S:11004 E:11016 ||| FW
( ||| S:11016 E:11017 ||| -LRB-
in  ||| S:11017 E:11020 ||| IN
growth  ||| S:11020 E:11027 ||| NN
phase  ||| S:11027 E:11033 ||| NN
2  ||| S:11033 E:11035 ||| CD
or  ||| S:11035 E:11038 ||| CC
in  ||| S:11038 E:11041 ||| IN
mitosis ||| S:11041 E:11048 ||| NN
,  ||| S:11048 E:11060 ||| ,
G2 ||| S:11060 E:11062 ||| NNP
/ ||| S:11062 E:11063 ||| NNP
M ||| S:11063 E:11064 ||| NNP
) ||| S:11064 E:11065 ||| -RRB-
,  ||| S:11065 E:11067 ||| ,
and  ||| S:11067 E:11071 ||| CC
cells  ||| S:11071 E:11077 ||| NNS
containing  ||| S:11077 E:11088 ||| VBG
a  ||| S:11088 E:11090 ||| DT
partially  ||| S:11090 E:11100 ||| RB
replicated  ||| S:11100 E:11111 ||| VBN
genome  ||| S:11111 E:11128 ||| JJ
intermediate  ||| S:11128 E:11141 ||| NN
between  ||| S:11141 E:11149 ||| IN
2n  ||| S:11149 E:11152 ||| NNP
and  ||| S:11152 E:11156 ||| CC
4n  ||| S:11156 E:11159 ||| NNP
( ||| S:11159 E:11160 ||| -LRB-
in  ||| S:11160 E:11163 ||| IN
S  ||| S:11163 E:11165 ||| NNP
phase ||| S:11165 E:11170 ||| NN
) ||| S:11170 E:11171 ||| -RRB-
.  ||| S:11171 E:11173 ||| .
As  ||| S:11173 E:11176 ||| RB
averaged  ||| S:11176 E:11195 ||| VBN
from  ||| S:11195 E:11200 ||| IN
nine  ||| S:11200 E:11205 ||| CD
independent  ||| S:11205 E:11217 ||| JJ
experiments ||| S:11217 E:11228 ||| NNS
,  ||| S:11228 E:11230 ||| ,
the  ||| S:11230 E:11234 ||| DT
proportion  ||| S:11234 E:11245 ||| NN
of  ||| S:11245 E:11258 ||| IN
growing  ||| S:11258 E:11266 ||| VBG
GHFT1-5  ||| S:11266 E:11274 ||| CD
cells  ||| S:11274 E:11280 ||| NNS
in  ||| S:11280 E:11283 ||| IN
G1 ||| S:11283 E:11285 ||| NNP
,  ||| S:11285 E:11287 ||| ,
S  ||| S:11287 E:11289 ||| NNP
and  ||| S:11289 E:11293 ||| CC
G2 ||| S:11293 E:11295 ||| NNP
/ ||| S:11295 E:11296 ||| NNP
M  ||| S:11296 E:11298 ||| NNP
corresponded  ||| S:11298 E:11311 ||| VBD
to  ||| S:11311 E:11324 ||| TO
42 ||| S:11324 E:11326 ||| CD
% ||| S:11326 E:11327 ||| NN
,  ||| S:11327 E:11329 ||| ,
38 ||| S:11329 E:11331 ||| CD
%  ||| S:11331 E:11333 ||| NN
and  ||| S:11333 E:11337 ||| CC
20 ||| S:11337 E:11339 ||| CD
% ||| S:11339 E:11340 ||| NN
,  ||| S:11340 E:11342 ||| ,
respectively  ||| S:11342 E:11355 ||| RB
( ||| S:11355 E:11356 ||| -LRB-
Fig  ||| S:11356 E:11360 ||| NNP
3 ||| S:11360 E:11361 ||| CD
,  ||| S:11361 E:11363 ||| ,
white  ||| S:11363 E:11369 ||| JJ
bars ||| S:11369 E:11373 ||| NNS
) ||| S:11373 E:11374 ||| -RRB-
.  ||| S:11374 E:11386 ||| .
We  ||| S:11386 E:11389 ||| PRP
next  ||| S:11389 E:11394 ||| IN
synchronized  ||| S:11394 E:11407 ||| CD
GHFT1-5  ||| S:11407 E:11415 ||| CD
cells  ||| S:11415 E:11421 ||| NNS
in  ||| S:11421 E:11424 ||| IN
particular  ||| S:11424 E:11445 ||| JJ
stages  ||| S:11445 E:11452 ||| NNS
of  ||| S:11452 E:11455 ||| IN
the  ||| S:11455 E:11459 ||| DT
cell  ||| S:11459 E:11464 ||| NN
cycle ||| S:11464 E:11469 ||| NN
.  ||| S:11469 E:11471 ||| .
GHFT1-5  ||| S:11471 E:11479 ||| NNP
cells  ||| S:11479 E:11485 ||| NNS
were  ||| S:11485 E:11490 ||| VBD
treated  ||| S:11490 E:11498 ||| VBN
for  ||| S:11498 E:11512 ||| IN
20  ||| S:11512 E:11515 ||| CD
hours  ||| S:11515 E:11521 ||| NNS
with  ||| S:11521 E:11526 ||| IN
nocodazole ||| S:11526 E:11536 ||| NN
,  ||| S:11536 E:11538 ||| ,
which  ||| S:11538 E:11544 ||| WDT
prevents  ||| S:11544 E:11553 ||| VBZ
microtubule  ||| S:11553 E:11575 ||| FW
polymerization ||| S:11575 E:11589 ||| FW
/ ||| S:11589 E:11590 ||| FW
depolymerization  ||| S:11590 E:11607 ||| FW
and  ||| S:11607 E:11611 ||| CC
exit  ||| S:11611 E:11616 ||| NN
from  ||| S:11616 E:11621 ||| IN
M  ||| S:11621 E:11623 ||| NNP
phase  ||| S:11623 E:11629 ||| NN
[  ||| S:11629 E:11641 ||| -LRB-
47  ||| S:11641 E:11644 ||| CD
]  ||| S:11644 E:11646 ||| -RRB-
.  ||| S:11646 E:11648 ||| .
The  ||| S:11648 E:11652 ||| DT
delivery  ||| S:11652 E:11661 ||| NN
vehicle ||| S:11661 E:11668 ||| NN
,  ||| S:11668 E:11670 ||| ,
DMSO ||| S:11670 E:11674 ||| NNP
,  ||| S:11674 E:11676 ||| ,
was  ||| S:11676 E:11680 ||| VBD
added  ||| S:11680 E:11686 ||| VBN
to  ||| S:11686 E:11689 ||| TO
parallel  ||| S:11689 E:11708 ||| VB
cell  ||| S:11708 E:11713 ||| NN
cultures ||| S:11713 E:11721 ||| NNS
.  ||| S:11721 E:11723 ||| .
Cells  ||| S:11723 E:11729 ||| NNS
also  ||| S:11729 E:11734 ||| RB
were  ||| S:11734 E:11739 ||| VBD
treated  ||| S:11739 E:11747 ||| VBN
with  ||| S:11747 E:11752 ||| IN
mimosine  ||| S:11752 E:11761 ||| NNS
( ||| S:11761 E:11762 ||| -LRB-
in  ||| S:11762 E:11775 ||| IN
DMSO ||| S:11775 E:11779 ||| NNP
) ||| S:11779 E:11780 ||| -RRB-
,  ||| S:11780 E:11782 ||| ,
which  ||| S:11782 E:11788 ||| WDT
blocks  ||| S:11788 E:11795 ||| VBZ
cells  ||| S:11795 E:11801 ||| NNS
in  ||| S:11801 E:11804 ||| IN
late  ||| S:11804 E:11809 ||| JJ
G1  ||| S:11809 E:11812 ||| NN
immediately  ||| S:11812 E:11824 ||| RB
before  ||| S:11824 E:11841 ||| IN
entry  ||| S:11841 E:11847 ||| NN
into  ||| S:11847 E:11852 ||| IN
S  ||| S:11852 E:11854 ||| NNP
phase  ||| S:11854 E:11860 ||| NN
[  ||| S:11860 E:11862 ||| -LRB-
48  ||| S:11862 E:11865 ||| CD
]  ||| S:11865 E:11867 ||| -RRB-
.  ||| S:11867 E:11869 ||| .
Mimosine  ||| S:11869 E:11878 ||| NNP
also  ||| S:11878 E:11883 ||| RB
prolongs  ||| S:11883 E:11892 ||| VB
some  ||| S:11892 E:11907 ||| DT
cell  ||| S:11907 E:11912 ||| NN
types  ||| S:11912 E:11918 ||| NNS
in  ||| S:11918 E:11921 ||| IN
the  ||| S:11921 E:11925 ||| DT
S  ||| S:11925 E:11927 ||| NNP
phase  ||| S:11927 E:11933 ||| NN
itself  ||| S:11933 E:11940 ||| PRP
[  ||| S:11940 E:11942 ||| -LRB-
48  ||| S:11942 E:11945 ||| CD
]  ||| S:11945 E:11947 ||| -RRB-
.  ||| S:11947 E:11949 ||| .
GHFT1-5  ||| S:11949 E:11957 ||| NNP
cells  ||| S:11957 E:11973 ||| NNS
grow  ||| S:11973 E:11978 ||| VBP
with  ||| S:11978 E:11983 ||| IN
an  ||| S:11983 E:11986 ||| DT
average  ||| S:11986 E:11994 ||| JJ
doubling  ||| S:11994 E:12003 ||| NN
time  ||| S:12003 E:12008 ||| NN
of  ||| S:12008 E:12011 ||| IN
approximately  ||| S:12011 E:12025 ||| RB
18  ||| S:12025 E:12028 ||| CD
to  ||| S:12028 E:12041 ||| TO
24  ||| S:12041 E:12044 ||| CD
hours.  ||| S:12044 E:12051 ||| CD
20  ||| S:12051 E:12054 ||| CD
hours  ||| S:12054 E:12060 ||| NNS
of  ||| S:12060 E:12063 ||| IN
treatment  ||| S:12063 E:12073 ||| NN
allowed  ||| S:12073 E:12081 ||| VBD
most  ||| S:12081 E:12086 ||| JJS
cells  ||| S:12086 E:12092 ||| NNS
to  ||| S:12092 E:12105 ||| TO
pass  ||| S:12105 E:12110 ||| VB
through  ||| S:12110 E:12118 ||| IN
one  ||| S:12118 E:12122 ||| CD
cell  ||| S:12122 E:12127 ||| NN
cycle  ||| S:12127 E:12133 ||| NN
and  ||| S:12133 E:12137 ||| CC
to  ||| S:12137 E:12140 ||| TO
accumulate  ||| S:12140 E:12151 ||| VB
as  ||| S:12151 E:12154 ||| IN
4n  ||| S:12154 E:12157 ||| CD
cells  ||| S:12157 E:12173 ||| NNS
upon  ||| S:12173 E:12178 ||| IN
nocodazole  ||| S:12178 E:12189 ||| JJ
treatment  ||| S:12189 E:12199 ||| NN
( ||| S:12199 E:12200 ||| -LRB-
Fig.  ||| S:12200 E:12205 ||| CD
3 ||| S:12205 E:12206 ||| CD
,  ||| S:12206 E:12208 ||| ,
light  ||| S:12208 E:12214 ||| JJ
gray  ||| S:12214 E:12219 ||| JJ
bars ||| S:12219 E:12223 ||| NNS
)  ||| S:12223 E:12225 ||| -RRB-
or  ||| S:12225 E:12228 ||| CC
as  ||| S:12228 E:12241 ||| IN
2n  ||| S:12241 E:12244 ||| CD
cells  ||| S:12244 E:12250 ||| NNS
at  ||| S:12250 E:12253 ||| IN
the  ||| S:12253 E:12257 ||| DT
G1 ||| S:12257 E:12259 ||| NNP
/ ||| S:12259 E:12260 ||| NNP
S  ||| S:12260 E:12262 ||| NNP
boundary  ||| S:12262 E:12271 ||| NN
upon  ||| S:12271 E:12276 ||| IN
mimosine  ||| S:12276 E:12285 ||| JJ
treatment  ||| S:12285 E:12305 ||| NN
( ||| S:12305 E:12306 ||| -LRB-
Fig.  ||| S:12306 E:12311 ||| CD
3 ||| S:12311 E:12312 ||| CD
,  ||| S:12312 E:12314 ||| ,
stippled  ||| S:12314 E:12323 ||| JJ
gray  ||| S:12323 E:12328 ||| JJ
bars ||| S:12328 E:12332 ||| NNS
) ||| S:12332 E:12333 ||| -RRB-
.  ||| S:12333 E:12335 ||| .
Thus ||| S:12335 E:12339 ||| RB
,  ||| S:12339 E:12341 ||| ,
GHFT1-5  ||| S:12341 E:12349 ||| CD
cells  ||| S:12349 E:12355 ||| NNS
can  ||| S:12355 E:12359 ||| MD
be  ||| S:12359 E:12372 ||| VB
synchronized  ||| S:12372 E:12385 ||| VBN
at  ||| S:12385 E:12388 ||| IN
particular  ||| S:12388 E:12399 ||| JJ
stages  ||| S:12399 E:12406 ||| NNS
of  ||| S:12406 E:12409 ||| IN
the  ||| S:12409 E:12413 ||| DT
cell  ||| S:12413 E:12418 ||| NN
cycle ||| S:12418 E:12423 ||| NN
.  ||| S:12423 E:12435 ||| .
Synchronization  ||| S:12435 E:12451 ||| JJ
facilitated  ||| S:12451 E:12463 ||| JJ
characterization  ||| S:12463 E:12480 ||| NN
of  ||| S:12480 E:12483 ||| IN
the  ||| S:12483 E:12487 ||| DT
cell  ||| S:12487 E:12502 ||| NN
cycle  ||| S:12502 E:12508 ||| NN
stages  ||| S:12508 E:12515 ||| NNS
blocked  ||| S:12515 E:12523 ||| VBN
or  ||| S:12523 E:12526 ||| CC
prolonged  ||| S:12526 E:12536 ||| VBN
by  ||| S:12536 E:12539 ||| IN
C ||| S:12539 E:12540 ||| $
/ ||| S:12540 E:12541 ||| CD
EBPα  ||| S:12541 E:12556 ||| JJ
expression ||| S:12556 E:12566 ||| NN
.  ||| S:12566 E:12596 ||| .
Transcriptionally  ||| S:12596 E:12614 ||| JJ
active  ||| S:12614 E:12621 ||| JJ
and  ||| S:12621 E:12625 ||| CC
inactive  ||| S:12625 E:12634 ||| JJ
C ||| S:12634 E:12635 ||| NNP
/ ||| S:12635 E:12636 ||| NNP
EBPα  ||| S:12636 E:12641 ||| NNP
both  ||| S:12641 E:12656 ||| CC
retain  ||| S:12656 E:12663 ||| VB
GHFT1-5  ||| S:12663 E:12671 ||| CD
cells  ||| S:12671 E:12677 ||| NNS
in  ||| S:12677 E:12680 ||| IN
the  ||| S:12680 E:12684 ||| DT
G1  ||| S:12684 E:12687 ||| NNP
and  ||| S:12687 E:12691 ||| CC
S  ||| S:12691 E:12693 ||| NNP
phases  ||| S:12693 E:12700 ||| NNS
of  ||| S:12700 E:12703 ||| IN
the  ||| S:12703 E:12707 ||| DT
cell  ||| S:12707 E:12722 ||| NN
cycle  ||| S:12722 E:12738 ||| NN
We  ||| S:12738 E:12741 ||| PRP
determined  ||| S:12741 E:12752 ||| VBD
if  ||| S:12752 E:12755 ||| IN
either  ||| S:12755 E:12762 ||| DT
C ||| S:12762 E:12763 ||| NNP
/ ||| S:12763 E:12764 ||| NNP
EBPα-GFP  ||| S:12764 E:12773 ||| NNP
or  ||| S:12773 E:12776 ||| CC
GFP-C ||| S:12776 E:12781 ||| NNP
/ ||| S:12781 E:12782 ||| NNP
EBPα  ||| S:12782 E:12797 ||| NNP
altered  ||| S:12797 E:12805 ||| VBD
the  ||| S:12805 E:12809 ||| DT
distribution  ||| S:12809 E:12822 ||| NN
of  ||| S:12822 E:12825 ||| IN
GHFT1-5  ||| S:12825 E:12833 ||| CD
cells  ||| S:12833 E:12839 ||| NNS
in  ||| S:12839 E:12842 ||| IN
the  ||| S:12842 E:12846 ||| DT
G1 ||| S:12846 E:12848 ||| NNP
,  ||| S:12848 E:12850 ||| ,
S  ||| S:12850 E:12852 ||| NNP
or  ||| S:12852 E:12865 ||| CC
G2 ||| S:12865 E:12867 ||| NNP
/ ||| S:12867 E:12868 ||| NNP
M  ||| S:12868 E:12870 ||| NNP
phases  ||| S:12870 E:12877 ||| NNS
of  ||| S:12877 E:12880 ||| IN
the  ||| S:12880 E:12884 ||| DT
cell  ||| S:12884 E:12889 ||| NN
cycle ||| S:12889 E:12894 ||| NN
.  ||| S:12894 E:12896 ||| .
GHFT1-5  ||| S:12896 E:12904 ||| NNP
cells  ||| S:12904 E:12910 ||| NNS
were  ||| S:12910 E:12925 ||| VBD
transfected  ||| S:12925 E:12937 ||| VBN
with  ||| S:12937 E:12942 ||| IN
the  ||| S:12942 E:12946 ||| DT
expression  ||| S:12946 E:12957 ||| NN
vectors  ||| S:12957 E:12965 ||| NN
for  ||| S:12965 E:12969 ||| IN
C ||| S:12969 E:12970 ||| NNP
/ ||| S:12970 E:12971 ||| NNP
EBPα-GFP  ||| S:12971 E:12980 ||| NNP
or  ||| S:12980 E:12993 ||| CC
GFP-C ||| S:12993 E:12998 ||| NNP
/ ||| S:12998 E:12999 ||| NNP
EBPα ||| S:12999 E:13003 ||| NNP
,  ||| S:13003 E:13005 ||| ,
or  ||| S:13005 E:13008 ||| CC
with  ||| S:13008 E:13013 ||| IN
the  ||| S:13013 E:13017 ||| DT
sham  ||| S:13017 E:13022 ||| JJ
expression  ||| S:13022 E:13033 ||| NN
vector  ||| S:13033 E:13040 ||| NN
not  ||| S:13040 E:13054 ||| RB
containing  ||| S:13054 E:13065 ||| VBG
the  ||| S:13065 E:13069 ||| DT
C ||| S:13069 E:13070 ||| NNP
/ ||| S:13070 E:13071 ||| NNP
EBPα  ||| S:13071 E:13076 ||| NNP
cDNA ||| S:13076 E:13080 ||| NNP
.  ||| S:13080 E:13082 ||| .
The  ||| S:13082 E:13086 ||| DT
cells  ||| S:13086 E:13092 ||| NNS
were  ||| S:13092 E:13097 ||| VBD
incubated  ||| S:13097 E:13107 ||| VBN
for  ||| S:13107 E:13121 ||| IN
one  ||| S:13121 E:13125 ||| CD
day  ||| S:13125 E:13129 ||| NN
to  ||| S:13129 E:13132 ||| TO
allow  ||| S:13132 E:13138 ||| VB
time  ||| S:13138 E:13143 ||| NN
for  ||| S:13143 E:13147 ||| IN
C ||| S:13147 E:13148 ||| $
/ ||| S:13148 E:13149 ||| CD
EBPα  ||| S:13149 E:13154 ||| JJ
expression ||| S:13154 E:13164 ||| NN
.  ||| S:13164 E:13166 ||| .
Cells  ||| S:13166 E:13172 ||| NNS
were  ||| S:13172 E:13187 ||| VBD
then  ||| S:13187 E:13192 ||| RB
synchronized  ||| S:13192 E:13205 ||| VBN
in  ||| S:13205 E:13208 ||| IN
M-phase  ||| S:13208 E:13216 ||| JJ
or  ||| S:13216 E:13219 ||| CC
in  ||| S:13219 E:13222 ||| IN
G1 ||| S:13222 E:13224 ||| NNP
/ ||| S:13224 E:13225 ||| NNP
S  ||| S:13225 E:13227 ||| NNP
by  ||| S:13227 E:13230 ||| IN
20-hour  ||| S:13230 E:13248 ||| JJ
incubations  ||| S:13248 E:13260 ||| NN
with  ||| S:13260 E:13265 ||| IN
nocodazole  ||| S:13265 E:13276 ||| NNS
( ||| S:13276 E:13277 ||| -LRB-
Fig.  ||| S:13277 E:13282 ||| NNP
4A ||| S:13282 E:13284 ||| NNP
)  ||| S:13284 E:13286 ||| -RRB-
or  ||| S:13286 E:13289 ||| CC
mimosine  ||| S:13289 E:13298 ||| NNS
( ||| S:13298 E:13299 ||| -LRB-
Fig.  ||| S:13299 E:13314 ||| NNP
4B ||| S:13314 E:13316 ||| NNP
) ||| S:13316 E:13317 ||| -RRB-
.  ||| S:13317 E:13319 ||| .
Cells  ||| S:13319 E:13325 ||| NNS
were  ||| S:13325 E:13330 ||| VBD
collected  ||| S:13330 E:13340 ||| VBN
and  ||| S:13340 E:13344 ||| CC
stained  ||| S:13344 E:13352 ||| NN
with  ||| S:13352 E:13357 ||| IN
propidium  ||| S:13357 E:13377 ||| JJ
iodide ||| S:13377 E:13383 ||| NN
.  ||| S:13383 E:13385 ||| .
Flow  ||| S:13385 E:13390 ||| NN
cytometry  ||| S:13390 E:13400 ||| NNS
was  ||| S:13400 E:13404 ||| VBD
used  ||| S:13404 E:13409 ||| VBN
to  ||| S:13409 E:13412 ||| TO
measure  ||| S:13412 E:13420 ||| VB
DNA  ||| S:13420 E:13424 ||| NN
content  ||| S:13424 E:13432 ||| NN
in  ||| S:13432 E:13445 ||| IN
1 ||| S:13445 E:13446 ||| CD
)  ||| S:13446 E:13448 ||| -RRB-
cells  ||| S:13448 E:13454 ||| NNS
transfected  ||| S:13454 E:13466 ||| VBN
with  ||| S:13466 E:13471 ||| IN
the  ||| S:13471 E:13475 ||| DT
sham  ||| S:13475 E:13480 ||| JJ
expression  ||| S:13480 E:13491 ||| NN
vector  ||| S:13491 E:13508 ||| NN
( ||| S:13508 E:13509 ||| -LRB-
Fig.  ||| S:13509 E:13514 ||| CD
4 ||| S:13514 E:13515 ||| CD
,  ||| S:13515 E:13517 ||| ,
Sham ||| S:13517 E:13521 ||| NNP
) ||| S:13521 E:13522 ||| -RRB-
,  ||| S:13522 E:13524 ||| ,
2 ||| S:13524 E:13525 ||| LS
)  ||| S:13525 E:13527 ||| -RRB-
green  ||| S:13527 E:13533 ||| JJ
fluorescent  ||| S:13533 E:13545 ||| JJ
cells  ||| S:13545 E:13551 ||| NNS
expressing  ||| S:13551 E:13572 ||| VBG
GFP-tagged  ||| S:13572 E:13583 ||| JJ
C ||| S:13583 E:13584 ||| NNP
/ ||| S:13584 E:13585 ||| NNP
EBPα  ||| S:13585 E:13590 ||| NNP
( ||| S:13590 E:13591 ||| -LRB-
Fig.  ||| S:13591 E:13596 ||| CD
4 ||| S:13596 E:13597 ||| CD
,  ||| S:13597 E:13599 ||| ,
C ||| S:13599 E:13600 ||| NNP
/ ||| S:13600 E:13601 ||| NNP
EBPα-GFP  ||| S:13601 E:13610 ||| NNP
or  ||| S:13610 E:13613 ||| CC
GFP-C ||| S:13613 E:13618 ||| NNP
/ ||| S:13618 E:13619 ||| NNP
EBPα ||| S:13619 E:13623 ||| NNP
)  ||| S:13623 E:13625 ||| -RRB-
or  ||| S:13625 E:13638 ||| CC
3 ||| S:13638 E:13639 ||| LS
)  ||| S:13639 E:13641 ||| -RRB-
the  ||| S:13641 E:13645 ||| DT
subpopulation  ||| S:13645 E:13659 ||| NN
of  ||| S:13659 E:13662 ||| IN
cells  ||| S:13662 E:13668 ||| NNS
from  ||| S:13668 E:13673 ||| IN
the  ||| S:13673 E:13677 ||| DT
C ||| S:13677 E:13678 ||| NNP
/ ||| S:13678 E:13679 ||| NNP
EBPα-GFP  ||| S:13679 E:13688 ||| NNP
or  ||| S:13688 E:13701 ||| CC
GFP-C ||| S:13701 E:13706 ||| JJ
/ ||| S:13706 E:13707 ||| CD
EBPα  ||| S:13707 E:13712 ||| JJ
transfections  ||| S:13712 E:13726 ||| NN
that  ||| S:13726 E:13731 ||| WDT
did  ||| S:13731 E:13735 ||| VBD
not  ||| S:13735 E:13739 ||| RB
express  ||| S:13739 E:13747 ||| VB
measurable  ||| S:13747 E:13768 ||| JJ
amounts  ||| S:13768 E:13776 ||| NNS
of  ||| S:13776 E:13779 ||| IN
green  ||| S:13779 E:13785 ||| JJ
fluorescent  ||| S:13785 E:13797 ||| JJ
C ||| S:13797 E:13798 ||| NNP
/ ||| S:13798 E:13799 ||| NNP
EBPα  ||| S:13799 E:13804 ||| NNP
( ||| S:13804 E:13805 ||| -LRB-
Fig.  ||| S:13805 E:13810 ||| CD
4 ||| S:13810 E:13811 ||| CD
,  ||| S:13811 E:13813 ||| ,
No  ||| S:13813 E:13816 ||| DT
C ||| S:13816 E:13817 ||| NNP
/ ||| S:13817 E:13818 ||| NNP
EBP ||| S:13818 E:13821 ||| NNP
) ||| S:13821 E:13822 ||| -RRB-
.  ||| S:13822 E:13834 ||| .
The  ||| S:13834 E:13838 ||| DT
"No  ||| S:13838 E:13842 ||| NNP
C ||| S:13842 E:13843 ||| NNP
/ ||| S:13843 E:13844 ||| NNP
EBP ||| S:13844 E:13847 ||| NNP
"  ||| S:13847 E:13849 ||| ''
cells  ||| S:13849 E:13855 ||| NNS
represent  ||| S:13855 E:13865 ||| VBP
an  ||| S:13865 E:13868 ||| DT
internal  ||| S:13868 E:13877 ||| JJ
control  ||| S:13877 E:13885 ||| NN
for  ||| S:13885 E:13899 ||| IN
cells  ||| S:13899 E:13905 ||| NNS
not  ||| S:13905 E:13909 ||| RB
expressing  ||| S:13909 E:13920 ||| VBG
C ||| S:13920 E:13921 ||| NNP
/ ||| S:13921 E:13922 ||| NNP
EBPα  ||| S:13922 E:13927 ||| NNP
collected  ||| S:13927 E:13937 ||| VBD
simultaneously  ||| S:13937 E:13952 ||| RB
with  ||| S:13952 E:13967 ||| IN
cells  ||| S:13967 E:13973 ||| NNS
expressing  ||| S:13973 E:13984 ||| VBG
C ||| S:13984 E:13985 ||| NNP
/ ||| S:13985 E:13986 ||| NNP
EBPα ||| S:13986 E:13990 ||| NNP
.  ||| S:13990 E:13992 ||| .
The  ||| S:13992 E:13996 ||| DT
No  ||| S:13996 E:13999 ||| NNP
C ||| S:13999 E:14000 ||| NNP
/ ||| S:14000 E:14001 ||| NNP
EBP  ||| S:14001 E:14005 ||| NNP
controls  ||| S:14005 E:14014 ||| VBZ
also  ||| S:14014 E:14029 ||| RB
indicated  ||| S:14029 E:14039 ||| VBD
the  ||| S:14039 E:14043 ||| DT
extent  ||| S:14043 E:14050 ||| NN
to  ||| S:14050 E:14053 ||| TO
which  ||| S:14053 E:14059 ||| WDT
green  ||| S:14059 E:14065 ||| JJ
fluorescent ||| S:14065 E:14076 ||| NN
,  ||| S:14076 E:14088 ||| ,
C ||| S:14088 E:14089 ||| NNP
/ ||| S:14089 E:14090 ||| NNP
EBPα-expressing  ||| S:14090 E:14106 ||| JJ
cells  ||| S:14106 E:14112 ||| NNS
were  ||| S:14112 E:14117 ||| VBD
distinguished  ||| S:14117 E:14131 ||| VBN
from  ||| S:14131 E:14146 ||| IN
non-expressing  ||| S:14146 E:14161 ||| JJ
cells  ||| S:14161 E:14167 ||| NNS
by  ||| S:14167 E:14170 ||| IN
flow  ||| S:14170 E:14175 ||| NN
cytometry ||| S:14175 E:14184 ||| NN
.  ||| S:14184 E:14186 ||| .
For  ||| S:14186 E:14190 ||| IN
all  ||| S:14190 E:14194 ||| PDT
our  ||| S:14194 E:14208 ||| PRP$
experiments ||| S:14208 E:14219 ||| NNS
,  ||| S:14219 E:14221 ||| ,
the  ||| S:14221 E:14225 ||| DT
distribution  ||| S:14225 E:14238 ||| NN
of  ||| S:14238 E:14241 ||| IN
cells  ||| S:14241 E:14247 ||| NNS
in  ||| S:14247 E:14250 ||| IN
the  ||| S:14250 E:14254 ||| DT
G1 ||| S:14254 E:14256 ||| NNP
,  ||| S:14256 E:14258 ||| ,
S  ||| S:14258 E:14260 ||| NNP
and  ||| S:14260 E:14274 ||| CC
G2 ||| S:14274 E:14276 ||| NNP
/ ||| S:14276 E:14277 ||| NNP
M  ||| S:14277 E:14279 ||| NNP
phases  ||| S:14279 E:14286 ||| NNS
was  ||| S:14286 E:14290 ||| VBD
similar  ||| S:14290 E:14298 ||| JJ
for  ||| S:14298 E:14302 ||| IN
the  ||| S:14302 E:14306 ||| DT
"No  ||| S:14306 E:14310 ||| NNP
C ||| S:14310 E:14311 ||| NNP
/ ||| S:14311 E:14312 ||| NNP
EBPα  ||| S:14312 E:14317 ||| NNP
"  ||| S:14317 E:14319 ||| ''
and  ||| S:14319 E:14333 ||| CC
sham-transfected  ||| S:14333 E:14350 ||| JJ
cells ||| S:14350 E:14355 ||| NNS
.  ||| S:14355 E:14367 ||| .
The  ||| S:14367 E:14371 ||| DT
expression  ||| S:14371 E:14382 ||| NN
of  ||| S:14382 E:14385 ||| IN
C ||| S:14385 E:14386 ||| NNP
/ ||| S:14386 E:14387 ||| NNP
EBPα-GFP  ||| S:14387 E:14396 ||| NNP
or  ||| S:14396 E:14399 ||| CC
GFP-C ||| S:14399 E:14404 ||| NNP
/ ||| S:14404 E:14405 ||| NNP
EBPα  ||| S:14405 E:14410 ||| NNP
resulted  ||| S:14410 E:14419 ||| VBD
in  ||| S:14419 E:14432 ||| IN
a  ||| S:14432 E:14434 ||| DT
statistically  ||| S:14434 E:14448 ||| JJ
significant  ||| S:14448 E:14460 ||| JJ
decrease  ||| S:14460 E:14469 ||| NN
in  ||| S:14469 E:14472 ||| IN
the  ||| S:14472 E:14476 ||| DT
amount  ||| S:14476 E:14483 ||| NN
of  ||| S:14483 E:14496 ||| IN
cells  ||| S:14496 E:14502 ||| NNS
blocked  ||| S:14502 E:14510 ||| VBN
in  ||| S:14510 E:14513 ||| IN
G2 ||| S:14513 E:14515 ||| NNP
/ ||| S:14515 E:14516 ||| NNP
M  ||| S:14516 E:14518 ||| NNP
upon  ||| S:14518 E:14523 ||| IN
nocodazole  ||| S:14523 E:14534 ||| JJ
treatment  ||| S:14534 E:14544 ||| NN
compared  ||| S:14544 E:14563 ||| VBN
to  ||| S:14563 E:14566 ||| TO
sham-transfected  ||| S:14566 E:14583 ||| JJ
cells  ||| S:14583 E:14589 ||| NNS
( ||| S:14589 E:14590 ||| -LRB-
Fig.  ||| S:14590 E:14595 ||| NNP
4A ||| S:14595 E:14597 ||| NNP
)  ||| S:14597 E:14599 ||| -RRB-
( ||| S:14599 E:14600 ||| -LRB-
p  ||| S:14600 E:14602 ||| CD
< ||| S:14602 E:14603 ||| SYM
< ||| S:14603 E:14605 ||| SYM
0.01 ||| S:14605 E:14609 ||| CD
,  ||| S:14609 E:14611 ||| ,
n  ||| S:14611 E:14613 ||| VBG
=  ||| S:14613 E:14625 ||| SYM
6 ||| S:14625 E:14626 ||| CD
) ||| S:14626 E:14627 ||| -RRB-
.  ||| S:14627 E:14629 ||| .
This  ||| S:14629 E:14634 ||| DT
indicated  ||| S:14634 E:14644 ||| VBN
that  ||| S:14644 E:14649 ||| IN
C ||| S:14649 E:14650 ||| $
/ ||| S:14650 E:14651 ||| CD
EBPα  ||| S:14651 E:14656 ||| JJ
expression  ||| S:14656 E:14667 ||| NN
prevented  ||| S:14667 E:14677 ||| VBD
a  ||| S:14677 E:14689 ||| DT
significant  ||| S:14689 E:14701 ||| JJ
proportion  ||| S:14701 E:14712 ||| NN
of  ||| S:14712 E:14715 ||| IN
GHFT1-5  ||| S:14715 E:14723 ||| CD
cells  ||| S:14723 E:14729 ||| NNS
from  ||| S:14729 E:14734 ||| IN
reaching  ||| S:14734 E:14753 ||| VBG
G2 ||| S:14753 E:14755 ||| NNP
/ ||| S:14755 E:14756 ||| NNP
M  ||| S:14756 E:14758 ||| NNP
to  ||| S:14758 E:14761 ||| TO
be  ||| S:14761 E:14764 ||| VB
blocked  ||| S:14764 E:14772 ||| VBN
by  ||| S:14772 E:14775 ||| IN
nocodazole ||| S:14775 E:14785 ||| NN
.  ||| S:14785 E:14787 ||| .
When  ||| S:14787 E:14792 ||| WRB
cells  ||| S:14792 E:14798 ||| NNS
were  ||| S:14798 E:14803 ||| VBD
blocked  ||| S:14803 E:14821 ||| VBN
in  ||| S:14821 E:14824 ||| IN
G1  ||| S:14824 E:14827 ||| CD
by  ||| S:14827 E:14830 ||| IN
mimosine  ||| S:14830 E:14839 ||| JJ
treatment ||| S:14839 E:14848 ||| NN
,  ||| S:14848 E:14850 ||| ,
C ||| S:14850 E:14851 ||| NNP
/ ||| S:14851 E:14852 ||| NNP
EBPα  ||| S:14852 E:14857 ||| JJ
expression  ||| S:14857 E:14868 ||| NN
caused  ||| S:14868 E:14875 ||| VBD
no  ||| S:14875 E:14888 ||| DT
decrease  ||| S:14888 E:14897 ||| NN
in  ||| S:14897 E:14900 ||| IN
the  ||| S:14900 E:14904 ||| DT
proportion  ||| S:14904 E:14915 ||| NN
of  ||| S:14915 E:14918 ||| IN
cells  ||| S:14918 E:14924 ||| NNS
in  ||| S:14924 E:14927 ||| IN
G2 ||| S:14927 E:14929 ||| NNP
/ ||| S:14929 E:14930 ||| NNP
M  ||| S:14930 E:14932 ||| NNP
( ||| S:14932 E:14933 ||| -LRB-
Fig.  ||| S:14933 E:14938 ||| NNP
4B ||| S:14938 E:14940 ||| NNP
) ||| S:14940 E:14941 ||| -RRB-
.  ||| S:14941 E:14953 ||| .
This  ||| S:14953 E:14958 ||| DT
demonstrated  ||| S:14958 E:14971 ||| VBN
that  ||| S:14971 E:14976 ||| IN
C ||| S:14976 E:14977 ||| $
/ ||| S:14977 E:14978 ||| CD
EBPα  ||| S:14978 E:14983 ||| JJ
expression  ||| S:14983 E:14994 ||| NN
did  ||| S:14994 E:14998 ||| VBD
not  ||| S:14998 E:15002 ||| RB
actively  ||| S:15002 E:15021 ||| RB
decrease  ||| S:15021 E:15030 ||| VB
the  ||| S:15030 E:15034 ||| DT
proportion  ||| S:15034 E:15045 ||| NN
of  ||| S:15045 E:15048 ||| IN
cells  ||| S:15048 E:15054 ||| NNS
in  ||| S:15054 E:15057 ||| IN
G2 ||| S:15057 E:15059 ||| NNP
/ ||| S:15059 E:15060 ||| NNP
M ||| S:15060 E:15061 ||| NNP
.  ||| S:15061 E:15073 ||| .
The  ||| S:15073 E:15077 ||| DT
C ||| S:15077 E:15078 ||| $
/ ||| S:15078 E:15079 ||| CD
EBPα-induced  ||| S:15079 E:15092 ||| JJ
reduction  ||| S:15092 E:15102 ||| NN
in  ||| S:15102 E:15105 ||| IN
cells  ||| S:15105 E:15111 ||| NNS
blocked  ||| S:15111 E:15119 ||| VBN
in  ||| S:15119 E:15122 ||| IN
G2 ||| S:15122 E:15124 ||| NNP
/ ||| S:15124 E:15125 ||| NNP
M  ||| S:15125 E:15137 ||| NNP
was  ||| S:15137 E:15141 ||| VBD
associated  ||| S:15141 E:15152 ||| VBN
with  ||| S:15152 E:15157 ||| IN
a  ||| S:15157 E:15159 ||| DT
highly  ||| S:15159 E:15166 ||| RB
statistically  ||| S:15166 E:15180 ||| RB
significant  ||| S:15180 E:15202 ||| JJ
increase  ||| S:15202 E:15211 ||| NN
in  ||| S:15211 E:15214 ||| IN
the  ||| S:15214 E:15218 ||| DT
proportion  ||| S:15218 E:15229 ||| NN
of  ||| S:15229 E:15232 ||| IN
GHFT1-5  ||| S:15232 E:15240 ||| CD
pituitary  ||| S:15240 E:15260 ||| CD
progenitor  ||| S:15260 E:15271 ||| CD
cells  ||| S:15271 E:15277 ||| NNS
in  ||| S:15277 E:15280 ||| IN
G1  ||| S:15280 E:15283 ||| NNP
( ||| S:15283 E:15284 ||| -LRB-
p  ||| S:15284 E:15286 ||| FW
< ||| S:15286 E:15288 ||| SYM
0.001 ||| S:15288 E:15293 ||| FW
)  ||| S:15293 E:15295 ||| -RRB-
and  ||| S:15295 E:15299 ||| CC
a  ||| S:15299 E:15301 ||| DT
statistically  ||| S:15301 E:15325 ||| JJ
significant  ||| S:15325 E:15337 ||| JJ
increase  ||| S:15337 E:15346 ||| NN
in  ||| S:15346 E:15349 ||| IN
the  ||| S:15349 E:15353 ||| DT
proportion  ||| S:15353 E:15364 ||| NN
of  ||| S:15364 E:15367 ||| IN
cells  ||| S:15367 E:15373 ||| NNS
in  ||| S:15373 E:15376 ||| IN
S  ||| S:15376 E:15388 ||| NNP
phase  ||| S:15388 E:15394 ||| NN
( ||| S:15394 E:15395 ||| -LRB-
p  ||| S:15395 E:15397 ||| CD
< ||| S:15397 E:15399 ||| SYM
0.03 ||| S:15399 E:15403 ||| CD
)  ||| S:15403 E:15405 ||| -RRB-
( ||| S:15405 E:15406 ||| -LRB-
Fig.  ||| S:15406 E:15411 ||| NNP
4A ||| S:15411 E:15413 ||| NNP
) ||| S:15413 E:15414 ||| -RRB-
.  ||| S:15414 E:15416 ||| .
This  ||| S:15416 E:15421 ||| DT
retention  ||| S:15421 E:15431 ||| NN
of  ||| S:15431 E:15434 ||| IN
GHFT1-5  ||| S:15434 E:15452 ||| CD
cells  ||| S:15452 E:15458 ||| NNS
in  ||| S:15458 E:15461 ||| IN
the  ||| S:15461 E:15465 ||| DT
G1  ||| S:15465 E:15468 ||| NNP
and  ||| S:15468 E:15472 ||| CC
S  ||| S:15472 E:15474 ||| NNP
phases  ||| S:15474 E:15481 ||| NNS
of  ||| S:15481 E:15484 ||| IN
the  ||| S:15484 E:15488 ||| DT
cell  ||| S:15488 E:15493 ||| NN
cycle  ||| S:15493 E:15499 ||| NN
occurred  ||| S:15499 E:15518 ||| VBD
for  ||| S:15518 E:15522 ||| IN
both  ||| S:15522 E:15527 ||| PDT
the  ||| S:15527 E:15531 ||| DT
transcriptionally  ||| S:15531 E:15549 ||| JJ
active  ||| S:15549 E:15556 ||| JJ
C ||| S:15556 E:15557 ||| NNP
/ ||| S:15557 E:15558 ||| NNP
EBPα-GFP  ||| S:15558 E:15567 ||| NNP
and  ||| S:15567 E:15581 ||| CC
inactive  ||| S:15581 E:15590 ||| FW
GFP-C ||| S:15590 E:15595 ||| FW
/ ||| S:15595 E:15596 ||| FW
EBPα  ||| S:15596 E:15601 ||| FW
fusions ||| S:15601 E:15608 ||| FW
.  ||| S:15608 E:15610 ||| .
The  ||| S:15610 E:15614 ||| DT
independence  ||| S:15614 E:15627 ||| NN
of  ||| S:15627 E:15640 ||| IN
C ||| S:15640 E:15641 ||| $
/ ||| S:15641 E:15642 ||| CD
EBPα-induced  ||| S:15642 E:15655 ||| JJ
proliferation  ||| S:15655 E:15669 ||| NN
arrest  ||| S:15669 E:15676 ||| NN
from  ||| S:15676 E:15681 ||| IN
C ||| S:15681 E:15682 ||| $
/ ||| S:15682 E:15683 ||| CD
EBPα-regulated  ||| S:15683 E:15708 ||| JJ
transcriptional  ||| S:15708 E:15724 ||| NNS
activation  ||| S:15724 E:15735 ||| VBP
also  ||| S:15735 E:15740 ||| RB
has  ||| S:15740 E:15744 ||| VBZ
been  ||| S:15744 E:15749 ||| VBN
observed  ||| S:15749 E:15758 ||| VBN
in  ||| S:15758 E:15771 ||| IN
other  ||| S:15771 E:15777 ||| JJ
studies  ||| S:15777 E:15785 ||| NNS
[  ||| S:15785 E:15787 ||| -LRB-
25  ||| S:15787 E:15790 ||| CD
26  ||| S:15790 E:15793 ||| CD
]  ||| S:15793 E:15795 ||| -RRB-
.  ||| S:15795 E:15797 ||| .
Thus ||| S:15797 E:15801 ||| RB
,  ||| S:15801 E:15803 ||| ,
simple  ||| S:15803 E:15810 ||| JJ
transcription  ||| S:15810 E:15834 ||| JJ
activation  ||| S:15834 E:15845 ||| JJ
mechanisms  ||| S:15845 E:15856 ||| NNS
do  ||| S:15856 E:15859 ||| VBP
not  ||| S:15859 E:15863 ||| RB
account  ||| S:15863 E:15871 ||| VBP
for  ||| S:15871 E:15875 ||| IN
the  ||| S:15875 E:15879 ||| DT
effect  ||| S:15879 E:15886 ||| NN
of  ||| S:15886 E:15899 ||| IN
C ||| S:15899 E:15900 ||| $
/ ||| S:15900 E:15901 ||| CD
EBPα  ||| S:15901 E:15906 ||| NN
on  ||| S:15906 E:15909 ||| IN
the  ||| S:15909 E:15913 ||| DT
cell  ||| S:15913 E:15918 ||| NN
cycle ||| S:15918 E:15923 ||| NN
.  ||| S:15923 E:15953 ||| .
Targeting  ||| S:15953 E:15963 ||| VBG
of  ||| S:15963 E:15966 ||| IN
C ||| S:15966 E:15967 ||| $
/ ||| S:15967 E:15968 ||| CD
EBPα  ||| S:15968 E:15973 ||| JJ
to  ||| S:15973 E:15976 ||| TO
the  ||| S:15976 E:15980 ||| DT
presumed  ||| S:15980 E:15989 ||| JJ
centromeric  ||| S:15989 E:16011 ||| JJ
G1 ||| S:16011 E:16013 ||| NNP
/ ||| S:16013 E:16014 ||| NNP
S  ||| S:16014 E:16016 ||| NNP
checkpoint  ||| S:16016 E:16027 ||| NN
is  ||| S:16027 E:16030 ||| VBZ
insufficient  ||| S:16030 E:16043 ||| JJ
for  ||| S:16043 E:16047 ||| IN
prolongation  ||| S:16047 E:16060 ||| NN
of  ||| S:16060 E:16073 ||| IN
G1  ||| S:16073 E:16086 ||| NNP
Our  ||| S:16086 E:16090 ||| PRP$
prior  ||| S:16090 E:16096 ||| JJ
fluorescence  ||| S:16096 E:16109 ||| JJ
microscopy  ||| S:16109 E:16120 ||| JJ
studies  ||| S:16120 E:16128 ||| NNS
showed  ||| S:16128 E:16135 ||| VBD
that  ||| S:16135 E:16150 ||| IN
C ||| S:16150 E:16151 ||| NNP
/ ||| S:16151 E:16152 ||| NNP
EBPα-GFP ||| S:16152 E:16160 ||| NNP
,  ||| S:16160 E:16162 ||| ,
GFP-C ||| S:16162 E:16167 ||| NNP
/ ||| S:16167 E:16168 ||| NNP
EBPα ||| S:16168 E:16172 ||| NNP
,  ||| S:16172 E:16174 ||| ,
and  ||| S:16174 E:16178 ||| CC
antibody-stained  ||| S:16178 E:16195 ||| NNP
C ||| S:16195 E:16196 ||| NNP
/ ||| S:16196 E:16197 ||| NNP
EBPα  ||| S:16197 E:16202 ||| NNP
[  ||| S:16202 E:16204 ||| -LRB-
45  ||| S:16204 E:16217 ||| CD
46  ||| S:16217 E:16220 ||| CD
]  ||| S:16220 E:16222 ||| -RRB-
,  ||| S:16222 E:16224 ||| ,
concentrated  ||| S:16224 E:16237 ||| VBN
at  ||| S:16237 E:16240 ||| IN
specific  ||| S:16240 E:16249 ||| JJ
intranuclear  ||| S:16249 E:16262 ||| JJ
domains  ||| S:16262 E:16270 ||| NN
in  ||| S:16270 E:16283 ||| IN
GHFT1-5  ||| S:16283 E:16291 ||| CD
cells  ||| S:16291 E:16297 ||| NNS
( ||| S:16297 E:16298 ||| -LRB-
see  ||| S:16298 E:16302 ||| VB
Fig.  ||| S:16302 E:16307 ||| CD
5A ||| S:16307 E:16309 ||| CD
,  ||| S:16309 E:16311 ||| ,
GFP-C ||| S:16311 E:16316 ||| NNP
/ ||| S:16316 E:16317 ||| NNP
EBPα ||| S:16317 E:16321 ||| NNP
) ||| S:16321 E:16322 ||| -RRB-
.  ||| S:16322 E:16324 ||| .
These  ||| S:16324 E:16330 ||| DT
domains  ||| S:16330 E:16348 ||| JJ
coincide  ||| S:16348 E:16357 ||| NN
with  ||| S:16357 E:16362 ||| IN
regions  ||| S:16362 E:16370 ||| NNS
that  ||| S:16370 E:16375 ||| IN
stain  ||| S:16375 E:16381 ||| NN
with  ||| S:16381 E:16386 ||| IN
the  ||| S:16386 E:16390 ||| DT
blue  ||| S:16390 E:16405 ||| JJ
fluorescent  ||| S:16405 E:16417 ||| JJ
DNA-binding  ||| S:16417 E:16429 ||| JJ
dye  ||| S:16429 E:16433 ||| JJ
Hoechst  ||| S:16433 E:16441 ||| NNP
33342  ||| S:16441 E:16447 ||| CD
( ||| S:16447 E:16448 ||| -LRB-
Fig.  ||| S:16448 E:16453 ||| NNP
5A ||| S:16453 E:16455 ||| NNP
,  ||| S:16455 E:16467 ||| ,
Hoechst  ||| S:16467 E:16475 ||| NNP
33342 ||| S:16475 E:16480 ||| CD
) ||| S:16480 E:16481 ||| -RRB-
.  ||| S:16481 E:16483 ||| .
Hoechst  ||| S:16483 E:16491 ||| NNP
33342  ||| S:16491 E:16497 ||| CD
stains  ||| S:16497 E:16504 ||| NNS
AT-rich  ||| S:16504 E:16512 ||| JJ
DNA  ||| S:16512 E:16516 ||| NN
that  ||| S:16516 E:16531 ||| WDT
concentrates  ||| S:16531 E:16544 ||| VBZ
around  ||| S:16544 E:16551 ||| IN
the  ||| S:16551 E:16555 ||| DT
centromeres  ||| S:16555 E:16567 ||| NN
[  ||| S:16567 E:16569 ||| -LRB-
45  ||| S:16569 E:16572 ||| CD
49  ||| S:16572 E:16575 ||| CD
]  ||| S:16575 E:16577 ||| -RRB-
.  ||| S:16577 E:16579 ||| .
Given  ||| S:16579 E:16585 ||| VBN
the  ||| S:16585 E:16599 ||| DT
role  ||| S:16599 E:16604 ||| NN
of  ||| S:16604 E:16607 ||| IN
the  ||| S:16607 E:16611 ||| DT
centromere  ||| S:16611 E:16622 ||| NN
as  ||| S:16622 E:16625 ||| IN
a  ||| S:16625 E:16627 ||| DT
checkpoint  ||| S:16627 E:16638 ||| NN
for  ||| S:16638 E:16642 ||| IN
regulation  ||| S:16642 E:16653 ||| NN
of  ||| S:16653 E:16666 ||| IN
the  ||| S:16666 E:16670 ||| DT
mitotic  ||| S:16670 E:16678 ||| JJ
phase  ||| S:16678 E:16684 ||| NN
of  ||| S:16684 E:16687 ||| IN
the  ||| S:16687 E:16691 ||| DT
cell  ||| S:16691 E:16696 ||| NN
cycle  ||| S:16696 E:16702 ||| NN
[  ||| S:16702 E:16704 ||| -LRB-
50  ||| S:16704 E:16707 ||| CD
51  ||| S:16707 E:16710 ||| CD
]  ||| S:16710 E:16712 ||| -RRB-
,  ||| S:16712 E:16714 ||| ,
it  ||| S:16714 E:16717 ||| PRP
was  ||| S:16717 E:16731 ||| VBD
hypothesized  ||| S:16731 E:16744 ||| VBN
that  ||| S:16744 E:16749 ||| IN
C ||| S:16749 E:16750 ||| $
/ ||| S:16750 E:16751 ||| CD
EBPα  ||| S:16751 E:16756 ||| JJ
localization  ||| S:16756 E:16769 ||| NN
around  ||| S:16769 E:16776 ||| IN
the  ||| S:16776 E:16790 ||| DT
centromere  ||| S:16790 E:16801 ||| NN
could  ||| S:16801 E:16807 ||| MD
play  ||| S:16807 E:16812 ||| VB
a  ||| S:16812 E:16814 ||| DT
role  ||| S:16814 E:16819 ||| NN
in  ||| S:16819 E:16822 ||| IN
C ||| S:16822 E:16823 ||| $
/ ||| S:16823 E:16824 ||| CD
EBPα  ||| S:16824 E:16829 ||| JJ
regulation  ||| S:16829 E:16840 ||| NN
of  ||| S:16840 E:16843 ||| IN
the  ||| S:16843 E:16857 ||| DT
cell  ||| S:16857 E:16862 ||| NN
cycle  ||| S:16862 E:16868 ||| NN
[  ||| S:16868 E:16870 ||| -LRB-
49  ||| S:16870 E:16873 ||| CD
]  ||| S:16873 E:16875 ||| -RRB-
.  ||| S:16875 E:16887 ||| .
To  ||| S:16887 E:16890 ||| TO
investigate  ||| S:16890 E:16902 ||| VB
if  ||| S:16902 E:16905 ||| IN
targeting  ||| S:16905 E:16915 ||| VBG
of  ||| S:16915 E:16918 ||| IN
C ||| S:16918 E:16919 ||| $
/ ||| S:16919 E:16920 ||| CD
EBPα  ||| S:16920 E:16925 ||| JJ
to  ||| S:16925 E:16928 ||| TO
the  ||| S:16928 E:16942 ||| DT
peri-centromeric  ||| S:16942 E:16959 ||| JJ
chromatin  ||| S:16959 E:16969 ||| NN
is  ||| S:16969 E:16972 ||| VBZ
necessary  ||| S:16972 E:16982 ||| JJ
or  ||| S:16982 E:16985 ||| CC
sufficient  ||| S:16985 E:16996 ||| JJ
to  ||| S:16996 E:17009 ||| TO
cause  ||| S:17009 E:17015 ||| VB
G1  ||| S:17015 E:17018 ||| NNP
and  ||| S:17018 E:17022 ||| CC
S  ||| S:17022 E:17024 ||| NNP
phase  ||| S:17024 E:17030 ||| NN
prolongation  ||| S:17030 E:17043 ||| NN
in  ||| S:17043 E:17046 ||| IN
GHFT1-5  ||| S:17046 E:17054 ||| CD
cells ||| S:17054 E:17059 ||| NNS
,  ||| S:17059 E:17061 ||| ,
we  ||| S:17061 E:17074 ||| PRP
first  ||| S:17074 E:17080 ||| RB
determined  ||| S:17080 E:17091 ||| VBN
the  ||| S:17091 E:17095 ||| DT
domain  ||| S:17095 E:17102 ||| NN
of  ||| S:17102 E:17105 ||| IN
C ||| S:17105 E:17106 ||| NNP
/ ||| S:17106 E:17107 ||| NNP
EBPα  ||| S:17107 E:17112 ||| NNP
required  ||| S:17112 E:17121 ||| VBD
to  ||| S:17121 E:17124 ||| TO
target  ||| S:17124 E:17141 ||| VB
C ||| S:17141 E:17142 ||| $
/ ||| S:17142 E:17143 ||| CD
EBPα  ||| S:17143 E:17148 ||| JJ
to  ||| S:17148 E:17151 ||| TO
the  ||| S:17151 E:17155 ||| DT
peri-centromeric  ||| S:17155 E:17172 ||| JJ
chromatin ||| S:17172 E:17181 ||| NN
.  ||| S:17181 E:17183 ||| .
It  ||| S:17183 E:17186 ||| PRP
was  ||| S:17186 E:17200 ||| VBD
previously  ||| S:17200 E:17211 ||| RB
suggested  ||| S:17211 E:17221 ||| VBN
that  ||| S:17221 E:17226 ||| IN
the  ||| S:17226 E:17230 ||| DT
peri-centromeric  ||| S:17230 E:17247 ||| JJ
targeting  ||| S:17247 E:17267 ||| NN
of  ||| S:17267 E:17270 ||| IN
C ||| S:17270 E:17271 ||| NNP
/ ||| S:17271 E:17272 ||| NNP
EBPα  ||| S:17272 E:17277 ||| NNP
was  ||| S:17277 E:17281 ||| VBD
a  ||| S:17281 E:17283 ||| DT
function  ||| S:17283 E:17292 ||| NN
of  ||| S:17292 E:17295 ||| IN
DNA  ||| S:17295 E:17299 ||| NNP
binding ||| S:17299 E:17306 ||| NN
:  ||| S:17306 E:17308 ||| :
C ||| S:17308 E:17309 ||| $
/ ||| S:17309 E:17310 ||| CD
EBPα  ||| S:17310 E:17315 ||| JJ
binding  ||| S:17315 E:17333 ||| JJ
sites  ||| S:17333 E:17339 ||| NNS
are  ||| S:17339 E:17343 ||| VBP
concentrated  ||| S:17343 E:17356 ||| VBN
within  ||| S:17356 E:17363 ||| IN
the  ||| S:17363 E:17367 ||| DT
repeated  ||| S:17367 E:17376 ||| JJ
DNA  ||| S:17376 E:17380 ||| NN
sequences  ||| S:17380 E:17400 ||| NNS
that  ||| S:17400 E:17405 ||| WDT
comprise  ||| S:17405 E:17414 ||| VBP
the  ||| S:17414 E:17418 ||| DT
bulk  ||| S:17418 E:17423 ||| NN
of  ||| S:17423 E:17426 ||| IN
peri-centromeric  ||| S:17426 E:17443 ||| JJ
chromatin  ||| S:17443 E:17453 ||| NNS
[  ||| S:17453 E:17455 ||| -LRB-
49  ||| S:17455 E:17468 ||| CD
]  ||| S:17468 E:17470 ||| -RRB-
.  ||| S:17470 E:17472 ||| .
Indeed ||| S:17472 E:17478 ||| RB
,  ||| S:17478 E:17480 ||| ,
C ||| S:17480 E:17481 ||| NNP
/ ||| S:17481 E:17482 ||| NNP
EBPα  ||| S:17482 E:17487 ||| JJ
truncated  ||| S:17487 E:17497 ||| NN
to  ||| S:17497 E:17500 ||| TO
contain  ||| S:17500 E:17508 ||| VB
little  ||| S:17508 E:17515 ||| RB
more  ||| S:17515 E:17520 ||| JJR
than  ||| S:17520 E:17535 ||| IN
the  ||| S:17535 E:17539 ||| DT
DNA  ||| S:17539 E:17543 ||| NN
binding ||| S:17543 E:17550 ||| NN
,  ||| S:17550 E:17552 ||| ,
bZIP  ||| S:17552 E:17557 ||| JJ
domain  ||| S:17557 E:17564 ||| NN
still  ||| S:17564 E:17570 ||| RB
concentrated  ||| S:17570 E:17583 ||| VBN
at  ||| S:17583 E:17596 ||| IN
peri-centromeric  ||| S:17596 E:17613 ||| JJ
chromatin  ||| S:17613 E:17623 ||| NNS
[  ||| S:17623 E:17625 ||| -LRB-
45  ||| S:17625 E:17628 ||| CD
]  ||| S:17628 E:17630 ||| -RRB-
.  ||| S:17630 E:17632 ||| .
By  ||| S:17632 E:17635 ||| IN
contrast ||| S:17635 E:17643 ||| NN
,  ||| S:17643 E:17645 ||| ,
C ||| S:17645 E:17646 ||| NNP
/ ||| S:17646 E:17647 ||| NNP
EBPα  ||| S:17647 E:17662 ||| JJ
deleted  ||| S:17662 E:17670 ||| NN
of  ||| S:17670 E:17673 ||| IN
amino  ||| S:17673 E:17679 ||| CD
acids  ||| S:17679 E:17685 ||| CD
310  ||| S:17685 E:17689 ||| CD
to  ||| S:17689 E:17692 ||| TO
358  ||| S:17692 E:17696 ||| CD
( ||| S:17696 E:17697 ||| -LRB-
Fig.  ||| S:17697 E:17702 ||| NNP
1B ||| S:17702 E:17704 ||| NNP
,  ||| S:17704 E:17706 ||| ,
ΔLZ ||| S:17706 E:17709 ||| NNP
)  ||| S:17709 E:17711 ||| -RRB-
no  ||| S:17711 E:17724 ||| RB
longer  ||| S:17724 E:17731 ||| RB
targeted  ||| S:17731 E:17740 ||| VBN
to  ||| S:17740 E:17743 ||| TO
the  ||| S:17743 E:17747 ||| DT
peri-centromeric  ||| S:17747 E:17764 ||| JJ
DNA  ||| S:17764 E:17768 ||| NN
( ||| S:17768 E:17769 ||| -LRB-
Fig.  ||| S:17769 E:17774 ||| NNP
5B ||| S:17774 E:17776 ||| NNP
) ||| S:17776 E:17777 ||| -RRB-
.  ||| S:17777 E:17789 ||| .
This  ||| S:17789 E:17794 ||| DT
deletion  ||| S:17794 E:17803 ||| JJ
disrupts  ||| S:17803 E:17812 ||| JJ
DNA  ||| S:17812 E:17816 ||| NN
binding  ||| S:17816 E:17824 ||| NNS
( ||| S:17824 E:17825 ||| -LRB-
Fig.  ||| S:17825 E:17830 ||| NNP
2C ||| S:17830 E:17832 ||| NNP
)  ||| S:17832 E:17834 ||| -RRB-
by  ||| S:17834 E:17847 ||| IN
eliminating  ||| S:17847 E:17859 ||| VBG
the  ||| S:17859 E:17863 ||| DT
leucine  ||| S:17863 E:17871 ||| JJ
zipper  ||| S:17871 E:17878 ||| NNS
required  ||| S:17878 E:17887 ||| VBN
for  ||| S:17887 E:17891 ||| IN
DNA  ||| S:17891 E:17895 ||| NNP
binding  ||| S:17895 E:17913 ||| NN
by  ||| S:17913 E:17916 ||| IN
all  ||| S:17916 E:17920 ||| DT
members  ||| S:17920 E:17928 ||| NNS
of  ||| S:17928 E:17931 ||| IN
the  ||| S:17931 E:17935 ||| DT
bZIP  ||| S:17935 E:17940 ||| JJ
family  ||| S:17940 E:17947 ||| NN
of  ||| S:17947 E:17950 ||| IN
transcription  ||| S:17950 E:17974 ||| JJ
factors  ||| S:17974 E:17982 ||| NNS
[  ||| S:17982 E:17984 ||| -LRB-
52  ||| S:17984 E:17987 ||| CD
]  ||| S:17987 E:17989 ||| -RRB-
.  ||| S:17989 E:17991 ||| .
Thus ||| S:17991 E:17995 ||| RB
,  ||| S:17995 E:17997 ||| ,
as  ||| S:17997 E:18000 ||| RB
predicted  ||| S:18000 E:18010 ||| VBD
[  ||| S:18010 E:18012 ||| -LRB-
49  ||| S:18012 E:18015 ||| CD
]  ||| S:18015 E:18017 ||| -RRB-
,  ||| S:18017 E:18019 ||| ,
the  ||| S:18019 E:18023 ||| DT
bZIP  ||| S:18023 E:18038 ||| JJ
domain  ||| S:18038 E:18045 ||| NN
is  ||| S:18045 E:18048 ||| VBZ
necessary  ||| S:18048 E:18058 ||| JJ
and  ||| S:18058 E:18062 ||| CC
sufficient  ||| S:18062 E:18073 ||| JJ
for  ||| S:18073 E:18077 ||| IN
C ||| S:18077 E:18078 ||| $
/ ||| S:18078 E:18079 ||| CD
EBPα  ||| S:18079 E:18084 ||| JJ
targeting  ||| S:18084 E:18104 ||| VBG
to  ||| S:18104 E:18107 ||| TO
peri-centromeric  ||| S:18107 E:18124 ||| JJ
chromatin ||| S:18124 E:18133 ||| NN
.  ||| S:18133 E:18145 ||| .
When  ||| S:18145 E:18150 ||| WRB
expressed  ||| S:18150 E:18160 ||| VBN
in  ||| S:18160 E:18163 ||| IN
GHFT1-5  ||| S:18163 E:18171 ||| CD
cells ||| S:18171 E:18176 ||| NNS
,  ||| S:18176 E:18178 ||| ,
ΔLZ  ||| S:18178 E:18182 ||| NNP
was  ||| S:18182 E:18186 ||| VBD
as  ||| S:18186 E:18189 ||| IN
effective  ||| S:18189 E:18209 ||| JJ
as  ||| S:18209 E:18212 ||| IN
full-length  ||| S:18212 E:18224 ||| JJ
GFP-C ||| S:18224 E:18229 ||| JJ
/ ||| S:18229 E:18230 ||| CD
EBPα  ||| S:18230 E:18235 ||| NN
in  ||| S:18235 E:18238 ||| IN
prolonging  ||| S:18238 E:18249 ||| VBG
both  ||| S:18249 E:18254 ||| DT
G1  ||| S:18254 E:18257 ||| NNP
and  ||| S:18257 E:18261 ||| CC
S  ||| S:18261 E:18273 ||| NNP
( ||| S:18273 E:18274 ||| -LRB-
Fig.  ||| S:18274 E:18279 ||| NNP
6A ||| S:18279 E:18281 ||| NNP
) ||| S:18281 E:18282 ||| -RRB-
.  ||| S:18282 E:18284 ||| .
Thus ||| S:18284 E:18288 ||| RB
,  ||| S:18288 E:18290 ||| ,
leucine  ||| S:18290 E:18298 ||| FW
zipper  ||| S:18298 E:18305 ||| FW
dimerization ||| S:18305 E:18317 ||| FW
,  ||| S:18317 E:18329 ||| ,
site-specific  ||| S:18329 E:18343 ||| JJ
DNA  ||| S:18343 E:18347 ||| NN
binding  ||| S:18347 E:18355 ||| NNS
and  ||| S:18355 E:18359 ||| CC
targeting  ||| S:18359 E:18369 ||| VBG
of  ||| S:18369 E:18372 ||| IN
C ||| S:18372 E:18373 ||| $
/ ||| S:18373 E:18374 ||| CD
EBPα  ||| S:18374 E:18379 ||| JJ
to  ||| S:18379 E:18392 ||| TO
peri-centromeric  ||| S:18392 E:18409 ||| NNP
were  ||| S:18409 E:18414 ||| VBD
not  ||| S:18414 E:18418 ||| RB
required  ||| S:18418 E:18427 ||| VBN
for  ||| S:18427 E:18431 ||| IN
C ||| S:18431 E:18432 ||| $
/ ||| S:18432 E:18433 ||| CD
EBPα  ||| S:18433 E:18448 ||| JJ
prolongation  ||| S:18448 E:18461 ||| NN
in  ||| S:18461 E:18464 ||| IN
G1  ||| S:18464 E:18467 ||| NNP
and  ||| S:18467 E:18471 ||| CC
S.  ||| S:18471 E:18474 ||| NNP
In  ||| S:18474 E:18477 ||| IN
contrast ||| S:18477 E:18485 ||| NN
,  ||| S:18485 E:18487 ||| ,
the  ||| S:18487 E:18491 ||| DT
isolated  ||| S:18491 E:18510 ||| JJ
C ||| S:18510 E:18511 ||| NNP
/ ||| S:18511 E:18512 ||| NNP
EBPα  ||| S:18512 E:18517 ||| NNP
bZIP  ||| S:18517 E:18522 ||| NNP
DNA  ||| S:18522 E:18526 ||| NNP
binding  ||| S:18526 E:18534 ||| JJ
domain  ||| S:18534 E:18541 ||| NN
( ||| S:18541 E:18542 ||| -LRB-
Fig.  ||| S:18542 E:18547 ||| NNP
1B ||| S:18547 E:18549 ||| NNP
,  ||| S:18549 E:18551 ||| ,
DBD ||| S:18551 E:18554 ||| NNP
) ||| S:18554 E:18555 ||| -RRB-
,  ||| S:18555 E:18557 ||| ,
which  ||| S:18557 E:18573 ||| WDT
still  ||| S:18573 E:18579 ||| RB
targeted  ||| S:18579 E:18588 ||| VBN
to  ||| S:18588 E:18591 ||| TO
peri-centromeric  ||| S:18591 E:18608 ||| JJ
chromatin ||| S:18608 E:18617 ||| NN
,  ||| S:18617 E:18619 ||| ,
did  ||| S:18619 E:18623 ||| VBD
not  ||| S:18623 E:18637 ||| RB
prolong  ||| S:18637 E:18645 ||| VB
G1  ||| S:18645 E:18648 ||| NNP
( ||| S:18648 E:18649 ||| -LRB-
Fig.  ||| S:18649 E:18654 ||| NNP
6B ||| S:18654 E:18656 ||| NNP
) ||| S:18656 E:18657 ||| -RRB-
.  ||| S:18657 E:18659 ||| .
S  ||| S:18659 E:18661 ||| NNP
phase  ||| S:18661 E:18667 ||| NN
remained  ||| S:18667 E:18676 ||| VBD
prolonged  ||| S:18676 E:18686 ||| VBN
upon  ||| S:18686 E:18691 ||| IN
DBD  ||| S:18691 E:18705 ||| NNP
expression ||| S:18705 E:18715 ||| NN
.  ||| S:18715 E:18717 ||| .
The  ||| S:18717 E:18721 ||| DT
different  ||| S:18721 E:18731 ||| JJ
effects  ||| S:18731 E:18739 ||| NNS
of  ||| S:18739 E:18742 ||| IN
the  ||| S:18742 E:18746 ||| DT
isolated  ||| S:18746 E:18755 ||| JJ
DBD  ||| S:18755 E:18759 ||| NN
on  ||| S:18759 E:18772 ||| IN
G1  ||| S:18772 E:18775 ||| NNP
and  ||| S:18775 E:18779 ||| CC
S  ||| S:18779 E:18781 ||| NNP
blockage  ||| S:18781 E:18790 ||| VBD
indicated  ||| S:18790 E:18800 ||| VBN
that  ||| S:18800 E:18805 ||| IN
C ||| S:18805 E:18806 ||| $
/ ||| S:18806 E:18807 ||| CD
EBPα  ||| S:18807 E:18812 ||| JJ
regulation  ||| S:18812 E:18823 ||| NN
of  ||| S:18823 E:18826 ||| IN
G1  ||| S:18826 E:18839 ||| NNP
and  ||| S:18839 E:18843 ||| CC
S  ||| S:18843 E:18845 ||| NNP
phase  ||| S:18845 E:18851 ||| NN
arrest  ||| S:18851 E:18858 ||| NN
was  ||| S:18858 E:18862 ||| VBD
mechanistically  ||| S:18862 E:18878 ||| JJ
distinct ||| S:18878 E:18886 ||| NN
.  ||| S:18886 E:18888 ||| .
Thus ||| S:18888 E:18892 ||| RB
,  ||| S:18892 E:18904 ||| ,
C ||| S:18904 E:18905 ||| NNP
/ ||| S:18905 E:18906 ||| NNP
EBPα  ||| S:18906 E:18911 ||| NNP
regulates  ||| S:18911 E:18921 ||| VBZ
proliferation  ||| S:18921 E:18935 ||| NN
by  ||| S:18935 E:18938 ||| IN
two  ||| S:18938 E:18942 ||| CD
distinct  ||| S:18942 E:18951 ||| JJ
pathways ||| S:18951 E:18959 ||| NN
.  ||| S:18959 E:18971 ||| .
Both  ||| S:18971 E:18976 ||| DT
pathways  ||| S:18976 E:18985 ||| NNS
do  ||| S:18985 E:18988 ||| VBP
not  ||| S:18988 E:18992 ||| RB
depend  ||| S:18992 E:18999 ||| VB
upon  ||| S:18999 E:19004 ||| IN
site-specific  ||| S:19004 E:19018 ||| JJ
DNA  ||| S:19018 E:19032 ||| NN
binding ||| S:19032 E:19039 ||| NN
,  ||| S:19039 E:19041 ||| ,
which  ||| S:19041 E:19047 ||| WDT
is  ||| S:19047 E:19050 ||| VBZ
commonly  ||| S:19050 E:19059 ||| RB
considered  ||| S:19059 E:19070 ||| VBN
a  ||| S:19070 E:19072 ||| DT
prerequisite  ||| S:19072 E:19085 ||| NN
for  ||| S:19085 E:19099 ||| IN
gene-specific  ||| S:19099 E:19113 ||| JJ
transcription ||| S:19113 E:19126 ||| NN
.  ||| S:19126 E:19156 ||| .
Prolongation  ||| S:19156 E:19169 ||| NNP
in  ||| S:19169 E:19172 ||| IN
G1  ||| S:19172 E:19175 ||| NNP
requires  ||| S:19175 E:19184 ||| VBZ
the  ||| S:19184 E:19188 ||| DT
amino  ||| S:19188 E:19194 ||| JJ
terminal  ||| S:19194 E:19213 ||| NN
domain  ||| S:19213 E:19220 ||| NN
of  ||| S:19220 E:19223 ||| IN
C ||| S:19223 E:19224 ||| NNP
/ ||| S:19224 E:19225 ||| NNP
EBPα  ||| S:19225 E:19240 ||| NNP
The  ||| S:19240 E:19244 ||| NNP
C ||| S:19244 E:19245 ||| NNP
/ ||| S:19245 E:19246 ||| NNP
EBPα  ||| S:19246 E:19251 ||| NNP
DBD  ||| S:19251 E:19255 ||| NNP
therefore  ||| S:19255 E:19265 ||| RB
was  ||| S:19265 E:19269 ||| VBD
insufficient  ||| S:19269 E:19282 ||| JJ
for  ||| S:19282 E:19296 ||| IN
prolongation  ||| S:19296 E:19309 ||| NN
of  ||| S:19309 E:19312 ||| IN
G1  ||| S:19312 E:19315 ||| NNP
( ||| S:19315 E:19316 ||| -LRB-
Fig.  ||| S:19316 E:19321 ||| NNP
6B ||| S:19321 E:19323 ||| NNP
) ||| S:19323 E:19324 ||| -RRB-
.  ||| S:19324 E:19326 ||| .
We  ||| S:19326 E:19329 ||| PRP
next  ||| S:19329 E:19334 ||| JJ
determined  ||| S:19334 E:19345 ||| NN
which  ||| S:19345 E:19361 ||| WDT
additional  ||| S:19361 E:19372 ||| JJ
domains  ||| S:19372 E:19380 ||| NN
of  ||| S:19380 E:19383 ||| IN
C ||| S:19383 E:19384 ||| NNP
/ ||| S:19384 E:19385 ||| NNP
EBPα  ||| S:19385 E:19390 ||| NNP
were  ||| S:19390 E:19395 ||| VBD
required  ||| S:19395 E:19404 ||| VBN
for  ||| S:19404 E:19408 ||| IN
G1  ||| S:19408 E:19421 ||| CD
prolongation ||| S:19421 E:19433 ||| NNS
.  ||| S:19433 E:19435 ||| .
C ||| S:19435 E:19436 ||| SYM
/ ||| S:19436 E:19437 ||| FW
EBPα  ||| S:19437 E:19442 ||| FW
amino  ||| S:19442 E:19448 ||| FW
acids  ||| S:19448 E:19454 ||| FW
1-154  ||| S:19454 E:19460 ||| FW
or  ||| S:19460 E:19463 ||| CC
154-257  ||| S:19463 E:19471 ||| NNP
were  ||| S:19471 E:19486 ||| VBD
appended  ||| S:19486 E:19495 ||| VBN
to  ||| S:19495 E:19498 ||| TO
the  ||| S:19498 E:19502 ||| DT
DBD  ||| S:19502 E:19506 ||| NNP
( ||| S:19506 E:19507 ||| -LRB-
see  ||| S:19507 E:19511 ||| VB
Fig.  ||| S:19511 E:19516 ||| CD
1B ||| S:19516 E:19518 ||| CD
) ||| S:19518 E:19519 ||| -RRB-
.  ||| S:19519 E:19521 ||| .
The  ||| S:19521 E:19525 ||| DT
addition  ||| S:19525 E:19534 ||| NN
of  ||| S:19534 E:19537 ||| IN
amino  ||| S:19537 E:19553 ||| FW
acids  ||| S:19553 E:19559 ||| FW
1-154  ||| S:19559 E:19565 ||| FW
( ||| S:19565 E:19566 ||| -LRB-
Fig.  ||| S:19566 E:19571 ||| CD
7 ||| S:19571 E:19572 ||| CD
,  ||| S:19572 E:19574 ||| ,
DBD  ||| S:19574 E:19578 ||| NNP
+  ||| S:19578 E:19580 ||| NNP
1-154 ||| S:19580 E:19585 ||| NNP
)  ||| S:19585 E:19587 ||| -RRB-
caused  ||| S:19587 E:19594 ||| VBD
a  ||| S:19594 E:19596 ||| DT
statistically  ||| S:19596 E:19620 ||| JJ
significant  ||| S:19620 E:19632 ||| JJ
increase ||| S:19632 E:19640 ||| NN
,  ||| S:19640 E:19642 ||| ,
relative  ||| S:19642 E:19651 ||| JJ
to  ||| S:19651 E:19654 ||| TO
sham-transfected  ||| S:19654 E:19671 ||| JJ
cells ||| S:19671 E:19676 ||| NNS
,  ||| S:19676 E:19688 ||| ,
in  ||| S:19688 E:19691 ||| IN
the  ||| S:19691 E:19695 ||| DT
proportion  ||| S:19695 E:19706 ||| NN
of  ||| S:19706 E:19709 ||| IN
cells  ||| S:19709 E:19715 ||| NNS
in  ||| S:19715 E:19718 ||| IN
G1  ||| S:19718 E:19721 ||| NNP
( ||| S:19721 E:19722 ||| -LRB-
p  ||| S:19722 E:19724 ||| CD
< ||| S:19724 E:19725 ||| SYM
< ||| S:19725 E:19727 ||| SYM
0.01 ||| S:19727 E:19731 ||| CD
,  ||| S:19731 E:19733 ||| ,
n  ||| S:19733 E:19735 ||| VBG
=  ||| S:19735 E:19747 ||| SYM
6 ||| S:19747 E:19748 ||| CD
) ||| S:19748 E:19749 ||| -RRB-
.  ||| S:19749 E:19751 ||| .
The  ||| S:19751 E:19755 ||| DT
proportion  ||| S:19755 E:19766 ||| NN
of  ||| S:19766 E:19769 ||| IN
cells  ||| S:19769 E:19775 ||| NNS
in  ||| S:19775 E:19778 ||| IN
G1  ||| S:19778 E:19781 ||| NNP
was  ||| S:19781 E:19785 ||| VBD
not  ||| S:19785 E:19789 ||| RB
statistically  ||| S:19789 E:19813 ||| RB
different  ||| S:19813 E:19823 ||| JJ
in  ||| S:19823 E:19826 ||| IN
cells  ||| S:19826 E:19832 ||| NNS
expressing  ||| S:19832 E:19843 ||| VBG
DBD  ||| S:19843 E:19847 ||| NNP
+  ||| S:19847 E:19849 ||| NNP
1-154  ||| S:19849 E:19855 ||| NNP
from  ||| S:19855 E:19860 ||| IN
that  ||| S:19860 E:19865 ||| DT
in  ||| S:19865 E:19878 ||| IN
cells  ||| S:19878 E:19884 ||| NNS
expressing  ||| S:19884 E:19895 ||| VBG
full-length  ||| S:19895 E:19907 ||| JJ
C ||| S:19907 E:19908 ||| NNP
/ ||| S:19908 E:19909 ||| NNP
EBPα-GFP ||| S:19909 E:19917 ||| NNP
.  ||| S:19917 E:19919 ||| .
Adding  ||| S:19919 E:19926 ||| VBG
amino  ||| S:19926 E:19942 ||| JJ
acids  ||| S:19942 E:19948 ||| JJ
1-125 ||| S:19948 E:19953 ||| NN
,  ||| S:19953 E:19955 ||| ,
instead  ||| S:19955 E:19963 ||| RB
of  ||| S:19963 E:19966 ||| IN
amino  ||| S:19966 E:19972 ||| CD
acids  ||| S:19972 E:19978 ||| CD
1-154 ||| S:19978 E:19983 ||| CD
,  ||| S:19983 E:19985 ||| ,
caused  ||| S:19985 E:19992 ||| VBD
a  ||| S:19992 E:20004 ||| DT
similar  ||| S:20004 E:20012 ||| JJ
prolongation  ||| S:20012 E:20025 ||| NN
in  ||| S:20025 E:20028 ||| IN
G1  ||| S:20028 E:20031 ||| NNP
( ||| S:20031 E:20032 ||| -LRB-
Fig.  ||| S:20032 E:20037 ||| CD
7 ||| S:20037 E:20038 ||| CD
,  ||| S:20038 E:20040 ||| ,
DBD  ||| S:20040 E:20044 ||| NNP
+  ||| S:20044 E:20046 ||| NNP
1-125 ||| S:20046 E:20051 ||| NNP
) ||| S:20051 E:20052 ||| -RRB-
.  ||| S:20052 E:20054 ||| .
Thus ||| S:20054 E:20058 ||| RB
,  ||| S:20058 E:20070 ||| ,
an  ||| S:20070 E:20073 ||| DT
element  ||| S:20073 E:20081 ||| NN
in  ||| S:20081 E:20084 ||| IN
the  ||| S:20084 E:20088 ||| DT
amino  ||| S:20088 E:20094 ||| JJ
terminal  ||| S:20094 E:20103 ||| NN
domain  ||| S:20103 E:20110 ||| NN
of  ||| S:20110 E:20113 ||| IN
C ||| S:20113 E:20114 ||| NNP
/ ||| S:20114 E:20115 ||| NNP
EBPα  ||| S:20115 E:20120 ||| NNP
was  ||| S:20120 E:20134 ||| VBD
required  ||| S:20134 E:20143 ||| VBN
for  ||| S:20143 E:20147 ||| IN
G1  ||| S:20147 E:20150 ||| CD
prolongation ||| S:20150 E:20162 ||| NNS
.  ||| S:20162 E:20174 ||| .
In  ||| S:20174 E:20177 ||| IN
contrast ||| S:20177 E:20185 ||| NN
,  ||| S:20185 E:20187 ||| ,
addition  ||| S:20187 E:20196 ||| NN
of  ||| S:20196 E:20199 ||| IN
amino  ||| S:20199 E:20205 ||| CD
acids  ||| S:20205 E:20211 ||| CD
154-257  ||| S:20211 E:20219 ||| CD
to  ||| S:20219 E:20222 ||| TO
C ||| S:20222 E:20223 ||| NNP
/ ||| S:20223 E:20224 ||| NNP
EBPα  ||| S:20224 E:20239 ||| NNP
DBD  ||| S:20239 E:20243 ||| NNP
did  ||| S:20243 E:20247 ||| VBD
not  ||| S:20247 E:20251 ||| RB
rescue  ||| S:20251 E:20258 ||| VB
G1  ||| S:20258 E:20261 ||| CD
prolongation  ||| S:20261 E:20274 ||| NNS
( ||| S:20274 E:20275 ||| -LRB-
Fig.  ||| S:20275 E:20280 ||| CD
7 ||| S:20280 E:20281 ||| CD
,  ||| S:20281 E:20283 ||| ,
DBD  ||| S:20283 E:20287 ||| NNP
+  ||| S:20287 E:20299 ||| NNP
154-257 ||| S:20299 E:20306 ||| NNP
) ||| S:20306 E:20307 ||| -RRB-
.  ||| S:20307 E:20309 ||| .
Again ||| S:20309 E:20314 ||| RB
,  ||| S:20314 E:20316 ||| ,
appending  ||| S:20316 E:20326 ||| FW
amino  ||| S:20326 E:20332 ||| FW
acids  ||| S:20332 E:20338 ||| FW
1-125  ||| S:20338 E:20344 ||| FW
to  ||| S:20344 E:20347 ||| TO
this  ||| S:20347 E:20362 ||| DT
mutant  ||| S:20362 E:20369 ||| FW
restored  ||| S:20369 E:20378 ||| FW
G1  ||| S:20378 E:20381 ||| FW
prolongation  ||| S:20381 E:20394 ||| FW
( ||| S:20394 E:20395 ||| -LRB-
A126-153 ||| S:20395 E:20403 ||| NNP
) ||| S:20403 E:20404 ||| -RRB-
,  ||| S:20404 E:20406 ||| ,
as  ||| S:20406 E:20409 ||| RB
did  ||| S:20409 E:20413 ||| VBD
amino  ||| S:20413 E:20429 ||| FW
acids  ||| S:20429 E:20435 ||| FW
1-97  ||| S:20435 E:20440 ||| FW
( ||| S:20440 E:20441 ||| -LRB-
A  ||| S:20441 E:20443 ||| DT
98-153 ||| S:20443 E:20449 ||| CD
) ||| S:20449 E:20450 ||| -RRB-
.  ||| S:20450 E:20452 ||| .
All  ||| S:20452 E:20456 ||| DT
of  ||| S:20456 E:20459 ||| IN
the  ||| S:20459 E:20463 ||| DT
mutants  ||| S:20463 E:20471 ||| NN
contained  ||| S:20471 E:20481 ||| VBD
the  ||| S:20481 E:20495 ||| DT
DBD  ||| S:20495 E:20499 ||| NNP
and  ||| S:20499 E:20503 ||| CC
prolonged  ||| S:20503 E:20513 ||| VBN
the  ||| S:20513 E:20517 ||| DT
cell  ||| S:20517 E:20522 ||| NN
cycle  ||| S:20522 E:20528 ||| NN
in  ||| S:20528 E:20531 ||| IN
S  ||| S:20531 E:20533 ||| NNP
phase  ||| S:20533 E:20539 ||| NN
( ||| S:20539 E:20540 ||| -LRB-
Fig.  ||| S:20540 E:20545 ||| CD
7 ||| S:20545 E:20546 ||| CD
) ||| S:20546 E:20547 ||| -RRB-
.  ||| S:20547 E:20559 ||| .
Thus ||| S:20559 E:20563 ||| RB
,  ||| S:20563 E:20565 ||| ,
the  ||| S:20565 E:20569 ||| DT
DNA  ||| S:20569 E:20573 ||| NN
binding ||| S:20573 E:20580 ||| NN
,  ||| S:20580 E:20582 ||| ,
bZIP  ||| S:20582 E:20587 ||| JJ
domain  ||| S:20587 E:20594 ||| NN
was  ||| S:20594 E:20598 ||| VBD
sufficient  ||| S:20598 E:20609 ||| JJ
to  ||| S:20609 E:20622 ||| TO
direct  ||| S:20622 E:20629 ||| VB
S  ||| S:20629 E:20631 ||| NNP
phase  ||| S:20631 E:20637 ||| NN
regulation  ||| S:20637 E:20648 ||| NN
by  ||| S:20648 E:20651 ||| IN
C ||| S:20651 E:20652 ||| NNP
/ ||| S:20652 E:20653 ||| FW
EBPα  ||| S:20653 E:20658 ||| FW
whereas  ||| S:20658 E:20666 ||| FW
amino  ||| S:20666 E:20672 ||| FW
acids  ||| S:20672 E:20688 ||| FW
1-97  ||| S:20688 E:20693 ||| NNP
contained  ||| S:20693 E:20703 ||| VBD
a  ||| S:20703 E:20705 ||| DT
domain  ||| S:20705 E:20712 ||| NN
required  ||| S:20712 E:20721 ||| VBN
for  ||| S:20721 E:20725 ||| IN
G1  ||| S:20725 E:20728 ||| CD
regulation ||| S:20728 E:20738 ||| NN
.  ||| S:20738 E:20771 ||| .
Discussion  ||| S:20771 E:20801 ||| NNP
C ||| S:20801 E:20802 ||| NNP
/ ||| S:20802 E:20803 ||| NNP
EBPα  ||| S:20803 E:20808 ||| NNP
prolongs  ||| S:20808 E:20817 ||| VBD
GHFT1-5  ||| S:20817 E:20825 ||| CD
cells  ||| S:20825 E:20831 ||| NNS
in  ||| S:20831 E:20834 ||| IN
G1  ||| S:20834 E:20837 ||| NNP
and  ||| S:20837 E:20841 ||| CC
S  ||| S:20841 E:20853 ||| NNP
The  ||| S:20853 E:20857 ||| DT
differentiative  ||| S:20857 E:20873 ||| NN
and  ||| S:20873 E:20877 ||| CC
anti-mitotic  ||| S:20877 E:20890 ||| JJ
actions  ||| S:20890 E:20898 ||| NNS
of  ||| S:20898 E:20901 ||| IN
C ||| S:20901 E:20902 ||| $
/ ||| S:20902 E:20903 ||| CD
EBPα  ||| S:20903 E:20918 ||| NNS
have  ||| S:20918 E:20923 ||| VBP
been  ||| S:20923 E:20928 ||| VBN
observed  ||| S:20928 E:20937 ||| VBN
in  ||| S:20937 E:20940 ||| IN
a  ||| S:20940 E:20942 ||| DT
variety  ||| S:20942 E:20950 ||| NN
of  ||| S:20950 E:20953 ||| IN
cell  ||| S:20953 E:20958 ||| NN
culture  ||| S:20958 E:20966 ||| NN
models  ||| S:20966 E:20973 ||| NNS
[  ||| S:20973 E:20985 ||| -LRB-
23  ||| S:20985 E:20988 ||| CD
24  ||| S:20988 E:20991 ||| CD
26  ||| S:20991 E:20994 ||| CD
40  ||| S:20994 E:20997 ||| CD
53  ||| S:20997 E:21000 ||| CD
]  ||| S:21000 E:21002 ||| -RRB-
.  ||| S:21002 E:21004 ||| .
To  ||| S:21004 E:21007 ||| TO
date ||| S:21007 E:21011 ||| NN
,  ||| S:21011 E:21013 ||| ,
studies  ||| S:21013 E:21021 ||| NNS
of  ||| S:21021 E:21024 ||| IN
the  ||| S:21024 E:21028 ||| DT
C ||| S:21028 E:21029 ||| $
/ ||| S:21029 E:21030 ||| CD
EBPα  ||| S:21030 E:21035 ||| JJ
block  ||| S:21035 E:21051 ||| NN
of  ||| S:21051 E:21054 ||| IN
proliferation  ||| S:21054 E:21068 ||| NNS
have  ||| S:21068 E:21073 ||| VBP
relied  ||| S:21073 E:21080 ||| VBN
on  ||| S:21080 E:21083 ||| IN
comparing  ||| S:21083 E:21093 ||| VBG
the  ||| S:21093 E:21097 ||| DT
growth  ||| S:21097 E:21104 ||| NN
[  ||| S:21104 E:21106 ||| -LRB-
23  ||| S:21106 E:21119 ||| CD
24  ||| S:21119 E:21122 ||| CD
25  ||| S:21122 E:21125 ||| CD
40  ||| S:21125 E:21128 ||| CD
]  ||| S:21128 E:21130 ||| -RRB-
or  ||| S:21130 E:21133 ||| CC
DNA  ||| S:21133 E:21137 ||| NNP
synthetic  ||| S:21137 E:21147 ||| NN
[  ||| S:21147 E:21149 ||| -LRB-
22  ||| S:21149 E:21152 ||| CD
24  ||| S:21152 E:21155 ||| CD
25  ||| S:21155 E:21158 ||| CD
26  ||| S:21158 E:21161 ||| CD
27  ||| S:21161 E:21164 ||| CD
]  ||| S:21164 E:21166 ||| -RRB-
rates  ||| S:21166 E:21172 ||| NNS
of  ||| S:21172 E:21185 ||| IN
C ||| S:21185 E:21186 ||| NNP
/ ||| S:21186 E:21187 ||| NNP
EBPα-expressing  ||| S:21187 E:21203 ||| NNP
and  ||| S:21203 E:21207 ||| CC
non-expressing  ||| S:21207 E:21222 ||| JJ
cells ||| S:21222 E:21227 ||| NNS
.  ||| S:21227 E:21229 ||| .
These  ||| S:21229 E:21235 ||| DT
studies  ||| S:21235 E:21253 ||| NNS
suggest  ||| S:21253 E:21261 ||| VBP
that  ||| S:21261 E:21266 ||| DT
multiple ||| S:21266 E:21274 ||| NN
,  ||| S:21274 E:21276 ||| ,
possibly  ||| S:21276 E:21285 ||| RB
independent ||| S:21285 E:21296 ||| JJ
,  ||| S:21296 E:21298 ||| ,
mechanisms  ||| S:21298 E:21319 ||| NNS
may  ||| S:21319 E:21323 ||| MD
contribute  ||| S:21323 E:21334 ||| VB
to  ||| S:21334 E:21337 ||| TO
C ||| S:21337 E:21338 ||| $
/ ||| S:21338 E:21339 ||| CD
EBPα  ||| S:21339 E:21344 ||| JJ
arrest  ||| S:21344 E:21351 ||| NN
in  ||| S:21351 E:21354 ||| IN
a  ||| S:21354 E:21356 ||| DT
variety  ||| S:21356 E:21364 ||| NN
of  ||| S:21364 E:21367 ||| IN
cells  ||| S:21367 E:21373 ||| NNS
[  ||| S:21373 E:21385 ||| -LRB-
18  ||| S:21385 E:21388 ||| CD
23  ||| S:21388 E:21391 ||| CD
24  ||| S:21391 E:21394 ||| CD
25  ||| S:21394 E:21397 ||| CD
26  ||| S:21397 E:21400 ||| CD
33  ||| S:21400 E:21403 ||| CD
34  ||| S:21403 E:21406 ||| CD
35  ||| S:21406 E:21409 ||| CD
36  ||| S:21409 E:21412 ||| CD
37  ||| S:21412 E:21415 ||| CD
40  ||| S:21415 E:21418 ||| CD
54  ||| S:21418 E:21421 ||| CD
55  ||| S:21421 E:21424 ||| CD
56  ||| S:21424 E:21427 ||| CD
]  ||| S:21427 E:21429 ||| -RRB-
.  ||| S:21429 E:21431 ||| .
Studies  ||| S:21431 E:21449 ||| NNS
that  ||| S:21449 E:21454 ||| WDT
distinguish  ||| S:21454 E:21466 ||| VBZ
the  ||| S:21466 E:21470 ||| DT
anti-proliferative  ||| S:21470 E:21489 ||| JJ
actions  ||| S:21489 E:21497 ||| NNS
of  ||| S:21497 E:21500 ||| IN
C ||| S:21500 E:21501 ||| $
/ ||| S:21501 E:21502 ||| CD
EBPα  ||| S:21502 E:21517 ||| NN
at  ||| S:21517 E:21520 ||| IN
different  ||| S:21520 E:21530 ||| JJ
phases  ||| S:21530 E:21537 ||| NNS
of  ||| S:21537 E:21540 ||| IN
the  ||| S:21540 E:21544 ||| DT
cell  ||| S:21544 E:21549 ||| NN
cycle ||| S:21549 E:21554 ||| NN
,  ||| S:21554 E:21556 ||| ,
and  ||| S:21556 E:21560 ||| CC
in  ||| S:21560 E:21563 ||| IN
specific  ||| S:21563 E:21582 ||| JJ
cell  ||| S:21582 E:21587 ||| NN
types ||| S:21587 E:21592 ||| NNS
,  ||| S:21592 E:21594 ||| ,
may  ||| S:21594 E:21598 ||| MD
clarify  ||| S:21598 E:21606 ||| VB
these  ||| S:21606 E:21612 ||| DT
discrepancies ||| S:21612 E:21625 ||| NNS
.  ||| S:21625 E:21637 ||| .
Our  ||| S:21637 E:21641 ||| PRP$
studies  ||| S:21641 E:21649 ||| NNS
showed  ||| S:21649 E:21656 ||| VBD
that  ||| S:21656 E:21661 ||| IN
C ||| S:21661 E:21662 ||| $
/ ||| S:21662 E:21663 ||| CD
EBPα  ||| S:21663 E:21668 ||| JJ
expression  ||| S:21668 E:21679 ||| NN
prolonged  ||| S:21679 E:21699 ||| VBN
the  ||| S:21699 E:21703 ||| DT
proliferation  ||| S:21703 E:21717 ||| NN
of  ||| S:21717 E:21720 ||| IN
GHFT1-5  ||| S:21720 E:21728 ||| CD
pituitary  ||| S:21728 E:21738 ||| CD
progenitor  ||| S:21738 E:21749 ||| CD
cells  ||| S:21749 E:21765 ||| NNS
at  ||| S:21765 E:21768 ||| IN
two  ||| S:21768 E:21772 ||| CD
different  ||| S:21772 E:21782 ||| JJ
phases  ||| S:21782 E:21789 ||| NNS
of  ||| S:21789 E:21792 ||| IN
the  ||| S:21792 E:21796 ||| DT
cell  ||| S:21796 E:21801 ||| NN
cycle ||| S:21801 E:21806 ||| NN
,  ||| S:21806 E:21808 ||| ,
G1  ||| S:21808 E:21811 ||| NNP
and  ||| S:21811 E:21815 ||| CC
S  ||| S:21815 E:21817 ||| NNP
( ||| S:21817 E:21818 ||| -LRB-
Fig.  ||| S:21818 E:21833 ||| CD
4 ||| S:21833 E:21834 ||| CD
) ||| S:21834 E:21835 ||| -RRB-
.  ||| S:21835 E:21837 ||| .
A  ||| S:21837 E:21839 ||| DT
G1  ||| S:21839 E:21842 ||| JJ
block  ||| S:21842 E:21848 ||| NN
has  ||| S:21848 E:21852 ||| VBZ
been  ||| S:21852 E:21857 ||| VBN
reported  ||| S:21857 E:21866 ||| VBN
previously  ||| S:21866 E:21877 ||| RB
in  ||| S:21877 E:21890 ||| IN
C ||| S:21890 E:21891 ||| $
/ ||| S:21891 E:21892 ||| CD
EBPα-expressing  ||| S:21892 E:21908 ||| JJ
mouse  ||| S:21908 E:21914 ||| NN
L  ||| S:21914 E:21916 ||| NNP
cells  ||| S:21916 E:21922 ||| NNS
[  ||| S:21922 E:21924 ||| -LRB-
26  ||| S:21924 E:21927 ||| CD
]  ||| S:21927 E:21929 ||| -RRB-
.  ||| S:21929 E:21931 ||| .
However ||| S:21931 E:21938 ||| RB
,  ||| S:21938 E:21940 ||| ,
those  ||| S:21940 E:21956 ||| DT
studies  ||| S:21956 E:21964 ||| NNS
did  ||| S:21964 E:21968 ||| VBD
not  ||| S:21968 E:21972 ||| RB
define  ||| S:21972 E:21979 ||| VB
the  ||| S:21979 E:21983 ||| DT
activities  ||| S:21983 E:21994 ||| NNS
within  ||| S:21994 E:22001 ||| IN
C ||| S:22001 E:22002 ||| $
/ ||| S:22002 E:22003 ||| CD
EBPα  ||| S:22003 E:22018 ||| NNS
required  ||| S:22018 E:22027 ||| VBN
for  ||| S:22027 E:22031 ||| IN
that  ||| S:22031 E:22036 ||| DT
blockage ||| S:22036 E:22044 ||| NN
.  ||| S:22044 E:22046 ||| .
Here ||| S:22046 E:22050 ||| RB
,  ||| S:22050 E:22052 ||| ,
we  ||| S:22052 E:22055 ||| PRP
observed  ||| S:22055 E:22064 ||| VBD
that  ||| S:22064 E:22079 ||| DT
prolongation  ||| S:22079 E:22092 ||| NN
in  ||| S:22092 E:22095 ||| IN
G1  ||| S:22095 E:22098 ||| NNP
required  ||| S:22098 E:22107 ||| VBD
the  ||| S:22107 E:22111 ||| DT
amino  ||| S:22111 E:22117 ||| JJ
terminal  ||| S:22117 E:22126 ||| NN
97  ||| S:22126 E:22129 ||| CD
amino  ||| S:22129 E:22145 ||| CD
acids  ||| S:22145 E:22151 ||| NNS
of  ||| S:22151 E:22154 ||| IN
C ||| S:22154 E:22155 ||| NNP
/ ||| S:22155 E:22156 ||| NNP
EBPα  ||| S:22156 E:22161 ||| NNP
( ||| S:22161 E:22162 ||| -LRB-
Fig.  ||| S:22162 E:22167 ||| NNP
7. ||| S:22167 E:22169 ||| NNP
) ||| S:22169 E:22170 ||| -RRB-
.  ||| S:22170 E:22172 ||| .
In  ||| S:22172 E:22175 ||| IN
contrast ||| S:22175 E:22183 ||| NN
,  ||| S:22183 E:22185 ||| ,
amino  ||| S:22185 E:22191 ||| CD
acids  ||| S:22191 E:22197 ||| CD
1  ||| S:22197 E:22199 ||| CD
to  ||| S:22199 E:22212 ||| TO
97  ||| S:22212 E:22215 ||| CD
were  ||| S:22215 E:22220 ||| VBD
not  ||| S:22220 E:22224 ||| RB
required  ||| S:22224 E:22233 ||| VBN
for  ||| S:22233 E:22237 ||| IN
S  ||| S:22237 E:22239 ||| NNP
phase  ||| S:22239 E:22245 ||| NN
arrest  ||| S:22245 E:22252 ||| NN
( ||| S:22252 E:22253 ||| -LRB-
Figs.  ||| S:22253 E:22259 ||| CD
6 ||| S:22259 E:22260 ||| CD
,  ||| S:22260 E:22262 ||| ,
7 ||| S:22262 E:22263 ||| CD
) ||| S:22263 E:22264 ||| -RRB-
.  ||| S:22264 E:22276 ||| .
This  ||| S:22276 E:22281 ||| DT
showed  ||| S:22281 E:22288 ||| VBD
that  ||| S:22288 E:22293 ||| IN
C ||| S:22293 E:22294 ||| $
/ ||| S:22294 E:22295 ||| CD
EBPα  ||| S:22295 E:22300 ||| JJ
prolongation  ||| S:22300 E:22313 ||| NN
of  ||| S:22313 E:22316 ||| IN
GHFT1-5  ||| S:22316 E:22324 ||| CD
cells  ||| S:22324 E:22330 ||| NNS
in  ||| S:22330 E:22343 ||| IN
the  ||| S:22343 E:22347 ||| DT
G1  ||| S:22347 E:22350 ||| NNP
and  ||| S:22350 E:22354 ||| CC
S  ||| S:22354 E:22356 ||| NNP
phases  ||| S:22356 E:22363 ||| NNS
occurred  ||| S:22363 E:22372 ||| VBD
through  ||| S:22372 E:22380 ||| IN
molecularly  ||| S:22380 E:22392 ||| JJ
distinct  ||| S:22392 E:22411 ||| JJ
pathways ||| S:22411 E:22419 ||| NN
.  ||| S:22419 E:22421 ||| .
Such  ||| S:22421 E:22426 ||| JJ
distinct  ||| S:22426 E:22435 ||| JJ
effects  ||| S:22435 E:22443 ||| NNS
on  ||| S:22443 E:22446 ||| IN
G1  ||| S:22446 E:22449 ||| NNP
and  ||| S:22449 E:22453 ||| CC
S  ||| S:22453 E:22455 ||| NNP
may  ||| S:22455 E:22469 ||| MD
contribute  ||| S:22469 E:22480 ||| VB
to  ||| S:22480 E:22483 ||| TO
the  ||| S:22483 E:22487 ||| DT
wide  ||| S:22487 E:22492 ||| JJ
variations  ||| S:22492 E:22503 ||| NNS
in  ||| S:22503 E:22506 ||| IN
mechanisms  ||| S:22506 E:22517 ||| NNS
reported ||| S:22517 E:22525 ||| VBD
,  ||| S:22525 E:22537 ||| ,
to  ||| S:22537 E:22540 ||| TO
date ||| S:22540 E:22544 ||| NN
,  ||| S:22544 E:22546 ||| ,
to  ||| S:22546 E:22549 ||| TO
participate  ||| S:22549 E:22561 ||| VB
in  ||| S:22561 E:22564 ||| IN
proliferation  ||| S:22564 E:22578 ||| NN
arrest  ||| S:22578 E:22585 ||| NN
by  ||| S:22585 E:22598 ||| IN
C ||| S:22598 E:22599 ||| NNP
/ ||| S:22599 E:22600 ||| NNP
EBPα ||| S:22600 E:22604 ||| NNP
.  ||| S:22604 E:22634 ||| .
Cell  ||| S:22634 E:22639 ||| NNP
Cycle  ||| S:22639 E:22645 ||| NNP
Proteins  ||| S:22645 E:22654 ||| NNPS
and  ||| S:22654 E:22658 ||| CC
C ||| S:22658 E:22659 ||| NNP
/ ||| S:22659 E:22660 ||| NNP
EBPα  ||| S:22660 E:22665 ||| NNP
Inhibition  ||| S:22665 E:22676 ||| NNP
of  ||| S:22676 E:22689 ||| IN
Proliferation  ||| S:22689 E:22713 ||| NNP
Candidate  ||| S:22713 E:22723 ||| NNP
mechanisms  ||| S:22723 E:22734 ||| NNS
for  ||| S:22734 E:22738 ||| IN
the  ||| S:22738 E:22742 ||| DT
block  ||| S:22742 E:22748 ||| NN
of  ||| S:22748 E:22751 ||| IN
proliferation  ||| S:22751 E:22765 ||| NN
by  ||| S:22765 E:22778 ||| IN
C ||| S:22778 E:22779 ||| $
/ ||| S:22779 E:22780 ||| CD
EBPα  ||| S:22780 E:22785 ||| NNS
include  ||| S:22785 E:22793 ||| VBP
1 ||| S:22793 E:22794 ||| CD
)  ||| S:22794 E:22796 ||| -RRB-
activation  ||| S:22796 E:22807 ||| NN
of  ||| S:22807 E:22810 ||| IN
the  ||| S:22810 E:22814 ||| DT
gene  ||| S:22814 E:22819 ||| NN
promoters  ||| S:22819 E:22829 ||| NNS
of  ||| S:22829 E:22832 ||| IN
the  ||| S:22832 E:22846 ||| DT
cyclin-dependent  ||| S:22846 E:22863 ||| JJ
kinase  ||| S:22863 E:22870 ||| FW
inhibitor  ||| S:22870 E:22880 ||| FW
p21  ||| S:22880 E:22884 ||| FW
[  ||| S:22884 E:22886 ||| -LRB-
37  ||| S:22886 E:22889 ||| CD
]  ||| S:22889 E:22891 ||| -RRB-
,  ||| S:22891 E:22893 ||| ,
gadd45  ||| S:22893 E:22900 ||| NNP
[  ||| S:22900 E:22902 ||| -LRB-
5  ||| S:22902 E:22914 ||| CD
6  ||| S:22914 E:22916 ||| CD
]  ||| S:22916 E:22918 ||| -RRB-
,  ||| S:22918 E:22920 ||| ,
gas2  ||| S:22920 E:22925 ||| NNP
and  ||| S:22925 E:22929 ||| CC
gas3  ||| S:22929 E:22934 ||| NNP
[  ||| S:22934 E:22936 ||| -LRB-
38  ||| S:22936 E:22939 ||| CD
39  ||| S:22939 E:22942 ||| CD
]  ||| S:22942 E:22944 ||| -RRB-
,  ||| S:22944 E:22946 ||| ,
2 ||| S:22946 E:22947 ||| LS
)  ||| S:22947 E:22949 ||| -RRB-
post-transcriptional  ||| S:22949 E:22980 ||| JJ
stabilization  ||| S:22980 E:22994 ||| NN
of  ||| S:22994 E:22997 ||| IN
p21  ||| S:22997 E:23001 ||| NNP
[  ||| S:23001 E:23003 ||| -LRB-
22  ||| S:23003 E:23006 ||| CD
]  ||| S:23006 E:23008 ||| -RRB-
,  ||| S:23008 E:23010 ||| ,
or  ||| S:23010 E:23013 ||| CC
3 ||| S:23013 E:23014 ||| LS
)  ||| S:23014 E:23016 ||| -RRB-
interactions  ||| S:23016 E:23029 ||| NN
of  ||| S:23029 E:23042 ||| IN
C ||| S:23042 E:23043 ||| $
/ ||| S:23043 E:23044 ||| CD
EBPα  ||| S:23044 E:23049 ||| NN
with  ||| S:23049 E:23054 ||| IN
cell  ||| S:23054 E:23059 ||| NN
cycle  ||| S:23059 E:23065 ||| NN
proteins  ||| S:23065 E:23074 ||| NNS
including  ||| S:23074 E:23084 ||| VBG
p21  ||| S:23084 E:23088 ||| NNP
[  ||| S:23088 E:23090 ||| -LRB-
22  ||| S:23090 E:23093 ||| CD
24  ||| S:23093 E:23096 ||| CD
25  ||| S:23096 E:23109 ||| CD
55  ||| S:23109 E:23112 ||| CD
]  ||| S:23112 E:23114 ||| -RRB-
,  ||| S:23114 E:23116 ||| ,
CDK2  ||| S:23116 E:23121 ||| NNP
[  ||| S:23121 E:23123 ||| -LRB-
25  ||| S:23123 E:23126 ||| CD
36  ||| S:23126 E:23129 ||| CD
]  ||| S:23129 E:23131 ||| -RRB-
,  ||| S:23131 E:23133 ||| ,
CDK4  ||| S:23133 E:23138 ||| NNP
[  ||| S:23138 E:23140 ||| -LRB-
36  ||| S:23140 E:23143 ||| CD
]  ||| S:23143 E:23145 ||| -RRB-
,  ||| S:23145 E:23147 ||| ,
retinoblastoma  ||| S:23147 E:23162 ||| NN
[  ||| S:23162 E:23164 ||| -LRB-
54  ||| S:23164 E:23177 ||| CD
]  ||| S:23177 E:23179 ||| -RRB-
,  ||| S:23179 E:23181 ||| ,
the  ||| S:23181 E:23185 ||| DT
retinoblastoma-related  ||| S:23185 E:23208 ||| JJ
protein  ||| S:23208 E:23216 ||| NN
p107  ||| S:23216 E:23221 ||| NNP
[  ||| S:23221 E:23223 ||| -LRB-
34  ||| S:23223 E:23226 ||| CD
]  ||| S:23226 E:23228 ||| -RRB-
and  ||| S:23228 E:23242 ||| CC
the  ||| S:23242 E:23246 ||| DT
G1 ||| S:23246 E:23248 ||| FW
/ ||| S:23248 E:23249 ||| FW
S-regulating  ||| S:23249 E:23262 ||| FW
E2F  ||| S:23262 E:23266 ||| FW
transcription  ||| S:23266 E:23280 ||| FW
complex  ||| S:23280 E:23288 ||| FW
[  ||| S:23288 E:23290 ||| -LRB-
26  ||| S:23290 E:23293 ||| CD
33  ||| S:23293 E:23296 ||| CD
]  ||| S:23296 E:23308 ||| -RRB-
( ||| S:23308 E:23309 ||| -LRB-
Fig.  ||| S:23309 E:23314 ||| NNP
1A ||| S:23314 E:23316 ||| NNP
) ||| S:23316 E:23317 ||| -RRB-
.  ||| S:23317 E:23319 ||| .
We  ||| S:23319 E:23322 ||| PRP
found  ||| S:23322 E:23328 ||| VBD
that  ||| S:23328 E:23333 ||| DT
transcriptional  ||| S:23333 E:23349 ||| JJ
activation  ||| S:23349 E:23370 ||| JJ
domain  ||| S:23370 E:23377 ||| NN
3  ||| S:23377 E:23379 ||| CD
and  ||| S:23379 E:23383 ||| CC
the  ||| S:23383 E:23387 ||| DT
leucine  ||| S:23387 E:23395 ||| JJ
zipper  ||| S:23395 E:23402 ||| NN
were  ||| S:23402 E:23407 ||| VBD
not  ||| S:23407 E:23411 ||| RB
required  ||| S:23411 E:23420 ||| VBN
for  ||| S:23420 E:23434 ||| IN
prolongation  ||| S:23434 E:23447 ||| NN
of  ||| S:23447 E:23450 ||| IN
either  ||| S:23450 E:23457 ||| DT
G1  ||| S:23457 E:23460 ||| NNP
or  ||| S:23460 E:23463 ||| CC
S  ||| S:23463 E:23465 ||| NNP
( ||| S:23465 E:23466 ||| -LRB-
Fig  ||| S:23466 E:23470 ||| NNP
7 ||| S:23470 E:23471 ||| CD
) ||| S:23471 E:23472 ||| -RRB-
.  ||| S:23472 E:23474 ||| .
These  ||| S:23474 E:23480 ||| DT
domains  ||| S:23480 E:23498 ||| JJ
interact  ||| S:23498 E:23507 ||| NN
with  ||| S:23507 E:23512 ||| IN
p21 ||| S:23512 E:23515 ||| NNP
,  ||| S:23515 E:23517 ||| ,
CDK2  ||| S:23517 E:23522 ||| NNP
and  ||| S:23522 E:23526 ||| CC
CDK4  ||| S:23526 E:23531 ||| NNP
[  ||| S:23531 E:23533 ||| -LRB-
22  ||| S:23533 E:23536 ||| CD
24  ||| S:23536 E:23539 ||| CD
25  ||| S:23539 E:23542 ||| CD
36  ||| S:23542 E:23545 ||| CD
55  ||| S:23545 E:23548 ||| CD
]  ||| S:23548 E:23550 ||| -RRB-
.  ||| S:23550 E:23562 ||| .
Thus ||| S:23562 E:23566 ||| RB
,  ||| S:23566 E:23568 ||| ,
C ||| S:23568 E:23569 ||| NNP
/ ||| S:23569 E:23570 ||| NNP
EBPα  ||| S:23570 E:23575 ||| JJ
interactions  ||| S:23575 E:23588 ||| NNS
with  ||| S:23588 E:23593 ||| IN
at  ||| S:23593 E:23596 ||| IN
least  ||| S:23596 E:23602 ||| JJS
p21  ||| S:23602 E:23606 ||| CD
and  ||| S:23606 E:23610 ||| CC
CDK4  ||| S:23610 E:23615 ||| NNP
were  ||| S:23615 E:23630 ||| VBD
not  ||| S:23630 E:23634 ||| RB
required  ||| S:23634 E:23643 ||| VBN
for  ||| S:23643 E:23647 ||| IN
the  ||| S:23647 E:23651 ||| DT
anti-proliferative  ||| S:23651 E:23670 ||| JJ
actions  ||| S:23670 E:23678 ||| NNS
of  ||| S:23678 E:23681 ||| IN
C ||| S:23681 E:23682 ||| $
/ ||| S:23682 E:23683 ||| CD
EBPα  ||| S:23683 E:23698 ||| NN
in  ||| S:23698 E:23701 ||| IN
GHFT1-5  ||| S:23701 E:23709 ||| CD
cells ||| S:23709 E:23714 ||| NNS
.  ||| S:23714 E:23716 ||| .
CDK2 ||| S:23716 E:23720 ||| NNP
,  ||| S:23720 E:23722 ||| ,
and  ||| S:23722 E:23726 ||| CC
other  ||| S:23726 E:23732 ||| JJ
proteins ||| S:23732 E:23740 ||| NNS
,  ||| S:23740 E:23742 ||| ,
also  ||| S:23742 E:23747 ||| RB
interact  ||| S:23747 E:23766 ||| VBN
with  ||| S:23766 E:23771 ||| IN
another  ||| S:23771 E:23779 ||| DT
domain  ||| S:23779 E:23786 ||| NN
of  ||| S:23786 E:23789 ||| IN
C ||| S:23789 E:23790 ||| NNP
/ ||| S:23790 E:23791 ||| NNP
EBPα  ||| S:23791 E:23796 ||| NNP
[  ||| S:23796 E:23798 ||| -LRB-
25  ||| S:23798 E:23801 ||| CD
]  ||| S:23801 E:23803 ||| -RRB-
required  ||| S:23803 E:23812 ||| VBN
for  ||| S:23812 E:23826 ||| IN
proliferation  ||| S:23826 E:23840 ||| NN
arrest  ||| S:23840 E:23847 ||| NN
( ||| S:23847 E:23848 ||| -LRB-
discussed  ||| S:23848 E:23858 ||| VBN
below ||| S:23858 E:23863 ||| IN
) ||| S:23863 E:23864 ||| -RRB-
.  ||| S:23864 E:23876 ||| .
Arrest  ||| S:23876 E:23883 ||| NN
in  ||| S:23883 E:23886 ||| IN
S  ||| S:23886 E:23888 ||| NNP
phase  ||| S:23888 E:23894 ||| NN
was  ||| S:23894 E:23898 ||| VBD
associated  ||| S:23898 E:23909 ||| VBN
with  ||| S:23909 E:23914 ||| IN
amino  ||| S:23914 E:23920 ||| CD
acids  ||| S:23920 E:23926 ||| CD
259  ||| S:23926 E:23940 ||| CD
to  ||| S:23940 E:23943 ||| TO
310  ||| S:23943 E:23947 ||| CD
( ||| S:23947 E:23948 ||| -LRB-
Fig.  ||| S:23948 E:23953 ||| CD
6 ||| S:23953 E:23954 ||| CD
) ||| S:23954 E:23955 ||| -RRB-
,  ||| S:23955 E:23957 ||| ,
which  ||| S:23957 E:23963 ||| WDT
include  ||| S:23963 E:23971 ||| VBP
the  ||| S:23971 E:23975 ||| DT
basic  ||| S:23975 E:23981 ||| JJ
amino  ||| S:23981 E:23987 ||| JJ
acid-rich ||| S:23987 E:23996 ||| NN
,  ||| S:23996 E:24008 ||| ,
DNA  ||| S:24008 E:24012 ||| NNP
binding  ||| S:24012 E:24020 ||| JJ
region  ||| S:24020 E:24027 ||| NN
of  ||| S:24027 E:24030 ||| IN
C ||| S:24030 E:24031 ||| NNP
/ ||| S:24031 E:24032 ||| NNP
EBPα ||| S:24032 E:24036 ||| NNP
.  ||| S:24036 E:24038 ||| .
C ||| S:24038 E:24039 ||| SYM
/ ||| S:24039 E:24040 ||| CD
EBPα  ||| S:24040 E:24045 ||| JJ
deleted  ||| S:24045 E:24053 ||| NN
of  ||| S:24053 E:24056 ||| IN
the  ||| S:24056 E:24070 ||| DT
leucine  ||| S:24070 E:24078 ||| JJ
zipper  ||| S:24078 E:24085 ||| JJ
dimerization  ||| S:24085 E:24098 ||| JJ
domain ||| S:24098 E:24104 ||| NN
,  ||| S:24104 E:24106 ||| ,
also  ||| S:24106 E:24111 ||| RB
required  ||| S:24111 E:24120 ||| VBN
for  ||| S:24120 E:24124 ||| IN
DNA  ||| S:24124 E:24138 ||| NNP
binding  ||| S:24138 E:24146 ||| NNS
[  ||| S:24146 E:24148 ||| -LRB-
25  ||| S:24148 E:24151 ||| CD
]  ||| S:24151 E:24153 ||| -RRB-
( ||| S:24153 E:24154 ||| -LRB-
Fig.  ||| S:24154 E:24159 ||| NNP
2C ||| S:24159 E:24161 ||| NNP
) ||| S:24161 E:24162 ||| -RRB-
,  ||| S:24162 E:24164 ||| ,
was  ||| S:24164 E:24168 ||| VBD
as  ||| S:24168 E:24171 ||| IN
effective  ||| S:24171 E:24181 ||| JJ
as  ||| S:24181 E:24184 ||| IN
full-length  ||| S:24184 E:24206 ||| JJ
GFP-C ||| S:24206 E:24211 ||| JJ
/ ||| S:24211 E:24212 ||| CD
EBPα  ||| S:24212 E:24217 ||| NN
in  ||| S:24217 E:24220 ||| IN
prolonging  ||| S:24220 E:24231 ||| VBG
both  ||| S:24231 E:24236 ||| DT
S  ||| S:24236 E:24238 ||| NNP
and  ||| S:24238 E:24242 ||| CC
G1  ||| S:24242 E:24245 ||| NNP
( ||| S:24245 E:24246 ||| -LRB-
Fig.  ||| S:24246 E:24251 ||| NNP
6A ||| S:24251 E:24253 ||| NNP
) ||| S:24253 E:24254 ||| -RRB-
.  ||| S:24254 E:24256 ||| .
Thus ||| S:24256 E:24260 ||| RB
,  ||| S:24260 E:24272 ||| ,
DNA  ||| S:24272 E:24276 ||| NNP
binding  ||| S:24276 E:24295 ||| FW
per  ||| S:24295 E:24299 ||| FW
se  ||| S:24299 E:24302 ||| FW
was  ||| S:24302 E:24306 ||| VBD
not  ||| S:24306 E:24310 ||| RB
required  ||| S:24310 E:24319 ||| VBN
for  ||| S:24319 E:24333 ||| IN
proliferation  ||| S:24333 E:24347 ||| NN
arrest ||| S:24347 E:24353 ||| NN
.  ||| S:24353 E:24355 ||| .
The  ||| S:24355 E:24359 ||| DT
basic  ||| S:24359 E:24365 ||| JJ
region  ||| S:24365 E:24372 ||| NN
of  ||| S:24372 E:24375 ||| IN
C ||| S:24375 E:24376 ||| $
/ ||| S:24376 E:24377 ||| CD
EBPα  ||| S:24377 E:24382 ||| JJ
blocks  ||| S:24382 E:24399 ||| NNS
the  ||| S:24399 E:24403 ||| DT
transcriptional  ||| S:24403 E:24419 ||| JJ
activity  ||| S:24419 E:24428 ||| NN
of  ||| S:24428 E:24431 ||| IN
E2F  ||| S:24431 E:24435 ||| CD
by  ||| S:24435 E:24438 ||| IN
unknown  ||| S:24438 E:24446 ||| JJ
mechanisms  ||| S:24446 E:24467 ||| NNS
[  ||| S:24467 E:24469 ||| -LRB-
33  ||| S:24469 E:24472 ||| CD
]  ||| S:24472 E:24474 ||| -RRB-
and  ||| S:24474 E:24478 ||| CC
contains  ||| S:24478 E:24487 ||| VBZ
another  ||| S:24487 E:24495 ||| DT
known  ||| S:24495 E:24501 ||| VBN
CDK2-interaction  ||| S:24501 E:24518 ||| CD
site  ||| S:24518 E:24523 ||| NN
[  ||| S:24523 E:24535 ||| -LRB-
25  ||| S:24535 E:24538 ||| CD
]  ||| S:24538 E:24540 ||| -RRB-
.  ||| S:24540 E:24542 ||| .
Either  ||| S:24542 E:24549 ||| RB
of  ||| S:24549 E:24552 ||| IN
these  ||| S:24552 E:24558 ||| DT
activities  ||| S:24558 E:24569 ||| NNS
may  ||| S:24569 E:24573 ||| MD
contribute  ||| S:24573 E:24584 ||| VB
to  ||| S:24584 E:24587 ||| TO
basic  ||| S:24587 E:24603 ||| JJ
region-dependent ||| S:24603 E:24619 ||| NN
,  ||| S:24619 E:24621 ||| ,
S  ||| S:24621 E:24623 ||| NNP
phase  ||| S:24623 E:24629 ||| NN
arrest  ||| S:24629 E:24636 ||| NN
of  ||| S:24636 E:24639 ||| IN
GHFT1-5  ||| S:24639 E:24647 ||| CD
cell  ||| S:24647 E:24662 ||| NN
proliferation ||| S:24662 E:24675 ||| NN
.  ||| S:24675 E:24687 ||| .
G1  ||| S:24687 E:24690 ||| NNP
block  ||| S:24690 E:24696 ||| NN
in  ||| S:24696 E:24699 ||| IN
GHFT1-5  ||| S:24699 E:24707 ||| CD
cells  ||| S:24707 E:24713 ||| NNS
required  ||| S:24713 E:24722 ||| VBN
C ||| S:24722 E:24723 ||| NNP
/ ||| S:24723 E:24724 ||| FW
EBPα  ||| S:24724 E:24729 ||| FW
amino  ||| S:24729 E:24735 ||| FW
acids  ||| S:24735 E:24751 ||| FW
1-97  ||| S:24751 E:24756 ||| FW
( ||| S:24756 E:24757 ||| -LRB-
Fig.  ||| S:24757 E:24762 ||| CD
7 ||| S:24762 E:24763 ||| CD
) ||| S:24763 E:24764 ||| -RRB-
,  ||| S:24764 E:24766 ||| ,
comprising  ||| S:24766 E:24777 ||| VBG
activation  ||| S:24777 E:24788 ||| CD
domains  ||| S:24788 E:24796 ||| CD
1  ||| S:24796 E:24798 ||| CD
and  ||| S:24798 E:24802 ||| CC
2  ||| S:24802 E:24804 ||| CD
[  ||| S:24804 E:24806 ||| -LRB-
31  ||| S:24806 E:24819 ||| CD
]  ||| S:24819 E:24821 ||| -RRB-
.  ||| S:24821 E:24823 ||| .
Amino  ||| S:24823 E:24829 ||| NNP
acids  ||| S:24829 E:24835 ||| VBD
1  ||| S:24835 E:24837 ||| CD
to  ||| S:24837 E:24840 ||| TO
97  ||| S:24840 E:24843 ||| CD
have  ||| S:24843 E:24848 ||| VBP
been  ||| S:24848 E:24853 ||| VBN
implicated  ||| S:24853 E:24864 ||| VBN
in  ||| S:24864 E:24867 ||| IN
C ||| S:24867 E:24868 ||| $
/ ||| S:24868 E:24869 ||| CD
EBPα  ||| S:24869 E:24884 ||| JJ
growth  ||| S:24884 E:24891 ||| NN
arrest  ||| S:24891 E:24898 ||| NN
via  ||| S:24898 E:24902 ||| IN
the  ||| S:24902 E:24906 ||| DT
E2F ||| S:24906 E:24909 ||| CD
/ ||| S:24909 E:24910 ||| CD
pl07  ||| S:24910 E:24915 ||| CD
complexes  ||| S:24915 E:24925 ||| NNS
[  ||| S:24925 E:24927 ||| -LRB-
34  ||| S:24927 E:24930 ||| CD
35  ||| S:24930 E:24933 ||| CD
]  ||| S:24933 E:24935 ||| -RRB-
.  ||| S:24935 E:24947 ||| .
C ||| S:24947 E:24948 ||| SYM
/ ||| S:24948 E:24949 ||| CD
EBPα  ||| S:24949 E:24954 ||| JJ
interaction  ||| S:24954 E:24966 ||| NN
with  ||| S:24966 E:24971 ||| IN
p107  ||| S:24971 E:24976 ||| NNP
is  ||| S:24976 E:24979 ||| VBZ
believed  ||| S:24979 E:24988 ||| VBN
to  ||| S:24988 E:24991 ||| TO
prevent  ||| S:24991 E:24999 ||| VB
the  ||| S:24999 E:25013 ||| DT
formation  ||| S:25013 E:25023 ||| NN
of  ||| S:25023 E:25026 ||| IN
an  ||| S:25026 E:25029 ||| DT
S-phase  ||| S:25029 E:25037 ||| JJ
promoting  ||| S:25037 E:25047 ||| VBG
complex  ||| S:25047 E:25055 ||| JJ
containing  ||| S:25055 E:25066 ||| VBG
p107  ||| S:25066 E:25081 ||| NNP
and  ||| S:25081 E:25085 ||| CC
E2F  ||| S:25085 E:25089 ||| NNP
[  ||| S:25089 E:25091 ||| -LRB-
26  ||| S:25091 E:25094 ||| CD
34  ||| S:25094 E:25097 ||| CD
35  ||| S:25097 E:25100 ||| CD
]  ||| S:25100 E:25102 ||| -RRB-
.  ||| S:25102 E:25104 ||| .
Thus ||| S:25104 E:25108 ||| RB
,  ||| S:25108 E:25110 ||| ,
G1  ||| S:25110 E:25113 ||| CD
block  ||| S:25113 E:25119 ||| NN
in  ||| S:25119 E:25122 ||| IN
GHFT1-5  ||| S:25122 E:25130 ||| CD
cells  ||| S:25130 E:25146 ||| NNS
may  ||| S:25146 E:25150 ||| MD
be  ||| S:25150 E:25153 ||| VB
related  ||| S:25153 E:25161 ||| VBN
to  ||| S:25161 E:25164 ||| TO
the  ||| S:25164 E:25168 ||| DT
ability  ||| S:25168 E:25176 ||| NN
of  ||| S:25176 E:25179 ||| IN
C ||| S:25179 E:25180 ||| $
/ ||| S:25180 E:25181 ||| CD
EBPα  ||| S:25181 E:25186 ||| JJ
to  ||| S:25186 E:25189 ||| TO
interact  ||| S:25189 E:25198 ||| VB
with  ||| S:25198 E:25213 ||| IN
p107 ||| S:25213 E:25217 ||| CD
.  ||| S:25217 E:25219 ||| .
However ||| S:25219 E:25226 ||| RB
,  ||| S:25226 E:25228 ||| ,
the  ||| S:25228 E:25232 ||| DT
amino  ||| S:25232 E:25238 ||| JJ
terminus  ||| S:25238 E:25247 ||| NN
of  ||| S:25247 E:25250 ||| IN
C ||| S:25250 E:25251 ||| NNP
/ ||| S:25251 E:25252 ||| NNP
EBPα  ||| S:25252 E:25257 ||| NNP
also  ||| S:25257 E:25272 ||| RB
functionally  ||| S:25272 E:25285 ||| JJ
interacts  ||| S:25285 E:25295 ||| NN
with  ||| S:25295 E:25300 ||| IN
a  ||| S:25300 E:25302 ||| DT
number  ||| S:25302 E:25309 ||| NN
of  ||| S:25309 E:25312 ||| IN
other  ||| S:25312 E:25318 ||| JJ
factors  ||| S:25318 E:25326 ||| NNS
[  ||| S:25326 E:25338 ||| -LRB-
31  ||| S:25338 E:25341 ||| CD
45  ||| S:25341 E:25344 ||| CD
46  ||| S:25344 E:25347 ||| CD
]  ||| S:25347 E:25349 ||| -RRB-
,  ||| S:25349 E:25351 ||| ,
any  ||| S:25351 E:25355 ||| DT
of  ||| S:25355 E:25358 ||| IN
which  ||| S:25358 E:25364 ||| WDT
might  ||| S:25364 E:25370 ||| MD
contribute  ||| S:25370 E:25381 ||| VB
to  ||| S:25381 E:25394 ||| TO
proliferation  ||| S:25394 E:25408 ||| VB
arrest ||| S:25408 E:25414 ||| NN
.  ||| S:25414 E:25444 ||| .
Subnuclear  ||| S:25444 E:25455 ||| NNP
Architecture  ||| S:25455 E:25468 ||| NNP
and  ||| S:25468 E:25472 ||| CC
C ||| S:25472 E:25473 ||| NNP
/ ||| S:25473 E:25474 ||| NNP
EBPα  ||| S:25474 E:25479 ||| NNP
Inhibition  ||| S:25479 E:25490 ||| NNP
of  ||| S:25490 E:25503 ||| IN
Proliferation  ||| S:25503 E:25527 ||| NNP
Tang  ||| S:25527 E:25532 ||| NNP
and  ||| S:25532 E:25536 ||| CC
Lane  ||| S:25536 E:25541 ||| NNP
[  ||| S:25541 E:25543 ||| -LRB-
49  ||| S:25543 E:25546 ||| CD
]  ||| S:25546 E:25548 ||| -RRB-
showed  ||| S:25548 E:25555 ||| VBD
that  ||| S:25555 E:25560 ||| IN
C ||| S:25560 E:25561 ||| NNP
/ ||| S:25561 E:25562 ||| NNP
EBPα  ||| S:25562 E:25567 ||| NNP
becomes  ||| S:25567 E:25585 ||| VBZ
associated  ||| S:25585 E:25596 ||| VBN
with  ||| S:25596 E:25601 ||| IN
peri-centromeric  ||| S:25601 E:25618 ||| JJ
chromatin  ||| S:25618 E:25628 ||| NN
upon  ||| S:25628 E:25643 ||| IN
expression  ||| S:25643 E:25654 ||| NN
during  ||| S:25654 E:25661 ||| IN
adipocyte  ||| S:25661 E:25671 ||| JJ
differentiation ||| S:25671 E:25686 ||| NN
.  ||| S:25686 E:25688 ||| .
We  ||| S:25688 E:25691 ||| PRP
observed  ||| S:25691 E:25710 ||| VBD
that  ||| S:25710 E:25715 ||| IN
C ||| S:25715 E:25716 ||| NNP
/ ||| S:25716 E:25717 ||| NNP
EBPα ||| S:25717 E:25721 ||| NNP
,  ||| S:25721 E:25723 ||| ,
expressed  ||| S:25723 E:25733 ||| VBN
in  ||| S:25733 E:25736 ||| IN
mouse  ||| S:25736 E:25742 ||| FW
pituitary  ||| S:25742 E:25752 ||| FW
progenitor  ||| S:25752 E:25773 ||| FW
GHFT1-5  ||| S:25773 E:25781 ||| FW
cells ||| S:25781 E:25786 ||| NNS
,  ||| S:25786 E:25788 ||| ,
also  ||| S:25788 E:25793 ||| RB
localized  ||| S:25793 E:25803 ||| VBN
to  ||| S:25803 E:25806 ||| TO
peri-centromeric  ||| S:25806 E:25833 ||| JJ
chromatin  ||| S:25833 E:25843 ||| NNS
[  ||| S:25843 E:25845 ||| -LRB-
45  ||| S:25845 E:25848 ||| CD
]  ||| S:25848 E:25850 ||| -RRB-
.  ||| S:25850 E:25852 ||| .
Here  ||| S:25852 E:25857 ||| RB
we  ||| S:25857 E:25860 ||| PRP
show  ||| S:25860 E:25865 ||| VBP
that  ||| S:25865 E:25870 ||| IN
targeting  ||| S:25870 E:25880 ||| VBG
of  ||| S:25880 E:25883 ||| IN
C ||| S:25883 E:25884 ||| $
/ ||| S:25884 E:25885 ||| CD
EBPα  ||| S:25885 E:25900 ||| JJ
to  ||| S:25900 E:25903 ||| TO
peri-centromeric  ||| S:25903 E:25920 ||| JJ
chromatin  ||| S:25920 E:25930 ||| NN
in  ||| S:25930 E:25933 ||| IN
GHFT1-5  ||| S:25933 E:25941 ||| CD
cells  ||| S:25941 E:25947 ||| NNS
required  ||| S:25947 E:25966 ||| VBD
the  ||| S:25966 E:25970 ||| DT
DNA  ||| S:25970 E:25974 ||| NN
binding  ||| S:25974 E:25982 ||| JJ
domain  ||| S:25982 E:25989 ||| NN
of  ||| S:25989 E:25992 ||| IN
C ||| S:25992 E:25993 ||| NNP
/ ||| S:25993 E:25994 ||| NNP
EBPα  ||| S:25994 E:25999 ||| NNP
( ||| S:25999 E:26000 ||| -LRB-
Fig.  ||| S:26000 E:26005 ||| CD
5 ||| S:26005 E:26006 ||| CD
) ||| S:26006 E:26007 ||| -RRB-
.  ||| S:26007 E:26009 ||| .
However ||| S:26009 E:26016 ||| RB
,  ||| S:26016 E:26028 ||| ,
C ||| S:26028 E:26029 ||| NNP
/ ||| S:26029 E:26030 ||| NNP
EBPα  ||| S:26030 E:26035 ||| JJ
deleted  ||| S:26035 E:26043 ||| NN
of  ||| S:26043 E:26046 ||| IN
the  ||| S:26046 E:26050 ||| DT
DNA  ||| S:26050 E:26054 ||| NN
binding  ||| S:26054 E:26062 ||| JJ
domain  ||| S:26062 E:26069 ||| NN
was  ||| S:26069 E:26073 ||| VBD
as  ||| S:26073 E:26076 ||| IN
effective  ||| S:26076 E:26096 ||| JJ
as  ||| S:26096 E:26099 ||| IN
full-length  ||| S:26099 E:26111 ||| JJ
C ||| S:26111 E:26112 ||| NNP
/ ||| S:26112 E:26113 ||| NNP
EBPα  ||| S:26113 E:26118 ||| NNP
in  ||| S:26118 E:26121 ||| IN
prolonging  ||| S:26121 E:26132 ||| CD
GHFT1-5  ||| S:26132 E:26140 ||| CD
cells  ||| S:26140 E:26146 ||| NNS
in  ||| S:26146 E:26149 ||| IN
the  ||| S:26149 E:26163 ||| DT
G1  ||| S:26163 E:26166 ||| NNP
and  ||| S:26166 E:26170 ||| CC
S  ||| S:26170 E:26172 ||| NNP
phases  ||| S:26172 E:26179 ||| NNS
of  ||| S:26179 E:26182 ||| IN
the  ||| S:26182 E:26186 ||| DT
cell  ||| S:26186 E:26191 ||| NN
cycle  ||| S:26191 E:26197 ||| NN
( ||| S:26197 E:26198 ||| -LRB-
Fig.  ||| S:26198 E:26203 ||| NNP
6A ||| S:26203 E:26205 ||| NNP
) ||| S:26205 E:26206 ||| -RRB-
.  ||| S:26206 E:26208 ||| .
Thus ||| S:26208 E:26212 ||| RB
,  ||| S:26212 E:26214 ||| ,
the  ||| S:26214 E:26228 ||| DT
specific  ||| S:26228 E:26237 ||| JJ
association  ||| S:26237 E:26249 ||| NN
of  ||| S:26249 E:26252 ||| IN
C ||| S:26252 E:26253 ||| $
/ ||| S:26253 E:26254 ||| CD
EBPα  ||| S:26254 E:26259 ||| NN
with  ||| S:26259 E:26264 ||| IN
peri-centromeric  ||| S:26264 E:26291 ||| JJ
chromatin ||| S:26291 E:26300 ||| NN
,  ||| S:26300 E:26302 ||| ,
speculated  ||| S:26302 E:26313 ||| VBD
to  ||| S:26313 E:26316 ||| TO
contribute  ||| S:26316 E:26327 ||| VB
to  ||| S:26327 E:26330 ||| TO
C ||| S:26330 E:26331 ||| $
/ ||| S:26331 E:26332 ||| CD
EBPα  ||| S:26332 E:26337 ||| JJ
growth  ||| S:26337 E:26354 ||| NN
arrest  ||| S:26354 E:26361 ||| NN
[  ||| S:26361 E:26363 ||| -LRB-
49  ||| S:26363 E:26366 ||| CD
]  ||| S:26366 E:26368 ||| -RRB-
,  ||| S:26368 E:26370 ||| ,
was  ||| S:26370 E:26374 ||| VBD
not  ||| S:26374 E:26378 ||| RB
necessary  ||| S:26378 E:26388 ||| JJ
for  ||| S:26388 E:26392 ||| IN
disruption  ||| S:26392 E:26403 ||| NN
of  ||| S:26403 E:26406 ||| IN
the  ||| S:26406 E:26420 ||| DT
cell  ||| S:26420 E:26425 ||| NN
cycle  ||| S:26425 E:26431 ||| NN
by  ||| S:26431 E:26434 ||| IN
C ||| S:26434 E:26435 ||| NNP
/ ||| S:26435 E:26436 ||| NNP
EBPα ||| S:26436 E:26440 ||| NNP
.  ||| S:26440 E:26442 ||| .
The  ||| S:26442 E:26446 ||| DT
independence  ||| S:26446 E:26459 ||| NN
of  ||| S:26459 E:26462 ||| IN
C ||| S:26462 E:26463 ||| $
/ ||| S:26463 E:26464 ||| CD
EBPα  ||| S:26464 E:26479 ||| JJ
regulation  ||| S:26479 E:26490 ||| NN
of  ||| S:26490 E:26493 ||| IN
proliferation  ||| S:26493 E:26507 ||| NN
from  ||| S:26507 E:26512 ||| IN
its  ||| S:26512 E:26516 ||| PRP$
intranuclear  ||| S:26516 E:26539 ||| JJ
localization  ||| S:26539 E:26552 ||| NN
may  ||| S:26552 E:26556 ||| MD
even  ||| S:26556 E:26561 ||| RB
be  ||| S:26561 E:26564 ||| VB
necessary  ||| S:26564 E:26574 ||| JJ
since  ||| S:26574 E:26580 ||| IN
we  ||| S:26580 E:26583 ||| PRP
have  ||| S:26583 E:26588 ||| VBP
recently  ||| S:26588 E:26607 ||| RB
determined  ||| S:26607 E:26618 ||| VBN
that  ||| S:26618 E:26623 ||| IN
pituitary  ||| S:26623 E:26633 ||| JJ
cell  ||| S:26633 E:26638 ||| NN
differentiation  ||| S:26638 E:26654 ||| NN
is  ||| S:26654 E:26667 ||| VBZ
associated  ||| S:26667 E:26678 ||| VBN
with  ||| S:26678 E:26683 ||| IN
the  ||| S:26683 E:26687 ||| DT
dispersal  ||| S:26687 E:26697 ||| NN
of  ||| S:26697 E:26700 ||| IN
C ||| S:26700 E:26701 ||| $
/ ||| S:26701 E:26702 ||| CD
EBPα  ||| S:26702 E:26707 ||| NN
from  ||| S:26707 E:26722 ||| IN
peri-centromeric  ||| S:26722 E:26739 ||| JJ
heterochromatin  ||| S:26739 E:26755 ||| NN
by  ||| S:26755 E:26758 ||| IN
the  ||| S:26758 E:26772 ||| DT
pituitary-specific  ||| S:26772 E:26791 ||| JJ
transcription  ||| S:26791 E:26805 ||| JJ
factor  ||| S:26805 E:26812 ||| NN
Pit-1  ||| S:26812 E:26818 ||| NNP
( ||| S:26818 E:26819 ||| -LRB-
J ||| S:26819 E:26820 ||| NNP
.  ||| S:26820 E:26822 ||| .
F.  ||| S:26822 E:26825 ||| NNP
E. ||| S:26825 E:26827 ||| NNP
,  ||| S:26827 E:26839 ||| ,
M.  ||| S:26839 E:26842 ||| NNP
A.  ||| S:26842 E:26845 ||| NNP
Kawecki ||| S:26845 E:26852 ||| NNP
,  ||| S:26852 E:26854 ||| ,
F.  ||| S:26854 E:26857 ||| NNP
S. ||| S:26857 E:26859 ||| NNP
,  ||| S:26859 E:26861 ||| ,
R.  ||| S:26861 E:26864 ||| NNP
N.  ||| S:26864 E:26867 ||| NNP
D. ||| S:26867 E:26869 ||| NNP
,  ||| S:26869 E:26871 ||| ,
submitted ||| S:26871 E:26880 ||| VBN
) ||| S:26880 E:26881 ||| -RRB-
.  ||| S:26881 E:26911 ||| .
Transcription-Independent  ||| S:26911 E:26937 ||| NNP
Inhibition  ||| S:26937 E:26948 ||| NNP
of  ||| S:26948 E:26961 ||| IN
Proliferation  ||| S:26961 E:26985 ||| NNP
Transcription  ||| S:26985 E:26999 ||| NNP
factors ||| S:26999 E:27006 ||| NNS
,  ||| S:27006 E:27008 ||| ,
like  ||| S:27008 E:27013 ||| IN
C ||| S:27013 E:27014 ||| NNP
/ ||| S:27014 E:27015 ||| NNP
EBPα ||| S:27015 E:27019 ||| NNP
,  ||| S:27019 E:27021 ||| ,
may  ||| S:27021 E:27025 ||| MD
regulate  ||| S:27025 E:27034 ||| VB
cell  ||| S:27034 E:27049 ||| NN
proliferation  ||| S:27049 E:27063 ||| NN
by  ||| S:27063 E:27066 ||| IN
directly  ||| S:27066 E:27075 ||| RB
controlling  ||| S:27075 E:27087 ||| VBG
the  ||| S:27087 E:27091 ||| DT
expression  ||| S:27091 E:27102 ||| NN
of  ||| S:27102 E:27115 ||| IN
proteins  ||| S:27115 E:27124 ||| NNS
required  ||| S:27124 E:27133 ||| VBN
for  ||| S:27133 E:27137 ||| IN
cell  ||| S:27137 E:27142 ||| NN
cycle  ||| S:27142 E:27148 ||| NN
progression ||| S:27148 E:27159 ||| NN
.  ||| S:27159 E:27161 ||| .
Indeed ||| S:27161 E:27167 ||| RB
,  ||| S:27167 E:27179 ||| ,
C ||| S:27179 E:27180 ||| NNP
/ ||| S:27180 E:27181 ||| NNP
EBPα  ||| S:27181 E:27186 ||| JJ
activates  ||| S:27186 E:27196 ||| JJ
transcription  ||| S:27196 E:27210 ||| NN
of  ||| S:27210 E:27213 ||| IN
the  ||| S:27213 E:27217 ||| DT
p21  ||| S:27217 E:27221 ||| NNP
[  ||| S:27221 E:27223 ||| -LRB-
37  ||| S:27223 E:27226 ||| CD
]  ||| S:27226 E:27228 ||| -RRB-
,  ||| S:27228 E:27230 ||| ,
gadd45  ||| S:27230 E:27247 ||| NNP
[  ||| S:27247 E:27249 ||| -LRB-
5  ||| S:27249 E:27251 ||| CD
6  ||| S:27251 E:27253 ||| CD
]  ||| S:27253 E:27255 ||| -RRB-
,  ||| S:27255 E:27257 ||| ,
gas2  ||| S:27257 E:27262 ||| NNP
and  ||| S:27262 E:27266 ||| CC
gas3  ||| S:27266 E:27271 ||| NNP
[  ||| S:27271 E:27273 ||| -LRB-
38  ||| S:27273 E:27276 ||| CD
39  ||| S:27276 E:27279 ||| CD
]  ||| S:27279 E:27281 ||| -RRB-
genes ||| S:27281 E:27286 ||| NNS
.  ||| S:27286 E:27288 ||| .
However ||| S:27288 E:27295 ||| RB
,  ||| S:27295 E:27297 ||| ,
similar  ||| S:27297 E:27315 ||| JJ
levels  ||| S:27315 E:27322 ||| NNS
of  ||| S:27322 E:27325 ||| IN
p21  ||| S:27325 E:27329 ||| CD
mRNA  ||| S:27329 E:27334 ||| NN
in  ||| S:27334 E:27337 ||| IN
the  ||| S:27337 E:27341 ||| DT
livers  ||| S:27341 E:27348 ||| NN
of  ||| S:27348 E:27351 ||| IN
wild-type  ||| S:27351 E:27361 ||| JJ
and  ||| S:27361 E:27375 ||| CC
homozygous  ||| S:27375 E:27386 ||| JJ
C ||| S:27386 E:27387 ||| $
/ ||| S:27387 E:27388 ||| CD
EBPα  ||| S:27388 E:27393 ||| JJ
knock-out  ||| S:27393 E:27403 ||| JJ
mice  ||| S:27403 E:27408 ||| NNS
[  ||| S:27408 E:27410 ||| -LRB-
22  ||| S:27410 E:27413 ||| CD
]  ||| S:27413 E:27415 ||| -RRB-
argue  ||| S:27415 E:27421 ||| VBP
against  ||| S:27421 E:27429 ||| IN
a  ||| S:27429 E:27441 ||| DT
physiologically  ||| S:27441 E:27457 ||| JJ
significant  ||| S:27457 E:27469 ||| JJ
contribution  ||| S:27469 E:27482 ||| NN
of  ||| S:27482 E:27485 ||| IN
C ||| S:27485 E:27486 ||| $
/ ||| S:27486 E:27487 ||| CD
EBPα  ||| S:27487 E:27492 ||| JJ
to  ||| S:27492 E:27495 ||| TO
p21  ||| S:27495 E:27509 ||| CD
gene  ||| S:27509 E:27514 ||| NN
transcription  ||| S:27514 E:27528 ||| NN
in  ||| S:27528 E:27531 ||| IN
the  ||| S:27531 E:27535 ||| DT
liver ||| S:27535 E:27540 ||| NN
.  ||| S:27540 E:27542 ||| .
We  ||| S:27542 E:27545 ||| PRP
also  ||| S:27545 E:27550 ||| RB
observed  ||| S:27550 E:27559 ||| VBN
that  ||| S:27559 E:27574 ||| IN
transcriptionally  ||| S:27574 E:27592 ||| JJ
inactive  ||| S:27592 E:27601 ||| NN
and  ||| S:27601 E:27605 ||| CC
DNA-binding-defective  ||| S:27605 E:27637 ||| JJ
forms  ||| S:27637 E:27643 ||| NNS
of  ||| S:27643 E:27646 ||| IN
C ||| S:27646 E:27647 ||| NNP
/ ||| S:27647 E:27648 ||| NNP
EBPα  ||| S:27648 E:27653 ||| NNP
still  ||| S:27653 E:27659 ||| RB
blocked  ||| S:27659 E:27667 ||| VBD
GHFT1-5  ||| S:27667 E:27675 ||| CD
cell  ||| S:27675 E:27680 ||| NN
proliferation  ||| S:27680 E:27704 ||| NN
in  ||| S:27704 E:27707 ||| IN
both  ||| S:27707 E:27712 ||| PDT
the  ||| S:27712 E:27716 ||| DT
G1  ||| S:27716 E:27719 ||| NNP
and  ||| S:27719 E:27723 ||| CC
S  ||| S:27723 E:27725 ||| NNP
phases  ||| S:27725 E:27732 ||| NNS
of  ||| S:27732 E:27735 ||| IN
the  ||| S:27735 E:27739 ||| DT
cell  ||| S:27739 E:27744 ||| NN
cycle  ||| S:27744 E:27750 ||| NN
( ||| S:27750 E:27751 ||| -LRB-
Figs.  ||| S:27751 E:27757 ||| CD
2 ||| S:27757 E:27758 ||| CD
,  ||| S:27758 E:27770 ||| ,
4 ||| S:27770 E:27771 ||| CD
,  ||| S:27771 E:27773 ||| ,
6 ||| S:27773 E:27774 ||| CD
) ||| S:27774 E:27775 ||| -RRB-
.  ||| S:27775 E:27777 ||| .
DNA-binding-defective  ||| S:27777 E:27799 ||| JJ
mutants  ||| S:27799 E:27807 ||| NN
of  ||| S:27807 E:27810 ||| IN
C ||| S:27810 E:27811 ||| $
/ ||| S:27811 E:27812 ||| CD
EBPα  ||| S:27812 E:27817 ||| NNS
have  ||| S:27817 E:27822 ||| VBP
also  ||| S:27822 E:27837 ||| RB
been  ||| S:27837 E:27842 ||| VBN
observed  ||| S:27842 E:27851 ||| VBN
to  ||| S:27851 E:27854 ||| TO
block  ||| S:27854 E:27860 ||| VB
proliferation  ||| S:27860 E:27874 ||| NN
in  ||| S:27874 E:27877 ||| IN
other  ||| S:27877 E:27883 ||| JJ
cell  ||| S:27883 E:27888 ||| NN
lines  ||| S:27888 E:27904 ||| NNS
[  ||| S:27904 E:27906 ||| -LRB-
25  ||| S:27906 E:27909 ||| CD
33  ||| S:27909 E:27912 ||| CD
]  ||| S:27912 E:27914 ||| -RRB-
.  ||| S:27914 E:27916 ||| .
Together ||| S:27916 E:27924 ||| RB
,  ||| S:27924 E:27926 ||| ,
this  ||| S:27926 E:27931 ||| DT
suggests  ||| S:27931 E:27940 ||| VBZ
that  ||| S:27940 E:27945 ||| IN
C ||| S:27945 E:27946 ||| $
/ ||| S:27946 E:27947 ||| CD
EBPα  ||| S:27947 E:27962 ||| JJ
regulation  ||| S:27962 E:27973 ||| NN
of  ||| S:27973 E:27976 ||| IN
transcription ||| S:27976 E:27989 ||| NN
,  ||| S:27989 E:27991 ||| ,
in  ||| S:27991 E:27994 ||| IN
general ||| S:27994 E:28001 ||| JJ
,  ||| S:28001 E:28003 ||| ,
might  ||| S:28003 E:28009 ||| MD
not  ||| S:28009 E:28023 ||| RB
contribute  ||| S:28023 E:28034 ||| VB
to  ||| S:28034 E:28037 ||| TO
the  ||| S:28037 E:28041 ||| DT
regulation  ||| S:28041 E:28052 ||| NN
of  ||| S:28052 E:28055 ||| IN
cell  ||| S:28055 E:28060 ||| NN
proliferation ||| S:28060 E:28073 ||| NN
.  ||| S:28073 E:28075 ||| .
It  ||| S:28075 E:28088 ||| PRP
remains  ||| S:28088 E:28096 ||| VBZ
possible  ||| S:28096 E:28105 ||| JJ
that  ||| S:28105 E:28110 ||| IN
C ||| S:28110 E:28111 ||| $
/ ||| S:28111 E:28112 ||| CD
EBPα  ||| S:28112 E:28117 ||| JJ
activation  ||| S:28117 E:28128 ||| NN
of  ||| S:28128 E:28131 ||| IN
the  ||| S:28131 E:28145 ||| DT
transcription  ||| S:28145 E:28159 ||| NN
of  ||| S:28159 E:28162 ||| IN
some  ||| S:28162 E:28167 ||| DT
cell  ||| S:28167 E:28172 ||| NN
cycle  ||| S:28172 E:28178 ||| NN
regulatory  ||| S:28178 E:28189 ||| JJ
genes  ||| S:28189 E:28195 ||| NNS
does  ||| S:28195 E:28210 ||| VBZ
control  ||| S:28210 E:28218 ||| NN
proliferation  ||| S:28218 E:28232 ||| NN
in  ||| S:28232 E:28235 ||| IN
some  ||| S:28235 E:28240 ||| DT
cell  ||| S:28240 E:28245 ||| NN
types  ||| S:28245 E:28251 ||| NNS
or  ||| S:28251 E:28254 ||| CC
under  ||| S:28254 E:28260 ||| IN
certain  ||| S:28260 E:28278 ||| JJ
conditions  ||| S:28278 E:28289 ||| NNS
[  ||| S:28289 E:28291 ||| -LRB-
8  ||| S:28291 E:28293 ||| CD
37  ||| S:28293 E:28296 ||| CD
38  ||| S:28296 E:28299 ||| CD
39  ||| S:28299 E:28302 ||| CD
56  ||| S:28302 E:28305 ||| CD
]  ||| S:28305 E:28307 ||| -RRB-
.  ||| S:28307 E:28319 ||| .
The  ||| S:28319 E:28323 ||| DT
absence  ||| S:28323 E:28331 ||| NN
of  ||| S:28331 E:28334 ||| IN
a  ||| S:28334 E:28336 ||| DT
dependence  ||| S:28336 E:28347 ||| NN
of  ||| S:28347 E:28350 ||| IN
GHFT1-5  ||| S:28350 E:28358 ||| CD
cell  ||| S:28358 E:28373 ||| NN
proliferation  ||| S:28373 E:28387 ||| NN
on  ||| S:28387 E:28390 ||| IN
transcription  ||| S:28390 E:28404 ||| JJ
factor  ||| S:28404 E:28411 ||| NN
activities  ||| S:28411 E:28422 ||| NNS
that  ||| S:28422 E:28427 ||| WDT
are  ||| S:28427 E:28441 ||| VBP
more  ||| S:28441 E:28446 ||| JJR
classically  ||| S:28446 E:28458 ||| NNS
associated  ||| S:28458 E:28469 ||| VBN
with  ||| S:28469 E:28474 ||| IN
transcription  ||| S:28474 E:28488 ||| JJ
regulation  ||| S:28488 E:28509 ||| NN
strongly  ||| S:28509 E:28518 ||| RB
suggests  ||| S:28518 E:28527 ||| VBZ
that  ||| S:28527 E:28532 ||| IN
C ||| S:28532 E:28533 ||| NNP
/ ||| S:28533 E:28534 ||| NNP
EBPα ||| S:28534 E:28538 ||| NNP
,  ||| S:28538 E:28540 ||| ,
and  ||| S:28540 E:28544 ||| CC
perhaps  ||| S:28544 E:28552 ||| RB
other  ||| S:28552 E:28568 ||| JJ
transcription  ||| S:28568 E:28582 ||| JJ
factors ||| S:28582 E:28589 ||| NNS
,  ||| S:28589 E:28591 ||| ,
control  ||| S:28591 E:28599 ||| NN
proliferation  ||| S:28599 E:28613 ||| NN
and  ||| S:28613 E:28627 ||| CC
transcription  ||| S:28627 E:28641 ||| NN
through  ||| S:28641 E:28649 ||| IN
completely  ||| S:28649 E:28660 ||| RB
separable  ||| S:28660 E:28670 ||| JJ
pathways ||| S:28670 E:28678 ||| NN
.  ||| S:28678 E:28680 ||| .
The  ||| S:28680 E:28694 ||| DT
effects  ||| S:28694 E:28702 ||| NNS
of  ||| S:28702 E:28705 ||| IN
human  ||| S:28705 E:28711 ||| JJ
papilloma  ||| S:28711 E:28721 ||| JJ
virus  ||| S:28721 E:28727 ||| NN
E7  ||| S:28727 E:28730 ||| CD
proteins  ||| S:28730 E:28739 ||| NNS
on  ||| S:28739 E:28752 ||| IN
C ||| S:28752 E:28753 ||| $
/ ||| S:28753 E:28754 ||| CD
EBPα-induced  ||| S:28754 E:28767 ||| JJ
differentiation  ||| S:28767 E:28783 ||| NN
and  ||| S:28783 E:28787 ||| CC
growth  ||| S:28787 E:28794 ||| NN
arrest  ||| S:28794 E:28801 ||| NN
also  ||| S:28801 E:28816 ||| RB
suggest  ||| S:28816 E:28824 ||| VB
that  ||| S:28824 E:28829 ||| IN
the  ||| S:28829 E:28833 ||| DT
effects  ||| S:28833 E:28841 ||| NNS
of  ||| S:28841 E:28844 ||| IN
C ||| S:28844 E:28845 ||| $
/ ||| S:28845 E:28846 ||| CD
EBPα  ||| S:28846 E:28851 ||| NN
on  ||| S:28851 E:28854 ||| IN
proliferation  ||| S:28854 E:28868 ||| NNS
are  ||| S:28868 E:28882 ||| VBP
mechanistically  ||| S:28882 E:28898 ||| JJ
divergent  ||| S:28898 E:28908 ||| NNS
[  ||| S:28908 E:28910 ||| -LRB-
40  ||| S:28910 E:28913 ||| CD
]  ||| S:28913 E:28915 ||| -RRB-
.  ||| S:28915 E:28917 ||| .
Having  ||| S:28917 E:28924 ||| VBG
distinct  ||| S:28924 E:28943 ||| JJ
mechanisms  ||| S:28943 E:28954 ||| NNS
for  ||| S:28954 E:28958 ||| IN
regulation  ||| S:28958 E:28969 ||| NN
of  ||| S:28969 E:28972 ||| IN
gene  ||| S:28972 E:28977 ||| NN
transcription  ||| S:28977 E:28991 ||| NNS
and  ||| S:28991 E:29005 ||| CC
proliferation  ||| S:29005 E:29019 ||| NN
allows  ||| S:29019 E:29026 ||| VBZ
a  ||| S:29026 E:29028 ||| DT
transcription  ||| S:29028 E:29042 ||| JJ
factor  ||| S:29042 E:29049 ||| NN
to  ||| S:29049 E:29052 ||| TO
regulate  ||| S:29052 E:29071 ||| VB
these  ||| S:29071 E:29077 ||| DT
two  ||| S:29077 E:29081 ||| CD
critical  ||| S:29081 E:29090 ||| JJ
processes  ||| S:29090 E:29100 ||| NNS
completely  ||| S:29100 E:29111 ||| RB
independently  ||| S:29111 E:29125 ||| RB
of  ||| S:29125 E:29138 ||| IN
one  ||| S:29138 E:29142 ||| CD
another ||| S:29142 E:29149 ||| DT
.  ||| S:29149 E:29151 ||| .
This  ||| S:29151 E:29156 ||| DT
may  ||| S:29156 E:29160 ||| MD
be  ||| S:29160 E:29163 ||| VB
particularly  ||| S:29163 E:29176 ||| RB
important  ||| S:29176 E:29186 ||| JJ
in  ||| S:29186 E:29199 ||| IN
differentiated ||| S:29199 E:29213 ||| NN
,  ||| S:29213 E:29215 ||| ,
non-proliferating  ||| S:29215 E:29233 ||| JJ
cells  ||| S:29233 E:29239 ||| NNS
in  ||| S:29239 E:29242 ||| IN
which  ||| S:29242 E:29248 ||| WDT
events  ||| S:29248 E:29265 ||| NNS
that  ||| S:29265 E:29270 ||| WDT
regulate  ||| S:29270 E:29279 ||| VBZ
a  ||| S:29279 E:29281 ||| DT
transcription  ||| S:29281 E:29295 ||| JJ
factor ||| S:29295 E:29301 ||| NN
's  ||| S:29301 E:29304 ||| POS
contribution  ||| S:29304 E:29317 ||| NN
to  ||| S:29317 E:29330 ||| TO
gene  ||| S:29330 E:29335 ||| NN
expression  ||| S:29335 E:29346 ||| NN
must  ||| S:29346 E:29351 ||| MD
be  ||| S:29351 E:29354 ||| VB
disconnected  ||| S:29354 E:29367 ||| VBN
from  ||| S:29367 E:29372 ||| IN
that  ||| S:29372 E:29387 ||| DT
transcription  ||| S:29387 E:29401 ||| JJ
factor ||| S:29401 E:29407 ||| NN
's  ||| S:29407 E:29410 ||| POS
continuing  ||| S:29410 E:29421 ||| JJ
blockage  ||| S:29421 E:29430 ||| NN
of  ||| S:29430 E:29443 ||| IN
proliferation ||| S:29443 E:29456 ||| NN
.  ||| S:29456 E:29489 ||| .
Conclusions  ||| S:29489 E:29509 ||| NNP
C ||| S:29509 E:29510 ||| NNP
/ ||| S:29510 E:29511 ||| NNP
EBPα  ||| S:29511 E:29516 ||| NNP
is  ||| S:29516 E:29519 ||| VBZ
a  ||| S:29519 E:29521 ||| DT
transcription  ||| S:29521 E:29535 ||| JJ
factor  ||| S:29535 E:29542 ||| NN
that  ||| S:29542 E:29547 ||| WDT
controls  ||| S:29547 E:29556 ||| VBZ
both  ||| S:29556 E:29569 ||| DT
proliferation  ||| S:29569 E:29583 ||| NN
and  ||| S:29583 E:29587 ||| CC
gene  ||| S:29587 E:29592 ||| NN
expression ||| S:29592 E:29602 ||| NN
.  ||| S:29602 E:29604 ||| .
C ||| S:29604 E:29605 ||| SYM
/ ||| S:29605 E:29606 ||| FW
EBPα  ||| S:29606 E:29611 ||| FW
uses  ||| S:29611 E:29616 ||| VBZ
molecularly  ||| S:29616 E:29636 ||| RB
distinct  ||| S:29636 E:29645 ||| JJ
mechanisms  ||| S:29645 E:29656 ||| NNS
to  ||| S:29656 E:29659 ||| TO
prolong  ||| S:29659 E:29667 ||| VB
the  ||| S:29667 E:29671 ||| DT
G1  ||| S:29671 E:29674 ||| NNP
and  ||| S:29674 E:29678 ||| CC
S  ||| S:29678 E:29680 ||| NNP
phases  ||| S:29680 E:29687 ||| NNS
of  ||| S:29687 E:29698 ||| IN
pituitary  ||| S:29698 E:29708 ||| CD
progenitor  ||| S:29708 E:29719 ||| CD
GHFT1-5  ||| S:29719 E:29727 ||| CD
cells ||| S:29727 E:29732 ||| NNS
.  ||| S:29732 E:29734 ||| .
The  ||| S:29734 E:29738 ||| DT
anti-proliferative  ||| S:29738 E:29765 ||| JJ
effects  ||| S:29765 E:29773 ||| NNS
of  ||| S:29773 E:29776 ||| IN
C ||| S:29776 E:29777 ||| $
/ ||| S:29777 E:29778 ||| CD
EBPα  ||| S:29778 E:29783 ||| NNS
do  ||| S:29783 E:29786 ||| VBP
not  ||| S:29786 E:29790 ||| RB
require  ||| S:29790 E:29798 ||| VB
activities  ||| S:29798 E:29809 ||| NNS
in  ||| S:29809 E:29812 ||| IN
C ||| S:29812 E:29813 ||| NNP
/ ||| S:29813 E:29814 ||| NNP
EBPα  ||| S:29814 E:29827 ||| NNP
commonly  ||| S:29827 E:29836 ||| RB
required  ||| S:29836 E:29845 ||| VBN
for  ||| S:29845 E:29849 ||| IN
gene-specific  ||| S:29849 E:29863 ||| JJ
transcription ||| S:29863 E:29876 ||| NN
.  ||| S:29876 E:29886 ||| .
Proliferation  ||| S:29886 E:29900 ||| NN
arrest  ||| S:29900 E:29907 ||| NN
instead  ||| S:29907 E:29915 ||| RB
corresponds  ||| S:29915 E:29927 ||| VBN
with  ||| S:29927 E:29932 ||| IN
C ||| S:29932 E:29933 ||| $
/ ||| S:29933 E:29934 ||| CD
EBPα  ||| S:29934 E:29947 ||| JJ
domains  ||| S:29947 E:29955 ||| NNS
previously  ||| S:29955 E:29966 ||| RB
implicated  ||| S:29966 E:29977 ||| VBN
in  ||| S:29977 E:29980 ||| IN
post-transcriptional  ||| S:29980 E:30009 ||| JJ
effects  ||| S:30009 E:30017 ||| NNS
on  ||| S:30017 E:30020 ||| IN
E2F  ||| S:30020 E:30024 ||| NNP
and ||| S:30024 E:30027 ||| CC
/ ||| S:30027 E:30028 ||| NNP
or  ||| S:30028 E:30031 ||| CC
CDK2  ||| S:30031 E:30036 ||| CD
activity ||| S:30036 E:30044 ||| NN
.  ||| S:30044 E:30068 ||| .
Materials  ||| S:30068 E:30078 ||| NNS
and  ||| S:30078 E:30082 ||| CC
Methods  ||| S:30082 E:30109 ||| NNP
Plasmid  ||| S:30109 E:30117 ||| NNP
construction  ||| S:30117 E:30140 ||| NN
The  ||| S:30140 E:30144 ||| DT
GFP-C ||| S:30144 E:30149 ||| JJ
/ ||| S:30149 E:30150 ||| CD
EBPα  ||| S:30150 E:30155 ||| JJ
vector  ||| S:30155 E:30162 ||| NN
was  ||| S:30162 E:30166 ||| VBD
constructed  ||| S:30166 E:30178 ||| VBN
by  ||| S:30178 E:30181 ||| IN
inserting  ||| S:30181 E:30191 ||| VBG
the  ||| S:30191 E:30205 ||| DT
cDNA  ||| S:30205 E:30210 ||| JJ
encoding  ||| S:30210 E:30219 ||| NNS
the  ||| S:30219 E:30223 ||| DT
S65T  ||| S:30223 E:30228 ||| JJ
derivative  ||| S:30228 E:30239 ||| JJ
of  ||| S:30239 E:30242 ||| IN
GFP  ||| S:30242 E:30246 ||| NNP
[  ||| S:30246 E:30248 ||| -LRB-
57  ||| S:30248 E:30251 ||| CD
]  ||| S:30251 E:30253 ||| -RRB-
at  ||| S:30253 E:30256 ||| IN
the  ||| S:30256 E:30270 ||| DT
start  ||| S:30270 E:30276 ||| NN
codon  ||| S:30276 E:30282 ||| NN
of  ||| S:30282 E:30285 ||| IN
the  ||| S:30285 E:30289 ||| DT
cDNA  ||| S:30289 E:30294 ||| JJ
encoding  ||| S:30294 E:30303 ||| JJ
rat  ||| S:30303 E:30307 ||| NN
C ||| S:30307 E:30308 ||| NNP
/ ||| S:30308 E:30309 ||| NNP
EBPα ||| S:30309 E:30313 ||| NNP
.  ||| S:30313 E:30315 ||| .
The  ||| S:30315 E:30319 ||| DT
fused  ||| S:30319 E:30335 ||| JJ
cDNA  ||| S:30335 E:30340 ||| NN
was  ||| S:30340 E:30344 ||| VBD
cloned  ||| S:30344 E:30351 ||| VBN
into  ||| S:30351 E:30356 ||| IN
a  ||| S:30356 E:30358 ||| DT
previously  ||| S:30358 E:30369 ||| RB
described  ||| S:30369 E:30379 ||| VBN
expression  ||| S:30379 E:30400 ||| NN
vector  ||| S:30400 E:30407 ||| NN
[  ||| S:30407 E:30409 ||| -LRB-
58  ||| S:30409 E:30412 ||| CD
]  ||| S:30412 E:30414 ||| -RRB-
.  ||| S:30414 E:30416 ||| .
The  ||| S:30416 E:30420 ||| DT
GFP  ||| S:30420 E:30424 ||| NNP
and  ||| S:30424 E:30428 ||| CC
C ||| S:30428 E:30429 ||| $
/ ||| S:30429 E:30430 ||| CD
EBPα  ||| S:30430 E:30435 ||| JJ
portions  ||| S:30435 E:30444 ||| NNS
of  ||| S:30444 E:30447 ||| IN
the  ||| S:30447 E:30451 ||| DT
fusion  ||| S:30451 E:30468 ||| NN
were  ||| S:30468 E:30473 ||| VBD
separated  ||| S:30473 E:30483 ||| VBN
by  ||| S:30483 E:30486 ||| IN
a  ||| S:30486 E:30488 ||| DT
16  ||| S:30488 E:30491 ||| CD
amino  ||| S:30491 E:30497 ||| JJ
acid  ||| S:30497 E:30502 ||| NN
long  ||| S:30502 E:30507 ||| RB
linker  ||| S:30507 E:30514 ||| VBP
including  ||| S:30514 E:30534 ||| VBG
the  ||| S:30534 E:30538 ||| DT
epitope  ||| S:30538 E:30546 ||| NN
for  ||| S:30546 E:30550 ||| IN
the  ||| S:30550 E:30554 ||| DT
FLAG  ||| S:30554 E:30559 ||| NNP
antibody ||| S:30559 E:30567 ||| NN
.  ||| S:30567 E:30569 ||| .
The  ||| S:30569 E:30573 ||| DT
C ||| S:30573 E:30574 ||| $
/ ||| S:30574 E:30575 ||| CD
EBPα-GFP  ||| S:30575 E:30584 ||| JJ
vector  ||| S:30584 E:30601 ||| NN
was  ||| S:30601 E:30605 ||| VBD
constructed  ||| S:30605 E:30617 ||| VBN
by  ||| S:30617 E:30620 ||| IN
inserting  ||| S:30620 E:30630 ||| VBG
the  ||| S:30630 E:30634 ||| DT
S65T  ||| S:30634 E:30639 ||| NNP
GFP  ||| S:30639 E:30643 ||| NNP
into  ||| S:30643 E:30648 ||| IN
the  ||| S:30648 E:30652 ||| DT
NcoI  ||| S:30652 E:30667 ||| JJ
site  ||| S:30667 E:30672 ||| NN
present  ||| S:30672 E:30680 ||| NN
near  ||| S:30680 E:30685 ||| IN
the  ||| S:30685 E:30689 ||| DT
carboxy  ||| S:30689 E:30697 ||| JJ
terminus  ||| S:30697 E:30706 ||| NN
of  ||| S:30706 E:30709 ||| IN
rat  ||| S:30709 E:30713 ||| JJ
C ||| S:30713 E:30714 ||| NNP
/ ||| S:30714 E:30715 ||| NNP
EBPα  ||| S:30715 E:30730 ||| NNP
( ||| S:30730 E:30731 ||| -LRB-
also  ||| S:30731 E:30736 ||| RB
tagged  ||| S:30736 E:30743 ||| VBN
at  ||| S:30743 E:30746 ||| IN
the  ||| S:30746 E:30750 ||| DT
amino  ||| S:30750 E:30756 ||| JJ
terminus  ||| S:30756 E:30765 ||| NN
with  ||| S:30765 E:30770 ||| IN
the  ||| S:30770 E:30774 ||| DT
FLAG  ||| S:30774 E:30779 ||| NNP
epitope ||| S:30779 E:30786 ||| CD
)  ||| S:30786 E:30798 ||| -RRB-
in  ||| S:30798 E:30801 ||| IN
our  ||| S:30801 E:30805 ||| PRP$
previously  ||| S:30805 E:30816 ||| RB
described  ||| S:30816 E:30826 ||| VBD
C ||| S:30826 E:30827 ||| $
/ ||| S:30827 E:30828 ||| CD
EBPα  ||| S:30828 E:30833 ||| JJ
expression  ||| S:30833 E:30844 ||| NN
vector  ||| S:30844 E:30851 ||| NN
[  ||| S:30851 E:30853 ||| -LRB-
42  ||| S:30853 E:30866 ||| CD
]  ||| S:30866 E:30868 ||| -RRB-
.  ||| S:30868 E:30870 ||| .
This  ||| S:30870 E:30875 ||| DT
resulted  ||| S:30875 E:30884 ||| VBN
in  ||| S:30884 E:30887 ||| IN
a  ||| S:30887 E:30889 ||| DT
deletion  ||| S:30889 E:30898 ||| NN
of  ||| S:30898 E:30901 ||| IN
the  ||| S:30901 E:30905 ||| DT
last  ||| S:30905 E:30910 ||| JJ
four  ||| S:30910 E:30915 ||| CD
amino  ||| S:30915 E:30931 ||| CD
acids  ||| S:30931 E:30937 ||| NNS
of  ||| S:30937 E:30940 ||| IN
C ||| S:30940 E:30941 ||| NNP
/ ||| S:30941 E:30942 ||| NNP
EBPα ||| S:30942 E:30946 ||| NNP
.  ||| S:30946 E:30948 ||| .
The  ||| S:30948 E:30952 ||| DT
DBD  ||| S:30952 E:30956 ||| NNP
and  ||| S:30956 E:30960 ||| CC
DBD  ||| S:30960 E:30964 ||| NNP
+  ||| S:30964 E:30966 ||| CD
154-257  ||| S:30966 E:30974 ||| CD
derivatives  ||| S:30974 E:30986 ||| NNS
of  ||| S:30986 E:30999 ||| IN
C ||| S:30999 E:31000 ||| NNP
/ ||| S:31000 E:31001 ||| NNP
EBPα  ||| S:31001 E:31006 ||| NNP
were  ||| S:31006 E:31011 ||| VBD
constructed  ||| S:31011 E:31023 ||| VBN
by  ||| S:31023 E:31026 ||| IN
replacing ||| S:31026 E:31035 ||| VBG
,  ||| S:31035 E:31037 ||| ,
respectively ||| S:31037 E:31049 ||| RB
,  ||| S:31049 E:31051 ||| ,
the  ||| S:31051 E:31065 ||| DT
amino  ||| S:31065 E:31071 ||| JJ
terminal  ||| S:31071 E:31080 ||| NN
257  ||| S:31080 E:31084 ||| CD
amino  ||| S:31084 E:31090 ||| CD
acids  ||| S:31090 E:31096 ||| NNS
of  ||| S:31096 E:31099 ||| IN
C ||| S:31099 E:31100 ||| NNP
/ ||| S:31100 E:31101 ||| NNP
EBPα-GFP  ||| S:31101 E:31110 ||| NNP
( ||| S:31110 E:31111 ||| -LRB-
to  ||| S:31111 E:31114 ||| TO
the  ||| S:31114 E:31128 ||| DT
SgrAI  ||| S:31128 E:31134 ||| JJ
site  ||| S:31134 E:31139 ||| NN
of  ||| S:31139 E:31142 ||| IN
C ||| S:31142 E:31143 ||| NNP
/ ||| S:31143 E:31144 ||| NNP
EBPα ||| S:31144 E:31148 ||| NNP
)  ||| S:31148 E:31150 ||| -RRB-
and  ||| S:31150 E:31154 ||| CC
the  ||| S:31154 E:31158 ||| DT
amino  ||| S:31158 E:31164 ||| JJ
terminal  ||| S:31164 E:31173 ||| NN
153  ||| S:31173 E:31177 ||| CD
amino  ||| S:31177 E:31193 ||| CD
acids  ||| S:31193 E:31199 ||| NNS
of  ||| S:31199 E:31202 ||| IN
C ||| S:31202 E:31203 ||| NNP
/ ||| S:31203 E:31204 ||| NNP
EBPα-GFP  ||| S:31204 E:31213 ||| NNP
( ||| S:31213 E:31214 ||| -LRB-
to  ||| S:31214 E:31217 ||| TO
the  ||| S:31217 E:31221 ||| DT
NotI  ||| S:31221 E:31226 ||| JJ
site  ||| S:31226 E:31231 ||| NN
of  ||| S:31231 E:31234 ||| IN
C ||| S:31234 E:31235 ||| NNP
/ ||| S:31235 E:31236 ||| NNP
EBPα ||| S:31236 E:31240 ||| NNP
)  ||| S:31240 E:31242 ||| -RRB-
with  ||| S:31242 E:31257 ||| IN
oligonucleotides  ||| S:31257 E:31274 ||| NNS
containing  ||| S:31274 E:31285 ||| VBG
a  ||| S:31285 E:31287 ||| DT
strong  ||| S:31287 E:31294 ||| JJ
Kozak  ||| S:31294 E:31300 ||| JJ
sequence ||| S:31300 E:31308 ||| NN
.  ||| S:31308 E:31310 ||| .
DBD  ||| S:31310 E:31324 ||| NNP
+  ||| S:31324 E:31326 ||| NNP
1-154  ||| S:31326 E:31332 ||| NNP
was  ||| S:31332 E:31336 ||| VBD
constructed  ||| S:31336 E:31348 ||| VBN
by  ||| S:31348 E:31351 ||| IN
replacing  ||| S:31351 E:31361 ||| VBG
amino  ||| S:31361 E:31367 ||| JJ
acids  ||| S:31367 E:31373 ||| NN
155  ||| S:31373 E:31377 ||| CD
to  ||| S:31377 E:31390 ||| TO
257  ||| S:31390 E:31394 ||| CD
( ||| S:31394 E:31395 ||| -LRB-
from  ||| S:31395 E:31400 ||| IN
the  ||| S:31400 E:31404 ||| DT
NotI  ||| S:31404 E:31409 ||| JJ
to  ||| S:31409 E:31412 ||| TO
SgrAI  ||| S:31412 E:31418 ||| JJ
sites ||| S:31418 E:31423 ||| NNS
)  ||| S:31423 E:31425 ||| -RRB-
with  ||| S:31425 E:31430 ||| IN
an  ||| S:31430 E:31443 ||| DT
oligonucleotide ||| S:31443 E:31458 ||| NN
.  ||| S:31458 E:31460 ||| .
The  ||| S:31460 E:31464 ||| DT
remaining  ||| S:31464 E:31474 ||| JJ
constructs  ||| S:31474 E:31485 ||| NNS
( ||| S:31485 E:31486 ||| -LRB-
Fig.  ||| S:31486 E:31491 ||| CD
7 ||| S:31491 E:31492 ||| CD
)  ||| S:31492 E:31494 ||| -RRB-
were  ||| S:31494 E:31509 ||| VBD
generated  ||| S:31509 E:31519 ||| VBN
by  ||| S:31519 E:31522 ||| IN
appending  ||| S:31522 E:31532 ||| JJ
C ||| S:31532 E:31533 ||| $
/ ||| S:31533 E:31534 ||| CD
EBPα  ||| S:31534 E:31539 ||| JJ
fragments  ||| S:31539 E:31549 ||| NNS
to  ||| S:31549 E:31552 ||| TO
the  ||| S:31552 E:31556 ||| DT
NotI  ||| S:31556 E:31561 ||| JJ
site  ||| S:31561 E:31576 ||| NN
of  ||| S:31576 E:31579 ||| IN
DBD  ||| S:31579 E:31583 ||| NNP
+  ||| S:31583 E:31585 ||| NNP
1-154 ||| S:31585 E:31590 ||| NNP
,  ||| S:31590 E:31592 ||| ,
or  ||| S:31592 E:31595 ||| CC
to  ||| S:31595 E:31598 ||| TO
the  ||| S:31598 E:31602 ||| DT
SgrAI  ||| S:31602 E:31608 ||| JJ
site  ||| S:31608 E:31613 ||| NN
of  ||| S:31613 E:31616 ||| IN
DBD ||| S:31616 E:31619 ||| NNP
.  ||| S:31619 E:31621 ||| .
ΔLZ  ||| S:31621 E:31625 ||| NNP
was  ||| S:31625 E:31639 ||| VBD
constructed  ||| S:31639 E:31651 ||| VBN
by  ||| S:31651 E:31654 ||| IN
deleting  ||| S:31654 E:31663 ||| VBG
amino  ||| S:31663 E:31669 ||| JJ
acids  ||| S:31669 E:31675 ||| NNS
from  ||| S:31675 E:31680 ||| IN
amino  ||| S:31680 E:31686 ||| JJ
acid  ||| S:31686 E:31691 ||| NN
310  ||| S:31691 E:31705 ||| CD
( ||| S:31705 E:31706 ||| -LRB-
Tth111II  ||| S:31706 E:31715 ||| NNP
site ||| S:31715 E:31719 ||| NN
)  ||| S:31719 E:31721 ||| -RRB-
at  ||| S:31721 E:31724 ||| IN
the  ||| S:31724 E:31728 ||| DT
junction  ||| S:31728 E:31737 ||| NN
of  ||| S:31737 E:31740 ||| IN
the  ||| S:31740 E:31744 ||| DT
basic  ||| S:31744 E:31750 ||| JJ
region  ||| S:31750 E:31757 ||| NN
and  ||| S:31757 E:31771 ||| CC
leucine  ||| S:31771 E:31779 ||| JJ
zipper  ||| S:31779 E:31786 ||| NN
of  ||| S:31786 E:31789 ||| IN
C ||| S:31789 E:31790 ||| $
/ ||| S:31790 E:31791 ||| CD
EBPα  ||| S:31791 E:31796 ||| JJ
to  ||| S:31796 E:31799 ||| TO
the  ||| S:31799 E:31803 ||| DT
carboxy  ||| S:31803 E:31811 ||| JJ
terminus  ||| S:31811 E:31820 ||| NN
of  ||| S:31820 E:31823 ||| IN
the  ||| S:31823 E:31837 ||| DT
GFP-C ||| S:31837 E:31842 ||| JJ
/ ||| S:31842 E:31843 ||| CD
EBPα  ||| S:31843 E:31848 ||| JJ
fusion ||| S:31848 E:31854 ||| NN
.  ||| S:31854 E:31856 ||| .
The  ||| S:31856 E:31860 ||| DT
C ||| S:31860 E:31861 ||| $
/ ||| S:31861 E:31862 ||| CD
EBP-TATA  ||| S:31862 E:31871 ||| JJ
reporter  ||| S:31871 E:31880 ||| NN
used  ||| S:31880 E:31885 ||| VBN
to  ||| S:31885 E:31898 ||| TO
determine  ||| S:31898 E:31908 ||| VB
the  ||| S:31908 E:31912 ||| DT
transcriptional  ||| S:31912 E:31928 ||| JJ
activity  ||| S:31928 E:31937 ||| NN
of  ||| S:31937 E:31940 ||| IN
the  ||| S:31940 E:31944 ||| DT
two  ||| S:31944 E:31948 ||| CD
GFP  ||| S:31948 E:31962 ||| JJ
fusion  ||| S:31962 E:31969 ||| NN
proteins  ||| S:31969 E:31978 ||| NNS
was  ||| S:31978 E:31982 ||| VBD
previously  ||| S:31982 E:31993 ||| RB
described  ||| S:31993 E:32003 ||| VBN
[  ||| S:32003 E:32005 ||| -LRB-
45  ||| S:32005 E:32008 ||| CD
]  ||| S:32008 E:32010 ||| -RRB-
.  ||| S:32010 E:32040 ||| .
Transfection  ||| S:32040 E:32063 ||| NNP
GHFT1-5  ||| S:32063 E:32071 ||| NNP
cells  ||| S:32071 E:32077 ||| NNS
were  ||| S:32077 E:32082 ||| VBD
propagated  ||| S:32082 E:32093 ||| VBN
at  ||| S:32093 E:32096 ||| IN
37°C  ||| S:32096 E:32101 ||| NNP
and  ||| S:32101 E:32105 ||| CC
5 ||| S:32105 E:32106 ||| CD
%  ||| S:32106 E:32108 ||| NN
CO  ||| S:32108 E:32122 ||| NNP
2  ||| S:32122 E:32124 ||| CD
in  ||| S:32124 E:32127 ||| IN
Dulbecco ||| S:32127 E:32135 ||| NNP
's  ||| S:32135 E:32138 ||| POS
modified  ||| S:32138 E:32147 ||| JJ
Eagle  ||| S:32147 E:32163 ||| NNP
( ||| S:32163 E:32164 ||| -LRB-
DME-H21 ||| S:32164 E:32171 ||| NNP
)  ||| S:32171 E:32173 ||| -RRB-
medium  ||| S:32173 E:32180 ||| NN
supplemented  ||| S:32180 E:32193 ||| NN
with  ||| S:32193 E:32198 ||| IN
10 ||| S:32198 E:32200 ||| CD
%  ||| S:32200 E:32202 ||| NN
fetal  ||| S:32202 E:32208 ||| JJ
calf  ||| S:32208 E:32213 ||| JJ
serum ||| S:32213 E:32218 ||| NN
.  ||| S:32218 E:32230 ||| .
Approximately  ||| S:32230 E:32244 ||| RB
1  ||| S:32244 E:32246 ||| CD
×  ||| S:32246 E:32248 ||| CD
10  ||| S:32248 E:32251 ||| CD
7cells  ||| S:32251 E:32258 ||| CD
were  ||| S:32258 E:32263 ||| VBD
transfected  ||| S:32263 E:32275 ||| VBN
by  ||| S:32275 E:32288 ||| IN
electroporation ||| S:32288 E:32303 ||| NN
,  ||| S:32303 E:32305 ||| ,
as  ||| S:32305 E:32308 ||| RB
previously  ||| S:32308 E:32319 ||| RB
described  ||| S:32319 E:32329 ||| VBN
[  ||| S:32329 E:32331 ||| -LRB-
42  ||| S:32331 E:32334 ||| CD
]  ||| S:32334 E:32336 ||| -RRB-
,  ||| S:32336 E:32338 ||| ,
with  ||| S:32338 E:32343 ||| IN
5  ||| S:32343 E:32355 ||| CD
μg  ||| S:32355 E:32358 ||| NN
of  ||| S:32358 E:32361 ||| IN
either  ||| S:32361 E:32368 ||| RB
the  ||| S:32368 E:32372 ||| DT
C ||| S:32372 E:32373 ||| NNP
/ ||| S:32373 E:32374 ||| NNP
EBPα-GFP ||| S:32374 E:32382 ||| NNP
,  ||| S:32382 E:32384 ||| ,
GFP-C ||| S:32384 E:32389 ||| NNP
/ ||| S:32389 E:32390 ||| NNP
EBPα ||| S:32390 E:32394 ||| NNP
,  ||| S:32394 E:32396 ||| ,
or  ||| S:32396 E:32399 ||| CC
control  ||| S:32399 E:32417 ||| NN
expression  ||| S:32417 E:32428 ||| NN
vectors ||| S:32428 E:32435 ||| NN
.  ||| S:32435 E:32437 ||| .
Following  ||| S:32437 E:32447 ||| VBG
transfection ||| S:32447 E:32459 ||| NN
,  ||| S:32459 E:32461 ||| ,
cells  ||| S:32461 E:32467 ||| NNS
were  ||| S:32467 E:32482 ||| VBD
propagated  ||| S:32482 E:32493 ||| VBN
at  ||| S:32493 E:32496 ||| IN
33°C ||| S:32496 E:32500 ||| CD
.  ||| S:32500 E:32502 ||| .
Incubation  ||| S:32502 E:32513 ||| NNP
at  ||| S:32513 E:32516 ||| IN
33°C  ||| S:32516 E:32521 ||| CD
results  ||| S:32521 E:32529 ||| NNS
in  ||| S:32529 E:32542 ||| IN
significantly  ||| S:32542 E:32556 ||| RB
higher  ||| S:32556 E:32563 ||| JJR
levels  ||| S:32563 E:32570 ||| NNS
of  ||| S:32570 E:32573 ||| IN
green  ||| S:32573 E:32579 ||| JJ
fluorescence  ||| S:32579 E:32602 ||| NNS
( ||| S:32602 E:32603 ||| -LRB-
unpublished  ||| S:32603 E:32615 ||| JJ
data ||| S:32615 E:32619 ||| NNS
) ||| S:32619 E:32620 ||| -RRB-
,  ||| S:32620 E:32622 ||| ,
presumably  ||| S:32622 E:32633 ||| RB
because  ||| S:32633 E:32641 ||| IN
of  ||| S:32641 E:32644 ||| IN
better  ||| S:32644 E:32651 ||| JJR
folding  ||| S:32651 E:32669 ||| NN
of  ||| S:32669 E:32672 ||| IN
the  ||| S:32672 E:32676 ||| DT
jellyfish  ||| S:32676 E:32686 ||| JJ
GFP ||| S:32686 E:32689 ||| NNP
.  ||| S:32689 E:32691 ||| .
Transfected  ||| S:32691 E:32703 ||| JJ
cells  ||| S:32703 E:32709 ||| NNS
were  ||| S:32709 E:32714 ||| VBD
maintained  ||| S:32714 E:32735 ||| VBN
in  ||| S:32735 E:32738 ||| IN
the  ||| S:32738 E:32742 ||| DT
dark  ||| S:32742 E:32747 ||| NN
throughout  ||| S:32747 E:32758 ||| IN
the  ||| S:32758 E:32762 ||| DT
experiment  ||| S:32762 E:32773 ||| NN
to  ||| S:32773 E:32776 ||| TO
minimize  ||| S:32776 E:32795 ||| VB
fluorescence  ||| S:32795 E:32808 ||| JJ
activation  ||| S:32808 E:32819 ||| NN
of  ||| S:32819 E:32822 ||| IN
GFP  ||| S:32822 E:32826 ||| NNP
prior  ||| S:32826 E:32832 ||| RB
to  ||| S:32832 E:32835 ||| TO
flow  ||| S:32835 E:32850 ||| VB
cytometry ||| S:32850 E:32859 ||| NNS
.  ||| S:32859 E:32889 ||| .
DNA  ||| S:32889 E:32893 ||| NNP
Binding  ||| S:32893 E:32901 ||| NNP
and  ||| S:32901 E:32905 ||| CC
Promoter  ||| S:32905 E:32914 ||| NNP
Activation  ||| S:32914 E:32935 ||| NNP
Electrophoretic  ||| S:32935 E:32951 ||| NNP
mobility  ||| S:32951 E:32960 ||| VBD
shifts  ||| S:32960 E:32967 ||| JJ
assays  ||| S:32967 E:32974 ||| NN
were  ||| S:32974 E:32979 ||| VBD
done  ||| S:32979 E:32984 ||| VBN
by  ||| S:32984 E:32997 ||| IN
mixing  ||| S:32997 E:33004 ||| VBG
a  ||| S:33004 E:33006 ||| DT
radiolabeled  ||| S:33006 E:33019 ||| JJ
oligonucleotide  ||| S:33019 E:33035 ||| NNS
containing  ||| S:33035 E:33046 ||| VBG
a  ||| S:33046 E:33058 ||| DT
consensus ||| S:33058 E:33067 ||| NN
,  ||| S:33067 E:33069 ||| ,
high  ||| S:33069 E:33074 ||| JJ
affinity  ||| S:33074 E:33083 ||| JJ
C ||| S:33083 E:33084 ||| NNP
/ ||| S:33084 E:33085 ||| NNP
EBP  ||| S:33085 E:33089 ||| NNP
binding  ||| S:33089 E:33097 ||| JJ
site  ||| S:33097 E:33112 ||| NN
( ||| S:33112 E:33113 ||| -LRB-
GATCGAGCCCCATTGCGCAATCATAGATC ||| S:33113 E:33142 ||| NNP
)  ||| S:33142 E:33144 ||| -RRB-
together  ||| S:33144 E:33153 ||| RB
with  ||| S:33153 E:33158 ||| IN
extracts  ||| S:33158 E:33177 ||| VBG
prepared  ||| S:33177 E:33186 ||| VBN
from  ||| S:33186 E:33191 ||| IN
transfected  ||| S:33191 E:33203 ||| JJ
cells  ||| S:33203 E:33209 ||| NNS
as  ||| S:33209 E:33212 ||| IN
previously  ||| S:33212 E:33223 ||| RB
described  ||| S:33223 E:33233 ||| VBN
[  ||| S:33233 E:33245 ||| -LRB-
58  ||| S:33245 E:33248 ||| CD
59  ||| S:33248 E:33251 ||| CD
]  ||| S:33251 E:33253 ||| -RRB-
.  ||| S:33253 E:33255 ||| .
Competition  ||| S:33255 E:33267 ||| NN
with  ||| S:33267 E:33272 ||| IN
the  ||| S:33272 E:33276 ||| DT
same ||| S:33276 E:33280 ||| JJ
,  ||| S:33280 E:33282 ||| ,
unlabeled  ||| S:33282 E:33302 ||| JJ
oligonucleotide  ||| S:33302 E:33318 ||| NN
in  ||| S:33318 E:33321 ||| IN
1 ||| S:33321 E:33322 ||| CD
,  ||| S:33322 E:33324 ||| ,
10  ||| S:33324 E:33327 ||| CD
or  ||| S:33327 E:33330 ||| CC
100  ||| S:33330 E:33334 ||| CD
molar  ||| S:33334 E:33340 ||| JJ
excess  ||| S:33340 E:33347 ||| NN
of  ||| S:33347 E:33350 ||| IN
the  ||| S:33350 E:33364 ||| DT
radiolabeled  ||| S:33364 E:33377 ||| JJ
probed  ||| S:33377 E:33384 ||| NN
indicated  ||| S:33384 E:33394 ||| VBD
specific  ||| S:33394 E:33403 ||| JJ
binding ||| S:33403 E:33410 ||| NN
.  ||| S:33410 E:33412 ||| .
The  ||| S:33412 E:33426 ||| DT
protein  ||| S:33426 E:33434 ||| NN
DNA  ||| S:33434 E:33438 ||| NN
complex  ||| S:33438 E:33446 ||| NN
was  ||| S:33446 E:33450 ||| VBD
supershifted  ||| S:33450 E:33463 ||| VBN
with  ||| S:33463 E:33468 ||| IN
an  ||| S:33468 E:33471 ||| DT
antibody  ||| S:33471 E:33490 ||| NN
directed  ||| S:33490 E:33499 ||| VBN
against  ||| S:33499 E:33507 ||| IN
C ||| S:33507 E:33508 ||| NNP
/ ||| S:33508 E:33509 ||| NNP
EBPα  ||| S:33509 E:33514 ||| NNP
( ||| S:33514 E:33515 ||| -LRB-
Santa  ||| S:33515 E:33521 ||| NNP
Cruz  ||| S:33521 E:33526 ||| NNP
Biotechnology ||| S:33526 E:33539 ||| NNP
,  ||| S:33539 E:33551 ||| ,
sc-61 ||| S:33551 E:33556 ||| CD
) ||| S:33556 E:33557 ||| -RRB-
.  ||| S:33557 E:33559 ||| .
For  ||| S:33559 E:33563 ||| IN
studies  ||| S:33563 E:33571 ||| NNS
of  ||| S:33571 E:33574 ||| IN
the  ||| S:33574 E:33578 ||| DT
transcriptional  ||| S:33578 E:33594 ||| JJ
activation  ||| S:33594 E:33615 ||| JJ
properties  ||| S:33615 E:33626 ||| NNS
of  ||| S:33626 E:33629 ||| IN
the  ||| S:33629 E:33633 ||| DT
fusion  ||| S:33633 E:33640 ||| NN
proteins ||| S:33640 E:33648 ||| NNS
,  ||| S:33648 E:33650 ||| ,
1  ||| S:33650 E:33652 ||| CD
μg  ||| S:33652 E:33655 ||| NN
of  ||| S:33655 E:33658 ||| IN
the  ||| S:33658 E:33662 ||| DT
C ||| S:33662 E:33663 ||| $
/ ||| S:33663 E:33664 ||| CD
EBP-TATA  ||| S:33664 E:33683 ||| JJ
vector  ||| S:33683 E:33690 ||| NN
[  ||| S:33690 E:33692 ||| -LRB-
45  ||| S:33692 E:33695 ||| CD
]  ||| S:33695 E:33697 ||| -RRB-
was  ||| S:33697 E:33701 ||| VBD
co-transfected  ||| S:33701 E:33716 ||| JJ
and  ||| S:33716 E:33720 ||| CC
transcriptional  ||| S:33720 E:33746 ||| JJ
activity  ||| S:33746 E:33755 ||| NN
was  ||| S:33755 E:33759 ||| VBD
assessed  ||| S:33759 E:33768 ||| VBN
by  ||| S:33768 E:33771 ||| IN
measuring  ||| S:33771 E:33781 ||| VBG
the  ||| S:33781 E:33785 ||| DT
amount  ||| S:33785 E:33792 ||| NN
of  ||| S:33792 E:33805 ||| IN
chloramphenicol  ||| S:33805 E:33821 ||| JJ
acetyltransferase  ||| S:33821 E:33839 ||| JJ
reporter  ||| S:33839 E:33848 ||| NN
expressed  ||| S:33848 E:33858 ||| VBD
with  ||| S:33858 E:33873 ||| IN
and  ||| S:33873 E:33877 ||| CC
without  ||| S:33877 E:33885 ||| IN
C ||| S:33885 E:33886 ||| $
/ ||| S:33886 E:33887 ||| CD
EBPα  ||| S:33887 E:33892 ||| JJ
expression  ||| S:33892 E:33903 ||| NN
[  ||| S:33903 E:33905 ||| -LRB-
45  ||| S:33905 E:33908 ||| CD
]  ||| S:33908 E:33910 ||| -RRB-
.  ||| S:33910 E:33940 ||| .
Fluorescence  ||| S:33940 E:33953 ||| NNP
Microscopy  ||| S:33953 E:33974 ||| NNP
Following  ||| S:33974 E:33984 ||| VBG
transfection ||| S:33984 E:33996 ||| NN
,  ||| S:33996 E:33998 ||| ,
most  ||| S:33998 E:34003 ||| JJS
cells  ||| S:34003 E:34009 ||| NNS
were  ||| S:34009 E:34014 ||| VBD
plated  ||| S:34014 E:34021 ||| VBN
into  ||| S:34021 E:34026 ||| IN
14  ||| S:34026 E:34039 ||| CD
cm  ||| S:34039 E:34042 ||| CD
dishes  ||| S:34042 E:34049 ||| NNS
and  ||| S:34049 E:34053 ||| CC
allowed  ||| S:34053 E:34061 ||| VBN
to  ||| S:34061 E:34064 ||| TO
grow  ||| S:34064 E:34069 ||| VB
for  ||| S:34069 E:34073 ||| IN
24  ||| S:34073 E:34076 ||| CD
hours ||| S:34076 E:34081 ||| NNS
.  ||| S:34081 E:34083 ||| .
This  ||| S:34083 E:34088 ||| DT
ensured  ||| S:34088 E:34106 ||| NN
that  ||| S:34106 E:34111 ||| IN
the  ||| S:34111 E:34115 ||| DT
cells  ||| S:34115 E:34121 ||| NNS
were  ||| S:34121 E:34126 ||| VBD
not  ||| S:34126 E:34130 ||| RB
confluent  ||| S:34130 E:34140 ||| VBN
by  ||| S:34140 E:34143 ||| IN
the  ||| S:34143 E:34147 ||| DT
time  ||| S:34147 E:34152 ||| NN
of  ||| S:34152 E:34165 ||| IN
collection  ||| S:34165 E:34176 ||| NN
for  ||| S:34176 E:34180 ||| IN
cell  ||| S:34180 E:34185 ||| NN
cycle  ||| S:34185 E:34191 ||| NN
analysis ||| S:34191 E:34199 ||| NN
.  ||| S:34199 E:34201 ||| .
A  ||| S:34201 E:34203 ||| DT
small  ||| S:34203 E:34209 ||| JJ
portion  ||| S:34209 E:34217 ||| NN
of  ||| S:34217 E:34230 ||| IN
the  ||| S:34230 E:34234 ||| DT
transfected  ||| S:34234 E:34246 ||| JJ
cells  ||| S:34246 E:34252 ||| NNS
were  ||| S:34252 E:34257 ||| VBD
cultivated  ||| S:34257 E:34268 ||| VBN
on  ||| S:34268 E:34271 ||| IN
a  ||| S:34271 E:34273 ||| DT
22  ||| S:34273 E:34276 ||| CD
×  ||| S:34276 E:34278 ||| CD
22  ||| S:34278 E:34281 ||| CD
mm  ||| S:34281 E:34284 ||| JJ
No.  ||| S:34284 E:34298 ||| NN
1  ||| S:34298 E:34300 ||| CD
borosilicate  ||| S:34300 E:34313 ||| JJ
glass  ||| S:34313 E:34319 ||| NN
cover  ||| S:34319 E:34325 ||| NN
slip  ||| S:34325 E:34330 ||| NN
in  ||| S:34330 E:34333 ||| IN
a  ||| S:34333 E:34335 ||| DT
separate  ||| S:34335 E:34344 ||| JJ
6-well  ||| S:34344 E:34351 ||| CD
dish  ||| S:34351 E:34366 ||| NN
and  ||| S:34366 E:34370 ||| CC
treated  ||| S:34370 E:34378 ||| VBN
with  ||| S:34378 E:34383 ||| IN
nocodazole ||| S:34383 E:34393 ||| NN
,  ||| S:34393 E:34395 ||| ,
mimosine  ||| S:34395 E:34404 ||| NN
or  ||| S:34404 E:34407 ||| CC
vehicle  ||| S:34407 E:34415 ||| NN
alone  ||| S:34415 E:34421 ||| RB
as  ||| S:34421 E:34434 ||| RB
described  ||| S:34434 E:34444 ||| VBN
below ||| S:34444 E:34449 ||| RB
.  ||| S:34449 E:34451 ||| .
The  ||| S:34451 E:34455 ||| DT
coverslips  ||| S:34455 E:34466 ||| NN
were  ||| S:34466 E:34471 ||| VBD
removed  ||| S:34471 E:34479 ||| VBN
for  ||| S:34479 E:34493 ||| IN
fluorescence  ||| S:34493 E:34506 ||| JJ
microscopic  ||| S:34506 E:34518 ||| NNS
observation  ||| S:34518 E:34530 ||| VBP
immediately  ||| S:34530 E:34542 ||| RB
before  ||| S:34542 E:34559 ||| IN
collecting  ||| S:34559 E:34570 ||| VBG
cells  ||| S:34570 E:34576 ||| NNS
for  ||| S:34576 E:34580 ||| IN
flow  ||| S:34580 E:34585 ||| NN
cytometric  ||| S:34585 E:34596 ||| NN
analysis  ||| S:34596 E:34605 ||| NN
of  ||| S:34605 E:34608 ||| IN
DNA  ||| S:34608 E:34622 ||| NNP
content  ||| S:34622 E:34630 ||| NN
and  ||| S:34630 E:34634 ||| CC
GFP  ||| S:34634 E:34638 ||| NNP
expression ||| S:34638 E:34648 ||| NN
.  ||| S:34648 E:34650 ||| .
Cells  ||| S:34650 E:34656 ||| NNS
were  ||| S:34656 E:34661 ||| VBD
stained  ||| S:34661 E:34669 ||| CD
10-20  ||| S:34669 E:34685 ||| CD
minutes  ||| S:34685 E:34693 ||| NNS
with  ||| S:34693 E:34698 ||| IN
5  ||| S:34698 E:34700 ||| CD
μg ||| S:34700 E:34702 ||| CD
/ ||| S:34702 E:34703 ||| CD
ml  ||| S:34703 E:34706 ||| NN
of  ||| S:34706 E:34709 ||| IN
the  ||| S:34709 E:34713 ||| DT
cell-permeable  ||| S:34713 E:34728 ||| JJ
DNA  ||| S:34728 E:34732 ||| NN
binding  ||| S:34732 E:34750 ||| VBG
dye  ||| S:34750 E:34754 ||| JJ
Hoechst  ||| S:34754 E:34762 ||| NNP
33342 ||| S:34762 E:34767 ||| CD
.  ||| S:34767 E:34769 ||| .
The  ||| S:34769 E:34773 ||| DT
green  ||| S:34773 E:34779 ||| JJ
fluorescence  ||| S:34779 E:34792 ||| JJ
emitted  ||| S:34792 E:34800 ||| NN
from  ||| S:34800 E:34815 ||| IN
C ||| S:34815 E:34816 ||| $
/ ||| S:34816 E:34817 ||| CD
EBPα  ||| S:34817 E:34822 ||| JJ
tagged  ||| S:34822 E:34829 ||| NN
with  ||| S:34829 E:34834 ||| IN
GFP  ||| S:34834 E:34838 ||| NNP
and  ||| S:34838 E:34842 ||| CC
the  ||| S:34842 E:34846 ||| DT
blue  ||| S:34846 E:34851 ||| JJ
fluorescence  ||| S:34851 E:34864 ||| JJ
emitted  ||| S:34864 E:34882 ||| NN
from  ||| S:34882 E:34887 ||| IN
Hoechst  ||| S:34887 E:34895 ||| NNP
33342-stained  ||| S:34895 E:34909 ||| NNP
DNA  ||| S:34909 E:34913 ||| NNP
were  ||| S:34913 E:34918 ||| VBD
readily  ||| S:34918 E:34926 ||| RB
distinguished  ||| S:34926 E:34950 ||| VBN
by  ||| S:34950 E:34953 ||| IN
selectively  ||| S:34953 E:34965 ||| RB
exciting  ||| S:34965 E:34974 ||| VB
each  ||| S:34974 E:34979 ||| DT
fluorophore  ||| S:34979 E:34991 ||| NN
and  ||| S:34991 E:34995 ||| CC
capturing  ||| S:34995 E:35015 ||| VBG
fluorescence  ||| S:35015 E:35028 ||| JJ
emissions  ||| S:35028 E:35038 ||| NNS
specific  ||| S:35038 E:35047 ||| JJ
for  ||| S:35047 E:35051 ||| IN
each  ||| S:35051 E:35056 ||| DT
fluorophore  ||| S:35056 E:35078 ||| NN
using  ||| S:35078 E:35084 ||| VBG
appropriate  ||| S:35084 E:35096 ||| JJ
excitation  ||| S:35096 E:35107 ||| NN
and  ||| S:35107 E:35111 ||| CC
emission  ||| S:35111 E:35120 ||| JJ
filter  ||| S:35120 E:35127 ||| NN
sets  ||| S:35127 E:35142 ||| NNS
( ||| S:35142 E:35143 ||| -LRB-
Chroma  ||| S:35143 E:35150 ||| NNP
Technology  ||| S:35150 E:35161 ||| NNP
Corporation ||| S:35161 E:35172 ||| NNP
,  ||| S:35172 E:35174 ||| ,
Brattelboro ||| S:35174 E:35185 ||| NNP
,  ||| S:35185 E:35187 ||| ,
VT ||| S:35187 E:35189 ||| NNP
)  ||| S:35189 E:35191 ||| -RRB-
[  ||| S:35191 E:35193 ||| -LRB-
45  ||| S:35193 E:35196 ||| CD
]  ||| S:35196 E:35198 ||| -RRB-
.  ||| S:35198 E:35210 ||| .
The  ||| S:35210 E:35214 ||| DT
images  ||| S:35214 E:35221 ||| NNS
shown  ||| S:35221 E:35227 ||| VBN
in  ||| S:35227 E:35230 ||| IN
Fig.  ||| S:35230 E:35235 ||| NNP
5were  ||| S:35235 E:35241 ||| NNP
acquired  ||| S:35241 E:35250 ||| VBD
using  ||| S:35250 E:35256 ||| VBG
an  ||| S:35256 E:35259 ||| DT
Olympus  ||| S:35259 E:35277 ||| NNP
40X  ||| S:35277 E:35281 ||| NNP
PlanApochromat  ||| S:35281 E:35296 ||| NNP
( ||| S:35296 E:35297 ||| -LRB-
0.95  ||| S:35297 E:35302 ||| CD
numerical  ||| S:35302 E:35312 ||| CD
aperture ||| S:35312 E:35320 ||| CD
)  ||| S:35320 E:35322 ||| -RRB-
objective  ||| S:35322 E:35332 ||| NN
on  ||| S:35332 E:35345 ||| IN
an  ||| S:35345 E:35348 ||| DT
Olympus  ||| S:35348 E:35356 ||| NNP
IX-70  ||| S:35356 E:35362 ||| NNP
microscope ||| S:35362 E:35372 ||| NN
.  ||| S:35372 E:35374 ||| .
Metamorph  ||| S:35374 E:35384 ||| JJ
acquisition  ||| S:35384 E:35406 ||| NN
software  ||| S:35406 E:35415 ||| NN
( ||| S:35415 E:35416 ||| -LRB-
Universal  ||| S:35416 E:35426 ||| NNP
Imaging  ||| S:35426 E:35434 ||| NNP
Corporation ||| S:35434 E:35445 ||| NNP
,  ||| S:35445 E:35447 ||| ,
Downingtown ||| S:35447 E:35458 ||| NNP
,  ||| S:35458 E:35460 ||| ,
PA ||| S:35460 E:35462 ||| NNP
)  ||| S:35462 E:35474 ||| -RRB-
on  ||| S:35474 E:35477 ||| IN
an  ||| S:35477 E:35480 ||| DT
Orca  ||| S:35480 E:35485 ||| NNP
cooled  ||| S:35485 E:35492 ||| VBD
interline  ||| S:35492 E:35502 ||| JJ
camera  ||| S:35502 E:35509 ||| NN
( ||| S:35509 E:35510 ||| -LRB-
Hamamatsu ||| S:35510 E:35519 ||| NNP
,  ||| S:35519 E:35531 ||| ,
Bridgewater ||| S:35531 E:35542 ||| NNP
,  ||| S:35542 E:35544 ||| ,
NJ ||| S:35544 E:35546 ||| NNP
)  ||| S:35546 E:35548 ||| -RRB-
were  ||| S:35548 E:35553 ||| VBD
used  ||| S:35553 E:35558 ||| VBN
to  ||| S:35558 E:35561 ||| TO
collect  ||| S:35561 E:35569 ||| VB
the  ||| S:35569 E:35573 ||| DT
images ||| S:35573 E:35579 ||| NNS
.  ||| S:35579 E:35609 ||| .
Post-transfection  ||| S:35609 E:35627 ||| NNP
Cell  ||| S:35627 E:35632 ||| NNP
Synchronization  ||| S:35632 E:35658 ||| NNP
The  ||| S:35658 E:35662 ||| DT
C ||| S:35662 E:35663 ||| $
/ ||| S:35663 E:35664 ||| CD
EBPα  ||| S:35664 E:35669 ||| JJ
fusion  ||| S:35669 E:35676 ||| NN
proteins  ||| S:35676 E:35685 ||| NNS
were  ||| S:35685 E:35690 ||| VBD
expressed  ||| S:35690 E:35700 ||| VBN
for  ||| S:35700 E:35704 ||| IN
one  ||| S:35704 E:35708 ||| CD
day  ||| S:35708 E:35722 ||| NN
following  ||| S:35722 E:35732 ||| VBG
transfection ||| S:35732 E:35744 ||| NN
,  ||| S:35744 E:35746 ||| ,
after  ||| S:35746 E:35752 ||| IN
which  ||| S:35752 E:35758 ||| WDT
we  ||| S:35758 E:35761 ||| PRP
added  ||| S:35761 E:35767 ||| VBD
to  ||| S:35767 E:35770 ||| TO
the  ||| S:35770 E:35774 ||| DT
cell  ||| S:35774 E:35789 ||| NN
culture  ||| S:35789 E:35797 ||| NN
media  ||| S:35797 E:35803 ||| NNS
100  ||| S:35803 E:35807 ||| CD
ng ||| S:35807 E:35809 ||| FW
/ ||| S:35809 E:35810 ||| FW
ml  ||| S:35810 E:35813 ||| FW
nocodazole  ||| S:35813 E:35824 ||| FW
( ||| S:35824 E:35825 ||| -LRB-
Sigma ||| S:35825 E:35830 ||| NNP
)  ||| S:35830 E:35832 ||| -RRB-
in  ||| S:35832 E:35845 ||| IN
dimethylsulphoxide  ||| S:35845 E:35864 ||| NNS
( ||| S:35864 E:35865 ||| -LRB-
DMSO ||| S:35865 E:35869 ||| NNP
) ||| S:35869 E:35870 ||| -RRB-
,  ||| S:35870 E:35872 ||| ,
0.5  ||| S:35872 E:35876 ||| CD
mM  ||| S:35876 E:35879 ||| JJ
mimosine  ||| S:35879 E:35888 ||| NNS
( ||| S:35888 E:35889 ||| -LRB-
Sigma ||| S:35889 E:35894 ||| NNP
)  ||| S:35894 E:35896 ||| -RRB-
in  ||| S:35896 E:35909 ||| IN
DMSO ||| S:35909 E:35913 ||| NNP
,  ||| S:35913 E:35915 ||| ,
or  ||| S:35915 E:35918 ||| CC
DMSO  ||| S:35918 E:35923 ||| NNP
vehicle ||| S:35923 E:35930 ||| NN
.  ||| S:35930 E:35932 ||| .
In  ||| S:35932 E:35935 ||| IN
some  ||| S:35935 E:35940 ||| DT
experiments ||| S:35940 E:35951 ||| NNS
,  ||| S:35951 E:35953 ||| ,
cells  ||| S:35953 E:35959 ||| NNS
were  ||| S:35959 E:35974 ||| VBD
also  ||| S:35974 E:35979 ||| RB
grown  ||| S:35979 E:35985 ||| VBN
for  ||| S:35985 E:35989 ||| IN
48  ||| S:35989 E:35992 ||| CD
and  ||| S:35992 E:35996 ||| CC
72  ||| S:35996 E:35999 ||| CD
hours  ||| S:35999 E:36005 ||| NNS
post-transfection  ||| S:36005 E:36023 ||| JJ
before  ||| S:36023 E:36040 ||| IN
applying  ||| S:36040 E:36049 ||| VBG
nocodazole  ||| S:36049 E:36060 ||| NNS
( ||| S:36060 E:36061 ||| -LRB-
data  ||| S:36061 E:36066 ||| NNS
not  ||| S:36066 E:36070 ||| RB
shown ||| S:36070 E:36075 ||| VBN
) ||| S:36075 E:36076 ||| -RRB-
.  ||| S:36076 E:36078 ||| .
The  ||| S:36078 E:36082 ||| DT
distributions  ||| S:36082 E:36106 ||| NNS
of  ||| S:36106 E:36109 ||| IN
cells  ||| S:36109 E:36115 ||| NNS
in  ||| S:36115 E:36118 ||| IN
G1 ||| S:36118 E:36120 ||| NNP
,  ||| S:36120 E:36122 ||| ,
S  ||| S:36122 E:36124 ||| NNP
and  ||| S:36124 E:36128 ||| CC
G2 ||| S:36128 E:36130 ||| NNP
/ ||| S:36130 E:36131 ||| NNP
M ||| S:36131 E:36132 ||| NNP
,  ||| S:36132 E:36134 ||| ,
in  ||| S:36134 E:36137 ||| IN
the  ||| S:36137 E:36141 ||| DT
presence  ||| S:36141 E:36150 ||| NN
or  ||| S:36150 E:36153 ||| CC
absence  ||| S:36153 E:36161 ||| NN
of  ||| S:36161 E:36174 ||| IN
C ||| S:36174 E:36175 ||| $
/ ||| S:36175 E:36176 ||| CD
EBPα  ||| S:36176 E:36181 ||| JJ
expression ||| S:36181 E:36191 ||| NN
,  ||| S:36191 E:36193 ||| ,
were  ||| S:36193 E:36198 ||| VBD
similar  ||| S:36198 E:36206 ||| JJ
for  ||| S:36206 E:36210 ||| IN
cells  ||| S:36210 E:36216 ||| NNS
grown  ||| S:36216 E:36222 ||| VBN
for  ||| S:36222 E:36226 ||| IN
24  ||| S:36226 E:36239 ||| CD
( ||| S:36239 E:36240 ||| -LRB-
reported  ||| S:36240 E:36249 ||| VBN
here ||| S:36249 E:36253 ||| RB
) ||| S:36253 E:36254 ||| -RRB-
,  ||| S:36254 E:36256 ||| ,
48  ||| S:36256 E:36259 ||| CD
or  ||| S:36259 E:36262 ||| CC
72  ||| S:36262 E:36265 ||| CD
hours  ||| S:36265 E:36271 ||| NNS
( ||| S:36271 E:36272 ||| -LRB-
data  ||| S:36272 E:36277 ||| NNS
not  ||| S:36277 E:36281 ||| RB
shown ||| S:36281 E:36286 ||| VBN
)  ||| S:36286 E:36288 ||| -RRB-
prior  ||| S:36288 E:36294 ||| RB
to  ||| S:36294 E:36307 ||| TO
nocodazole  ||| S:36307 E:36318 ||| VB
addition ||| S:36318 E:36326 ||| NN
.  ||| S:36326 E:36328 ||| .
Following  ||| S:36328 E:36338 ||| VBG
nocodazole ||| S:36338 E:36348 ||| NN
,  ||| S:36348 E:36350 ||| ,
mimosine  ||| S:36350 E:36359 ||| NN
or  ||| S:36359 E:36372 ||| CC
DMSO  ||| S:36372 E:36377 ||| NNP
addition ||| S:36377 E:36385 ||| NN
,  ||| S:36385 E:36387 ||| ,
the  ||| S:36387 E:36391 ||| DT
transfected  ||| S:36391 E:36403 ||| JJ
GHFT1-5  ||| S:36403 E:36411 ||| CD
cells  ||| S:36411 E:36417 ||| NNS
continued  ||| S:36417 E:36427 ||| VBD
to  ||| S:36427 E:36440 ||| TO
be  ||| S:36440 E:36443 ||| VB
cultivated  ||| S:36443 E:36454 ||| VBN
at  ||| S:36454 E:36457 ||| IN
33°C ||| S:36457 E:36461 ||| CD
.  ||| S:36461 E:36491 ||| .
Flow  ||| S:36491 E:36496 ||| NNP
Cytometry  ||| S:36496 E:36516 ||| NNP
24  ||| S:36516 E:36519 ||| CD
hours  ||| S:36519 E:36525 ||| NNS
after  ||| S:36525 E:36531 ||| IN
drug  ||| S:36531 E:36536 ||| NN
or  ||| S:36536 E:36539 ||| CC
vehicle  ||| S:36539 E:36547 ||| NN
treatment ||| S:36547 E:36556 ||| NN
,  ||| S:36556 E:36558 ||| ,
transfected  ||| S:36558 E:36580 ||| JJ
cells  ||| S:36580 E:36586 ||| NNS
were  ||| S:36586 E:36591 ||| VBD
trypsinized ||| S:36591 E:36602 ||| CD
,  ||| S:36602 E:36604 ||| ,
collected  ||| S:36604 E:36614 ||| VBN
in  ||| S:36614 E:36617 ||| IN
DME-H21  ||| S:36617 E:36625 ||| CD
media  ||| S:36625 E:36641 ||| NNS
containing  ||| S:36641 E:36652 ||| VBG
10 ||| S:36652 E:36654 ||| CD
%  ||| S:36654 E:36656 ||| NN
fetal  ||| S:36656 E:36662 ||| JJ
calf  ||| S:36662 E:36667 ||| JJ
serum ||| S:36667 E:36672 ||| NN
,  ||| S:36672 E:36674 ||| ,
and  ||| S:36674 E:36678 ||| CC
washed  ||| S:36678 E:36685 ||| VBD
twice  ||| S:36685 E:36691 ||| RB
with  ||| S:36691 E:36706 ||| IN
PBS ||| S:36706 E:36709 ||| NNP
.  ||| S:36709 E:36711 ||| .
The  ||| S:36711 E:36715 ||| DT
harvested  ||| S:36715 E:36725 ||| JJ
cells  ||| S:36725 E:36731 ||| NNS
( ||| S:36731 E:36732 ||| -LRB-
typically  ||| S:36732 E:36742 ||| RB
5  ||| S:36742 E:36744 ||| CD
×  ||| S:36744 E:36746 ||| CD
10  ||| S:36746 E:36749 ||| CD
6to  ||| S:36749 E:36753 ||| CD
1  ||| S:36753 E:36755 ||| CD
×  ||| S:36755 E:36757 ||| CD
10  ||| S:36757 E:36770 ||| CD
7cells ||| S:36770 E:36776 ||| CD
)  ||| S:36776 E:36778 ||| -RRB-
were  ||| S:36778 E:36783 ||| VBD
resuspended  ||| S:36783 E:36795 ||| VBN
in  ||| S:36795 E:36798 ||| IN
300  ||| S:36798 E:36802 ||| CD
μl  ||| S:36802 E:36805 ||| NN
of  ||| S:36805 E:36808 ||| IN
8  ||| S:36808 E:36810 ||| CD
μg ||| S:36810 E:36812 ||| FW
/ ||| S:36812 E:36813 ||| FW
ml  ||| S:36813 E:36816 ||| FW
propidium  ||| S:36816 E:36836 ||| FW
iodide  ||| S:36836 E:36843 ||| FW
( ||| S:36843 E:36844 ||| -LRB-
Molecular  ||| S:36844 E:36854 ||| NNP
Probes ||| S:36854 E:36860 ||| NNP
)  ||| S:36860 E:36862 ||| -RRB-
in  ||| S:36862 E:36865 ||| IN
PBS  ||| S:36865 E:36869 ||| NNP
containing  ||| S:36869 E:36880 ||| VBG
0.1 ||| S:36880 E:36883 ||| CD
%  ||| S:36883 E:36885 ||| NN
NP-40  ||| S:36885 E:36901 ||| NN
and  ||| S:36901 E:36905 ||| CC
10  ||| S:36905 E:36908 ||| CD
μg ||| S:36908 E:36910 ||| CD
/ ||| S:36910 E:36911 ||| CD
ml  ||| S:36911 E:36914 ||| CD
RNAse  ||| S:36914 E:36920 ||| JJ
A ||| S:36920 E:36921 ||| NN
,  ||| S:36921 E:36923 ||| ,
then  ||| S:36923 E:36928 ||| RB
incubated  ||| S:36928 E:36938 ||| VBN
at  ||| S:36938 E:36941 ||| IN
room  ||| S:36941 E:36946 ||| NN
temperature  ||| S:36946 E:36968 ||| NN
in  ||| S:36968 E:36971 ||| IN
the  ||| S:36971 E:36975 ||| DT
dark  ||| S:36975 E:36980 ||| NN
for  ||| S:36980 E:36984 ||| IN
30  ||| S:36984 E:36987 ||| CD
minutes ||| S:36987 E:36994 ||| NNS
.  ||| S:36994 E:36996 ||| .
The  ||| S:36996 E:37000 ||| DT
cell  ||| S:37000 E:37005 ||| NN
suspension  ||| S:37005 E:37016 ||| NN
was  ||| S:37016 E:37020 ||| VBD
then  ||| S:37020 E:37035 ||| RB
analyzed  ||| S:37035 E:37044 ||| VBN
on  ||| S:37044 E:37047 ||| IN
a  ||| S:37047 E:37049 ||| DT
FACScan  ||| S:37049 E:37057 ||| JJ
flow  ||| S:37057 E:37062 ||| NN
cytometer  ||| S:37062 E:37072 ||| NNS
( ||| S:37072 E:37073 ||| -LRB-
Becton  ||| S:37073 E:37080 ||| NNP
Dickinson ||| S:37080 E:37089 ||| NNP
)  ||| S:37089 E:37101 ||| -RRB-
at  ||| S:37101 E:37104 ||| IN
a  ||| S:37104 E:37106 ||| DT
flow  ||| S:37106 E:37111 ||| NN
rate  ||| S:37111 E:37116 ||| NN
of  ||| S:37116 E:37119 ||| IN
12  ||| S:37119 E:37122 ||| CD
μl ||| S:37122 E:37124 ||| CD
/ ||| S:37124 E:37125 ||| CD
min ||| S:37125 E:37128 ||| NNS
.  ||| S:37128 E:37130 ||| .
Fluorescence  ||| S:37130 E:37143 ||| NNP
of  ||| S:37143 E:37146 ||| IN
the  ||| S:37146 E:37150 ||| DT
GFP  ||| S:37150 E:37154 ||| NNP
and  ||| S:37154 E:37168 ||| CC
propidium  ||| S:37168 E:37178 ||| JJ
iodide-bound  ||| S:37178 E:37191 ||| JJ
DNA  ||| S:37191 E:37195 ||| NN
was  ||| S:37195 E:37199 ||| VBD
excited  ||| S:37199 E:37207 ||| VBN
with  ||| S:37207 E:37212 ||| IN
a  ||| S:37212 E:37214 ||| DT
488  ||| S:37214 E:37218 ||| CD
nm  ||| S:37218 E:37231 ||| CD
argon-ion  ||| S:37231 E:37241 ||| JJ
laser ||| S:37241 E:37246 ||| NN
.  ||| S:37246 E:37248 ||| .
Green  ||| S:37248 E:37254 ||| NNP
GFP  ||| S:37254 E:37258 ||| NNP
fluorescence  ||| S:37258 E:37271 ||| NN
was  ||| S:37271 E:37275 ||| VBD
collected  ||| S:37275 E:37295 ||| VBN
using  ||| S:37295 E:37301 ||| VBG
a  ||| S:37301 E:37303 ||| DT
530 ||| S:37303 E:37306 ||| CD
/ ||| S:37306 E:37307 ||| CD
30-nm  ||| S:37307 E:37313 ||| CD
band  ||| S:37313 E:37318 ||| NN
pass  ||| S:37318 E:37323 ||| NN
filter ||| S:37323 E:37329 ||| NN
,  ||| S:37329 E:37331 ||| ,
and  ||| S:37331 E:37335 ||| CC
orange  ||| S:37335 E:37342 ||| JJ
emission  ||| S:37342 E:37361 ||| NN
from  ||| S:37361 E:37366 ||| IN
propidium  ||| S:37366 E:37376 ||| JJ
iodide-bound  ||| S:37376 E:37389 ||| JJ
DNA  ||| S:37389 E:37393 ||| NN
was  ||| S:37393 E:37397 ||| VBD
detected  ||| S:37397 E:37406 ||| VBN
using  ||| S:37406 E:37412 ||| VBG
a  ||| S:37412 E:37424 ||| DT
585 ||| S:37424 E:37427 ||| CD
/ ||| S:37427 E:37428 ||| CD
42-nm  ||| S:37428 E:37434 ||| CD
band  ||| S:37434 E:37439 ||| NN
pass  ||| S:37439 E:37444 ||| NN
filter ||| S:37444 E:37450 ||| NN
.  ||| S:37450 E:37452 ||| .
Photomultiplier  ||| S:37452 E:37468 ||| JJ
tube  ||| S:37468 E:37473 ||| NN
voltage  ||| S:37473 E:37491 ||| NNS
and  ||| S:37491 E:37495 ||| CC
spectral  ||| S:37495 E:37504 ||| JJ
compensation  ||| S:37504 E:37517 ||| NN
were  ||| S:37517 E:37522 ||| VBD
initially  ||| S:37522 E:37532 ||| RB
set  ||| S:37532 E:37536 ||| VBN
using  ||| S:37536 E:37552 ||| VBG
single-stained  ||| S:37552 E:37567 ||| JJ
cells  ||| S:37567 E:37573 ||| NNS
( ||| S:37573 E:37574 ||| -LRB-
cells  ||| S:37574 E:37580 ||| FW
expressing  ||| S:37580 E:37591 ||| FW
GFP  ||| S:37591 E:37595 ||| FW
fusions  ||| S:37595 E:37603 ||| FW
with  ||| S:37603 E:37618 ||| IN
C ||| S:37618 E:37619 ||| NNP
/ ||| S:37619 E:37620 ||| NNP
EBPα  ||| S:37620 E:37625 ||| NNP
but  ||| S:37625 E:37629 ||| CC
not  ||| S:37629 E:37633 ||| RB
stained  ||| S:37633 E:37641 ||| VBN
with  ||| S:37641 E:37646 ||| IN
propidium  ||| S:37646 E:37656 ||| JJ
iodide  ||| S:37656 E:37663 ||| NN
and  ||| S:37663 E:37667 ||| CC
cells  ||| S:37667 E:37683 ||| NNS
transfected  ||| S:37683 E:37695 ||| VBN
with  ||| S:37695 E:37700 ||| IN
the  ||| S:37700 E:37704 ||| DT
control  ||| S:37704 E:37712 ||| NN
vector  ||| S:37712 E:37719 ||| NN
containing  ||| S:37719 E:37730 ||| VBG
no  ||| S:37730 E:37733 ||| DT
GFP  ||| S:37733 E:37747 ||| NNP
cDNA  ||| S:37747 E:37752 ||| NNP
but  ||| S:37752 E:37756 ||| CC
stained  ||| S:37756 E:37764 ||| NN
with  ||| S:37764 E:37769 ||| IN
propidium  ||| S:37769 E:37779 ||| JJ
iodide ||| S:37779 E:37785 ||| NN
) ||| S:37785 E:37786 ||| -RRB-
.  ||| S:37786 E:37788 ||| .
Electronic  ||| S:37788 E:37809 ||| JJ
compensation  ||| S:37809 E:37822 ||| NN
was  ||| S:37822 E:37826 ||| VBD
adjusted  ||| S:37826 E:37835 ||| VBN
among  ||| S:37835 E:37841 ||| IN
the  ||| S:37841 E:37845 ||| DT
fluorescence  ||| S:37845 E:37858 ||| JJ
channels  ||| S:37858 E:37877 ||| NNS
to  ||| S:37877 E:37880 ||| TO
remove  ||| S:37880 E:37887 ||| VB
residual  ||| S:37887 E:37896 ||| JJ
spectral  ||| S:37896 E:37905 ||| JJ
overlap ||| S:37905 E:37912 ||| NN
.  ||| S:37912 E:37914 ||| .
The  ||| S:37914 E:37918 ||| DT
area  ||| S:37918 E:37923 ||| NN
and  ||| S:37923 E:37927 ||| CC
width  ||| S:37927 E:37943 ||| NN
of  ||| S:37943 E:37946 ||| IN
each  ||| S:37946 E:37951 ||| DT
event  ||| S:37951 E:37957 ||| NN
were  ||| S:37957 E:37962 ||| VBD
measured  ||| S:37962 E:37971 ||| VBN
to  ||| S:37971 E:37974 ||| TO
discriminate  ||| S:37974 E:37987 ||| VB
intact  ||| S:37987 E:37994 ||| JJ
single  ||| S:37994 E:38011 ||| JJ
cells  ||| S:38011 E:38017 ||| NNS
from  ||| S:38017 E:38022 ||| IN
debris  ||| S:38022 E:38029 ||| NN
and  ||| S:38029 E:38033 ||| CC
from  ||| S:38033 E:38038 ||| IN
doublet  ||| S:38038 E:38046 ||| NN
or  ||| S:38046 E:38049 ||| CC
multiple  ||| S:38049 E:38058 ||| JJ
cells  ||| S:38058 E:38074 ||| NNS
stuck  ||| S:38074 E:38080 ||| VBD
together ||| S:38080 E:38088 ||| RB
.  ||| S:38088 E:38090 ||| .
GFP  ||| S:38090 E:38094 ||| NNP
fluorescence  ||| S:38094 E:38107 ||| NN
and  ||| S:38107 E:38111 ||| CC
propidium  ||| S:38111 E:38131 ||| JJ
iodide-stained  ||| S:38131 E:38146 ||| JJ
DNA  ||| S:38146 E:38150 ||| NN
fluorescence  ||| S:38150 E:38163 ||| NNS
was  ||| S:38163 E:38167 ||| VBD
thus  ||| S:38167 E:38172 ||| RB
collected  ||| S:38172 E:38182 ||| VBN
from  ||| S:38182 E:38197 ||| IN
single  ||| S:38197 E:38204 ||| JJ
cells ||| S:38204 E:38209 ||| NNS
.  ||| S:38209 E:38211 ||| .
A  ||| S:38211 E:38213 ||| DT
minimum  ||| S:38213 E:38221 ||| NN
of  ||| S:38221 E:38224 ||| IN
10,000  ||| S:38224 E:38231 ||| CD
cellular  ||| S:38231 E:38240 ||| JJ
events  ||| S:38240 E:38247 ||| NNS
was  ||| S:38247 E:38261 ||| VBD
collected  ||| S:38261 E:38271 ||| VBN
for  ||| S:38271 E:38275 ||| IN
each  ||| S:38275 E:38280 ||| DT
sample ||| S:38280 E:38286 ||| NN
.  ||| S:38286 E:38288 ||| .
Data  ||| S:38288 E:38293 ||| NNP
was  ||| S:38293 E:38297 ||| VBD
analyzed  ||| S:38297 E:38306 ||| VBN
using  ||| S:38306 E:38322 ||| VBG
CELLQuest  ||| S:38322 E:38332 ||| JJ
software  ||| S:38332 E:38341 ||| NN
( ||| S:38341 E:38342 ||| -LRB-
Becton  ||| S:38342 E:38349 ||| NNP
Dickenson ||| S:38349 E:38358 ||| NNP
) ||| S:38358 E:38359 ||| -RRB-
,  ||| S:38359 E:38361 ||| ,
and  ||| S:38361 E:38365 ||| CC
cell  ||| S:38365 E:38370 ||| NN
cycle  ||| S:38370 E:38386 ||| NN
subset  ||| S:38386 E:38393 ||| NN
analyses  ||| S:38393 E:38402 ||| NNS
of  ||| S:38402 E:38405 ||| IN
DNA  ||| S:38405 E:38409 ||| NNP
histograms  ||| S:38409 E:38420 ||| NN
were  ||| S:38420 E:38425 ||| VBD
performed  ||| S:38425 E:38435 ||| VBN
using  ||| S:38435 E:38451 ||| VBG
ModFitLT™  ||| S:38451 E:38461 ||| CD
software  ||| S:38461 E:38470 ||| NN
( ||| S:38470 E:38471 ||| -LRB-
Verity  ||| S:38471 E:38478 ||| NNP
Software  ||| S:38478 E:38487 ||| NNP
House ||| S:38487 E:38492 ||| NNP
,  ||| S:38492 E:38494 ||| ,
Topsham ||| S:38494 E:38501 ||| NNP
,  ||| S:38501 E:38513 ||| ,
ME ||| S:38513 E:38515 ||| NNP
) ||| S:38515 E:38516 ||| -RRB-
.  ||| S:38516 E:38546 ||| .
Statistical  ||| S:38546 E:38558 ||| NNP
Analysis  ||| S:38558 E:38577 ||| NNP
One-way  ||| S:38577 E:38585 ||| JJ
analysis  ||| S:38585 E:38594 ||| NN
of  ||| S:38594 E:38597 ||| IN
variance  ||| S:38597 E:38606 ||| NN
was  ||| S:38606 E:38610 ||| VBD
used  ||| S:38610 E:38615 ||| VBN
to  ||| S:38615 E:38618 ||| TO
compare  ||| S:38618 E:38626 ||| VB
data  ||| S:38626 E:38641 ||| NNS
from  ||| S:38641 E:38646 ||| IN
multiple  ||| S:38646 E:38655 ||| JJ
independent  ||| S:38655 E:38667 ||| JJ
experiments ||| S:38667 E:38678 ||| NNS
.  ||| S:38678 E:38680 ||| .
Statistically  ||| S:38680 E:38704 ||| RB
significant  ||| S:38704 E:38716 ||| JJ
differences  ||| S:38716 E:38728 ||| NNS
( ||| S:38728 E:38729 ||| -LRB-
** ||| S:38729 E:38731 ||| NNP
,  ||| S:38731 E:38733 ||| ,
p  ||| S:38733 E:38735 ||| CD
< ||| S:38735 E:38737 ||| SYM
0.01 ||| S:38737 E:38741 ||| CD
;  ||| S:38741 E:38743 ||| :
* ||| S:38743 E:38744 ||| CD
,  ||| S:38744 E:38746 ||| ,
p  ||| S:38746 E:38748 ||| CD
< ||| S:38748 E:38750 ||| SYM
0.05  ||| S:38750 E:38765 ||| CD
compared  ||| S:38765 E:38774 ||| VBN
to  ||| S:38774 E:38777 ||| TO
the  ||| S:38777 E:38781 ||| DT
Sham-transfected  ||| S:38781 E:38798 ||| JJ
cells ||| S:38798 E:38803 ||| NNS
)  ||| S:38803 E:38805 ||| -RRB-
and  ||| S:38805 E:38809 ||| CC
experiment  ||| S:38809 E:38830 ||| NN
number  ||| S:38830 E:38837 ||| NN
are  ||| S:38837 E:38841 ||| VBP
indicated  ||| S:38841 E:38851 ||| VBN
in  ||| S:38851 E:38854 ||| IN
the  ||| S:38854 E:38858 ||| DT
figures  ||| S:38858 E:38866 ||| NNS
and  ||| S:38866 E:38870 ||| CC
legends ||| S:38870 E:38877 ||| NN
.  ||| S:38877 E:38879 ||| .
All  ||| S:38879 E:38893 ||| DT
significant  ||| S:38893 E:38905 ||| JJ
differences  ||| S:38905 E:38917 ||| NNS
were  ||| S:38917 E:38922 ||| VBD
confirmed  ||| S:38922 E:38932 ||| VBN
by  ||| S:38932 E:38935 ||| IN
paired ||| S:38935 E:38941 ||| NN
,  ||| S:38941 E:38953 ||| ,
one-tailed  ||| S:38953 E:38964 ||| JJ
t-tests ||| S:38964 E:38971 ||| NN
.  ||| S:38971 E:39005 ||| .
List  ||| S:39005 E:39010 ||| NN
of  ||| S:39010 E:39013 ||| IN
abbreviations  ||| S:39013 E:39035 ||| JJ
C ||| S:39035 E:39036 ||| NNP
/ ||| S:39036 E:39037 ||| NNP
EBPα  ||| S:39037 E:39042 ||| NNP
CCAAT ||| S:39042 E:39047 ||| NNP
/ ||| S:39047 E:39048 ||| NNP
Enhancer  ||| S:39048 E:39057 ||| NNP
Binding  ||| S:39057 E:39065 ||| NNP
Protein  ||| S:39065 E:39073 ||| NNP
alpha  ||| S:39073 E:39087 ||| VBD
G1  ||| S:39087 E:39090 ||| CD
Growth  ||| S:39090 E:39097 ||| NN
phase  ||| S:39097 E:39103 ||| NN
1  ||| S:39103 E:39105 ||| CD
of  ||| S:39105 E:39108 ||| IN
the  ||| S:39108 E:39112 ||| DT
cell  ||| S:39112 E:39117 ||| NN
cycle  ||| S:39117 E:39131 ||| NN
S  ||| S:39131 E:39133 ||| NNP
DNA  ||| S:39133 E:39137 ||| NNP
Synthesis  ||| S:39137 E:39147 ||| NNP
phase  ||| S:39147 E:39153 ||| NN
of  ||| S:39153 E:39156 ||| IN
the  ||| S:39156 E:39160 ||| DT
cell  ||| S:39160 E:39165 ||| NN
cycle  ||| S:39165 E:39179 ||| NN
G2  ||| S:39179 E:39182 ||| CD
Growth  ||| S:39182 E:39189 ||| NN
phase  ||| S:39189 E:39195 ||| NN
2  ||| S:39195 E:39197 ||| CD
of  ||| S:39197 E:39200 ||| IN
the  ||| S:39200 E:39204 ||| DT
cell  ||| S:39204 E:39209 ||| NN
cycle  ||| S:39209 E:39223 ||| NN
M  ||| S:39223 E:39225 ||| NNP
Mitsosis  ||| S:39225 E:39234 ||| NNP
phase  ||| S:39234 E:39240 ||| NN
of  ||| S:39240 E:39243 ||| IN
the  ||| S:39243 E:39247 ||| DT
cell  ||| S:39247 E:39252 ||| NN
cycle  ||| S:39252 E:39266 ||| NN
CDK  ||| S:39266 E:39270 ||| NNP
Cyclin-Dependent  ||| S:39270 E:39287 ||| NNP
Kinase  ||| S:39287 E:39302 ||| NNP
GFP  ||| S:39302 E:39306 ||| NNP
Green  ||| S:39306 E:39312 ||| NNP
Fluorescent  ||| S:39312 E:39324 ||| NNP
Protein  ||| S:39324 E:39340 ||| NNP
GFP-C ||| S:39340 E:39345 ||| NNP
/ ||| S:39345 E:39346 ||| NNP
EBPα  ||| S:39346 E:39351 ||| NNP
Fusion  ||| S:39351 E:39358 ||| NNP
protein  ||| S:39358 E:39366 ||| NN
with  ||| S:39366 E:39371 ||| IN
GFP  ||| S:39371 E:39375 ||| NNP
attached  ||| S:39375 E:39384 ||| VBD
to  ||| S:39384 E:39387 ||| TO
the  ||| S:39387 E:39391 ||| DT
amino  ||| S:39391 E:39405 ||| JJ
terminus  ||| S:39405 E:39414 ||| NN
of  ||| S:39414 E:39417 ||| IN
C ||| S:39417 E:39418 ||| NNP
/ ||| S:39418 E:39419 ||| NNP
EBPα  ||| S:39419 E:39432 ||| NNP
C ||| S:39432 E:39433 ||| NNP
/ ||| S:39433 E:39434 ||| NNP
EBPα-GFP  ||| S:39434 E:39443 ||| NNP
Fusion  ||| S:39443 E:39450 ||| NNP
protein  ||| S:39450 E:39458 ||| NN
with  ||| S:39458 E:39463 ||| IN
GFP  ||| S:39463 E:39467 ||| NNP
attached  ||| S:39467 E:39476 ||| VBD
to  ||| S:39476 E:39479 ||| TO
the  ||| S:39479 E:39491 ||| DT
carboxy  ||| S:39491 E:39499 ||| JJ
terminus  ||| S:39499 E:39508 ||| NN
of  ||| S:39508 E:39511 ||| IN
C ||| S:39511 E:39512 ||| NNP
/ ||| S:39512 E:39513 ||| NNP
EBPα  ||| S:39513 E:39526 ||| NNP
Δ  ||| S:39526 E:39528 ||| NNP
Symbol  ||| S:39528 E:39535 ||| NNP
signifying  ||| S:39535 E:39546 ||| FW
"deletion ||| S:39546 E:39555 ||| FW
"  ||| S:39555 E:39557 ||| ''
when  ||| S:39557 E:39562 ||| WRB
naming  ||| S:39562 E:39577 ||| VBG
constructs  ||| S:39577 E:39596 ||| JJ
LZ  ||| S:39596 E:39599 ||| NNP
Leucine  ||| S:39599 E:39607 ||| NNP
Zipper  ||| S:39607 E:39622 ||| NNP
DBD  ||| S:39622 E:39626 ||| NNP
DNA  ||| S:39626 E:39630 ||| NNP
Binding  ||| S:39630 E:39638 ||| NNP
Domain  ||| S:39638 E:39653 ||| NNP
DMSO  ||| S:39653 E:39658 ||| NNP
Dimethyl  ||| S:39658 E:39667 ||| NNP
Sulfoxide  ||| S:39667 E:39692 ||| NNPS
